Prof Michael Berk

The Impact of Posttraumatic Stress Disorder on Pharmacologic Intervention Outcomes for Adults With Bipolar Disorder: A Systematic Review

S Russell, A Wrobel, D Skvarc, B Kavanagh, M Ashton, O Dean, M Berk, A Turner

(2023), Vol. 26, pp. 61-69, The international journal of neuropsychopharmacology, C1

Metformin is Protective Against the Development of Mood Disorders

J Lake, C Bortolasci, A Stuart, J Pasco, S Kidnapillai, B Spolding, T Truong, B Panizzutti, Z Liu, O Dean, T Crowley, M Richardson, J Kim, M Berk, L Williams, K Walder

(2023), Vol. 56, pp. 25-31, Pharmacopsychiatry, Germany, C1

Interactive relationships of Type 2 diabetes and bipolar disorder with cognition: evidence of putative premature cognitive ageing in the UK Biobank Cohort

E Ringin, D Dunstan, R McIntyre, M Berk, N Owen, S Rossell, T Van Rheenen

(2023), Vol. 48, pp. 362-370, Neuropsychopharmacology, England, C1

The effect of depressive symptoms on disability-free survival in healthy older adults: A prospective cohort study

G Roebuck, M Lotfaliany, B Agustini, M Forbes, M Mohebbi, J McNeil, R Woods, C Reid, M Nelson, R Shah, J Ryan, A Newman, A Owen, R Freak-Poli, N Stocks, M Berk

(2023), Vol. 147, pp. 92-104, Acta Psychiatrica Scandinavica, United States, C1

Diagnostic accuracy for self-reported methamphetamine use versus oral fluid test as the reference standard in a methamphetamine-dependent intervention trial population

G Carter, M Spittal, L Glowacki, D Gerostamoulos, P Dietze, B Sinclair, S Arunogiri, M Berk, D Lubman, V Manning, P Higgs, B Quinn, A Baker, O Dean, A Turner, R McKetin

(2023), Vol. 118, pp. 470-479, Addiction, England, C1

Development of an integrated microperfusion-EEG electrode for unbiased multimodal sampling of brain interstitial fluid and concurrent neural activity

L Stangler, E Nicolai, F Mivalt, S Chang, I Kim, A Kouzani, K Bennet, M Berk, S Uthamaraj, T Burns, G Worrell, C Howe

(2023), Vol. 20, pp. 016010-016010, Journal of neural engineering, England, C1

In vivo white matter microstructure in adolescents with early-onset psychosis: a multi-site mega-analysis

C Barth, S Kelly, S Nerland, N Jahanshad, C Alloza, S Ambrogi, O Andreassen, D Andreou, C Arango, I Baeza, N Banaj, C Bearden, M Berk, H Bohman, J Castro-Fornieles, Y Chye, B Crespo-Facorro, E de la Serna, C Díaz-Caneja, T Gurholt, C Hegarty, A James, J Janssen, C Johannessen, E Jönsson, K Karlsgodt, P Kochunov, N Lois, M Lundberg, A Myhre, S Pascual-Diaz, F Piras, R Smelror, G Spalletta, T Stokkan, G Sugranyes, C Suo, S Thomopoulos, D Tordesillas-Gutiérrez, D Vecchio, K Wedervang-Resell, L Wortinger, P Thompson, I Agartz

(2023), Vol. 28, pp. 1159-1169, Molecular Psychiatry, Berlin, Germany, C1

Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response

A Walker, M Mohebbi, M Maes, M Berk, K Walder, C Bortolasci, Z Liu, C Ng, M Ashton, L Berk, A Singh, G Malhi, O Dean

(2023), Vol. 27, pp. 100581-100581, Brain, Behavior, and Immunity - Health, United States, C1

Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults

M Solmi, T Thompson, A Estradé, A Agorastos, J Radua, S Cortese, E Dragioti, F Leisch, D Vancampfort, L Thygesen, H Aschauer, M Schlögelhofer, E Aschauer, A Schneeberger, C Huber, G Hasler, P Conus, K Do Cuénod, R von Känel, G Arrondo, P Fusar-Poli, P Gorwood, P Llorca, M Krebs, E Scanferla, T Kishimoto, G Rabbani, K Skonieczna-Żydecka, P Brambilla, A Favaro, A Takamiya, L Zoccante, M Colizzi, J Bourgin, K Kamiński, M Moghadasin, S Seedat, E Matthews, J Wells, E Vassilopoulou, A Gadelha, K Su, J Kwon, M Kim, T Lee, O Papsuev, D Manková, A Boscutti, C Gerunda, D Saccon, E Righi, F Monaco, G Croatto, G Cereda, J Demurtas, N Brondino, N Veronese, P Enrico, P Politi, V Ciappolino, A Pfennig, A Bechdolf, A Meyer-Lindenberg, K Kahl, K Domschke, M Bauer, N Koutsouleris, S Winter, S Borgwardt, I Bitter, J Balazs, P Czobor, Z Unoka, D Mavridis, K Tsamakis, V Bozikas, C Tunvirachaisakul, M Maes, T Rungnirundorn, T Supasitthumrong, A Haque, A Brunoni, C Costardi, F Schuch, G Polanczyk, J Luiz, L Fonseca, L Aparicio, S Valvassori, M Nordentoft, P Vendsborg, S Hoffmann, J Sehli, N Sartorius, S Heuss, D Guinart, J Hamilton, J Kane, J Rubio, M Sand

(2023), Vol. 326, pp. 249-261, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Safety and feasibility of faecal microbiota transplant for major depressive disorder: study protocol for a pilot randomised controlled trial

Jessica Green, Amelia McGuinness, Michael Berk, David Castle, Eugene Athan, Christopher Hair, Philip Strandwitz, Amy Loughman, Andrew Nierenberg, John Cryan, Mohammadreza Mohebbi, Felice Jacka

(2023), Vol. 9, pp. 1-14, Pilot and Feasibility Studies, London, Eng., C1

Predictors of suicidal ideation severity among treatment-seeking young people with major depressive disorder: The role of state and trait anxiety

C Moller, P Badcock, S Hetrick, S Rice, M Berk, K Witt, A Chanen, O Dean, C Gao, S Cotton, C Davey

(2023), pp. 000486742211442-000486742211442, Australian and New Zealand Journal of Psychiatry, England, C1

A preliminary investigation of the clinical and cognitive correlates of circulating vitamin D in bipolar disorder

T Van Rheenen, E Ringin, J Karantonis, L Furlong, K Bozaoglu, S Rossell, M Berk, V Balanzá-Martínez

(2023), Vol. 320, pp. 115013-115013, Psychiatry Research, Ireland, C1

A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention

A Ratheesh, D Hett, J Ramain, E Wong, L Berk, P Conus, M Fristad, T Goldstein, M Hillegers, S Jauhar, L Kessing, D Miklowitz, G Murray, J Scott, M Tohen, L Yatham, A Young, M Berk, S Marwaha

(2023), Vol. 11, International Journal of Bipolar Disorders, Germany, C1-1

Paper Charts: A Continued Barrier to Psychiatric Care in the Midst of a Broken and Fragmented Mental Health System

E Frost, J Donlon, A Mitwally, G Magnani, S Tomlin, M Berk, M Koola

(2023), Vol. 211, pp. 1-4, Journal of Bone and Joint Surgery, United States, C1

Increased cortical surface area but not altered cortical thickness or gyrification in bipolar disorder following stabilisation from a first episode of mania

T Van Rheenen, S Cotton, O Dandash, R Cooper, E Ringin, R Daglas-Georgiou, K Allott, Y Chye, C Suo, C Macneil, M Hasty, K Hallam, P McGorry, A Fornito, M Yücel, C Pantelis, M Berk

(2023), Vol. 122, pp. 1-9, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1

Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial

Jessica Green, Michael Berk, Mohammadreza Mohebbi, Amy Loughman, Amelia McGuinness, David Castle, Mary Chatterton, Joahna Perez, Philip Strandwitz, Eugene Athan, Christopher Hair, Andrew Nierenberg, John Cryan, Felice Jacka

(2023), pp. 1-12, The Canadian Journal of Psychiatry, London, Eng., C1

Childhood trauma and depressive symptoms in bipolar disorder: a network analysis

Anna Wrobel, Sue Cotton, Anuradhi Jayasinghe, Claudia Diaz‐Byrd, Anastasia Yocum, Alyna Turner, Olivia Dean, Samantha Russell, Elizabeth Duval, Tobin Ehrlich, David Marshall, Michael Berk, Melvin McInnis

(2023), Vol. 147, pp. 286-300, Acta Psychiatrica Scandinavica, London, Eng., C1

Surf therapy for improving child and adolescent mental health: A pilot randomised control trial

L Olive, M Dober, C Mazza, A Turner, M Mohebbi, M Berk, R Telford

(2023), Vol. 65, pp. 102349-102349, Psychology of Sport and Exercise, C1

Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction

E Dragioti, J Radua, M Solmi, C Gosling, D Oliver, F Lascialfari, M Ahmed, S Cortese, A Estradé, G Arrondo, M Gouva, M Fornaro, A Batiridou, K Dimou, D Tsartsalis, A Carvalho, J Shin, M Berk, S Stringhini, C Correll, P Fusar-Poli

(2023), Vol. 22, pp. 86-104, World Psychiatry, Italy, C1

Effect of vitamin D supplementation on depression in older Australian adults

S Rahman, M Waterhouse, B Romero, C Baxter, D English, O Almeida, M Berk, P Ebeling, B Armstrong, D McLeod, G Hartel, R O’Connell, H Pham, J Scott, J van der Pols, A Venn, P Webb, D Whiteman, R Neale

(2023), Vol. 38, pp. e5847-, International Journal of Geriatric Psychiatry, England, C1

Correlates of Meal Skipping in Community Dwelling Older Adults: A Cross-Sectional Study

H Wild, D Gasevic, R Woods, J Ryan, M Berk, R Wolfe, J McNeil, A Owen

(2023), Vol. 27, pp. 159-165, Journal of Nutrition, Health and Aging, France, C1

High frequency deep brain stimulation can mitigate the acute effects of cocaine administration on tonic dopamine levels in the rat nucleus accumbens

Jason Yuen, Abhinav Goyal, Aaron Rusheen, Abbas Kouzani, Michael Berk, Jee Kim, Susannah Tye, Charles Blaha, Kevin Bennet, Kendall Lee, Hojin Shin, Yoonbae Oh

(2023), Vol. 17, pp. 1061578-, Frontiers in Neuroscience, Switzerland, C1

Treating addiction with deep brain stimulation: Ethical and legal considerations

C Lo, M Mane, J Kim, M Berk, R Sharp, K Lee, J Yuen

(2023), Vol. 113, pp. 103964-103964, International Journal of Drug Policy, Netherlands, C1

The Impact of N-acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial

Samantha Russell, David Skvarc, Mohammadreza Mohebbi, David Camfield, Linda Byrne, Alyna Turner, Melanie Ashton, Michael Berk, Seetal Dodd, Gin Malhi, Sue Cotton, Ashley Bush, Olivia Dean

(2023), Vol. 21, pp. 320-331, Clinical Psychopharmacology and Neuroscience, Seoul, Korea, C1-1

Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: systematic review and implications for clinical practice.

Daniel Dietch, Jess Kerr-Gaffney, Meghan Hockey, Wolfgang Marx, Anu Ruusunen, Allan Young, Michael Berk, Valeria Mondelli

(2023), Vol. 9, pp. 1-15, BJPsych Open, Cambridge, Eng., C1

What we learn about bipolar disorder from large-scale neuroimaging: Findings and future directions from the ENIGMA Bipolar Disorder Working Group

C Ching, D Hibar, T Gurholt, A Nunes, S Thomopoulos, C Abé, I Agartz, R Brouwer, D Cannon, S de Zwarte, L Eyler, P Favre, T Hajek, U Haukvik, J Houenou, M Landén, T Lett, C McDonald, L Nabulsi, Y Patel, M Pauling, T Paus, J Radua, M Soeiro-de-Souza, G Tronchin, N van Haren, E Vieta, H Walter, L Zeng, M Alda, J Almeida, D Alnæs, S Alonso-Lana, C Altimus, M Bauer, B Baune, C Bearden, M Bellani, F Benedetti, M Berk, A Bilderbeck, H Blumberg, E Bøen, I Bollettini, C del Mar Bonnin, P Brambilla, E Canales-Rodríguez, X Caseras, O Dandash, U Dannlowski, G Delvecchio, A Díaz-Zuluaga, D Dima, É Duchesnay, T Elvsåshagen, S Fears, S Frangou, J Fullerton, D Glahn, J Goikolea, M Green, D Grotegerd, O Gruber, B Haarman, C Henry, F Howells, V Ives-Deliperi, A Jansen, T Kircher, C Knöchel, B Kramer, B Lafer, C López-Jaramillo, R Machado-Vieira, B MacIntosh, E Melloni, P Mitchell, I Nenadic, F Nery, A Nugent, V Oertel, R Ophoff, M Ota, B Overs, D Pham, M Phillips, J Pineda-Zapata, S Poletti, M Polosan, E Pomarol-Clotet, A Pouchon, Y Quidé, M Rive, G Roberts, H Ruhe, R Salvador, S Sarró, T Satterthwaite, A Schene, K Sim

(2022), Vol. 43, pp. 56-82, Human Brain Mapping, United States, C1

Intracranial and subcortical volumes in adolescents with early-onset psychosis: A multisite mega-analysis from the ENIGMA consortium

T Gurholt, V Lonning, S Nerland, K Jørgensen, U Haukvik, C Alloza, C Arango, C Barth, C Bearden, M Berk, H Bohman, O Dandash, C Díaz-Caneja, C Edbom, T van Erp, A Fett, S Frangou, B Goldstein, A Grigorian, N Jahanshad, A James, J Janssen, C Johannessen, K Karlsgodt, M Kempton, P Kochunov, L Krabbendam, M Kyriakopoulos, M Lundberg, B MacIntosh, B Rund, R Smelror, A Sultan, C Tamnes, S Thomopoulos, A Vajdi, K Wedervang-Resell, A Myhre, O Andreassen, P Thompson, I Agartz

(2022), Vol. 43, pp. 373-384, Human Brain Mapping, United States, C1

In vivo hippocampal subfield volumes in bipolar disorder-A mega-analysis from The Enhancing Neuro Imaging Genetics through Meta-Analysis Bipolar Disorder Working Group

U Haukvik, T Gurholt, S Nerland, T Elvsåshagen, T Akudjedu, M Alda, D Alnæs, S Alonso-Lana, J Bauer, B Baune, F Benedetti, M Berk, F Bettella, E Bøen, C Bonnín, P Brambilla, E Canales-Rodríguez, D Cannon, X Caseras, O Dandash, U Dannlowski, G Delvecchio, A Díaz-Zuluaga, T van Erp, M Fatjó-Vilas, S Foley, K Förster, J Fullerton, J Goikolea, D Grotegerd, O Gruber, B Haarman, B Haatveit, T Hajek, B Hallahan, M Harris, E Hawkins, F Howells, C Hülsmann, N Jahanshad, K Jørgensen, T Kircher, B Krämer, A Krug, R Kuplicki, T Lagerberg, T Lancaster, R Lenroot, V Lonning, C López-Jaramillo, U Malt, C McDonald, A McIntosh, G McPhilemy, D van der Meer, I Melle, E Melloni, P Mitchell, L Nabulsi, I Nenadić, V Oertel, L Oldani, N Opel, M Otaduy, B Overs, J Pineda-Zapata, E Pomarol-Clotet, J Radua, L Rauer, R Redlich, J Repple, M Rive, G Roberts, H Ruhe, L Salminen, R Salvador, S Sarró, J Savitz, A Schene, K Sim, M Soeiro-de-Souza, M Stäblein, D Stein, F Stein, C Tamnes, H Temmingh, S Thomopoulos, D Veltman, E Vieta, L Waltemate, L Westlye, H Whalley, P Sämann, P Thompson, C Ching, O Andreassen, I Agartz

(2022), Vol. 43, pp. 385-398, Human Brain Mapping, United States, C1

Confirmatory evaluation of the bipolar depression rating scale (BDRS) in a large sample of female patients with bipolar depression

V Khosravani, M Berk, S Samimi Ardestani, F Sharifi Bastan

(2022), Vol. 26, pp. 85-91, International Journal of Psychiatry in Clinical Practice, England, C1

Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder

R Zazula, S Dodd, O Dean, M Berk, C Bortolasci, W Verri, H Vargas, S Nunes

(2022), Vol. 23, pp. 67-77, World Journal of Biological Psychiatry, England, C1

Disruption of circadian rhythm and risk of autism spectrum disorder: Role of immune-inflammatory, oxidative stress, metabolic and neurotransmitter pathways

F Abdul, N Sreenivas, J Kommu, M Banerjee, M Berk, M Maes, M Leboyer, M Debnath

(2022), Vol. 33, pp. 93-109, Reviews in the Neurosciences, Germany, C1

Biomarkers for Deep Brain Stimulation in Animal Models of Depression

J Yuen, A Rusheen, J Price, A Barath, H Shin, A Kouzani, M Berk, C Blaha, K Lee, Y Oh

(2022), Vol. 25, pp. 161-170, Neuromodulation, United States, C1

Social isolation, social support and loneliness as independent concepts, and their relationship with health-related quality of life among older women

R Freak-Poli, J Ryan, T Tran, A Owen, J McHugh Power, M Berk, N Stocks, D Gonzalez-Chica, J Lowthian, J Fisher, J Byles

(2022), Vol. 26, pp. 1335-1344, Aging and Mental Health, England, C1

Cognitive Profile and Relationship with Quality of Life and Psychosocial Functioning in Mood Disorders

R Zazula, M Mohebbi, S Dodd, O Dean, M Berk, H Vargas, S Nunes

(2022), Vol. 37, pp. 376-389, Archives of Clinical Neuropsychology, United States, C1

Lithium therapy and weight change in people with bipolar disorder: A systematic review and meta-analysis

S Gomes-da-Costa, W Marx, F Corponi, G Anmella, A Murru, M Pons-Cabrera, A Giménez-Palomo, F Gutiérrez-Arango, C Llach, G Fico, G Kotzalidis, N Verdolini, M Valentí, M Berk, E Vieta, I Pacchiarotti

(2022), Vol. 134, pp. 104266-104266, Neuroscience and Biobehavioral Reviews, United States, C1

Not in education, employment and training status in the early stages of bipolar I disorder with psychotic features

S Cotton, K Filia, M Lambert, M Berk, A Ratheesh, B Schimmelmann, C Macneil, M Hasty, P McGorry, P Conus

(2022), Vol. 16, pp. 609-617, Early Intervention in Psychiatry, Australia, C1

A protocol for the first episode psychosis outcome study (FEPOS): ≥15 year follow-up after treatment at the Early Psychosis Prevention and Intervention Centre, Melbourne, Australia

S Cotton, K Filia, A Watson, A Mackinnon, L Hides, J Gleeson, M Berk, P Conus, M Lambert, B Schimmelmann, H Herrman, V Rayner, A Ratheesh, P McGorry

(2022), Vol. 16, pp. 715-723, Early Intervention in Psychiatry, Australia, C1

The influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: A systematic review and meta-analysis

A Wrobel, A Jayasinghe, S Russell, W Marx, L Alameda, O Dean, S Cotton, M Berk, A Turner

(2022), Vol. 296, pp. 350-362, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Inflammation and depression in young people: a systematic review and proposed inflammatory pathways

Y Toenders, L Laskaris, C Davey, M Berk, Y Milaneschi, F Lamers, B Penninx, L Schmaal

(2022), Vol. 27, pp. 315-327, Molecular Psychiatry, England, C1

Results of the COVID-19 mental health international for the general population (COMET-G) study

K Fountoulakis, G Karakatsoulis, S Abraham, K Adorjan, H Ahmed, R Alarcón, K Arai, S Auwal, M Berk, S Bjedov, J Bobes, T Bobes-Bascaran, J Bourgin-Duchesnay, C Bredicean, L Bukelskis, A Burkadze, I Abud, R Castilla-Puentes, M Cetkovich, H Colon-Rivera, R Corral, C Cortez-Vergara, P Crepin, D De Berardis, S Zamora Delgado, D De Lucena, A De Sousa, R Stefano, S Dodd, L Elek, A Elissa, B Erdelyi-Hamza, G Erzin, M Etchevers, P Falkai, A Farcas, I Fedotov, V Filatova, N Fountoulakis, I Frankova, F Franza, P Frias, T Galako, C Garay, L Garcia-Álvarez, M García-Portilla, X Gonda, T Gondek, D González, H Gould, P Grandinetti, A Grau, V Groudeva, M Hagin, T Harada, T Hasan, N Hashim, J Hilbig, S Hossain, R Iakimova, M Ibrahim, F Iftene, Y Ignatenko, M Irarrazaval, Z Ismail, J Ismayilova, A Jakobs, M Jakovljević, N Jakšić, A Javed, H Kafali, S Karia, O Kazakova, D Khalifa, O Khaustova, S Koh, S Kopishinskaia, K Kosenko, S Koupidis, I Kovacs, B Kulig, A Lalljee, J Liewig, A Majid, E Malashonkova, K Malik, N Malik, G Mammadzada, B Mandalia, D Marazziti, D Marčinko, S Martinez, E Matiekus, G Mejia, R Memon, X Martínez, D Mickevičiūtė, R Milev, M Mohammed, A Molina-López

(2022), Vol. 54, pp. 21-40, European Neuropsychopharmacology, Amsterdam, The Netherlands, C1

The Australian Genetics of Depression Study: New Risk Loci and Dissecting Heterogeneity Between Subtypes

B Mitchell, A Campos, D Whiteman, C Olsen, S Gordon, A Walker, O Dean, M Berk, I Hickie, S Medland, N Wray, N Martin, E Byrne

(2022), Vol. 92, pp. 227-235, Biological Psychiatry, United States, C1

What not to use in bipolar disorders: A systematic review of non-recommended treatments in clinical practice guidelines

F Gomes, R Cerqueira, Y Lee, R Mansur, F Kapczinski, R McIntyre, L Yatham, M Berk, R Milev, E Brietzke

(2022), Vol. 298, pp. 565-576, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Does metabolic syndrome or its component factors alter the course of bipolar disorder? A systematic review

A Giménez-Palomo, S Gomes-da-Costa, S Dodd, I Pachiarotti, N Verdolini, E Vieta, M Berk

(2022), Vol. 132, pp. 142-153, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

Intertwined associations between oxidative and nitrosative stress and endocannabinoid system pathways: Relevance for neuropsychiatric disorders

G Morris, K Walder, M Berk, A Carvalho, W Marx, C Bortolasci, A Yung, B Puri, M Maes

(2022), Vol. 114, pp. 1-17, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1

The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis

M Fornaro, A Carvalho, M De Prisco, A Mondin, M Billeci, P Selby, F Iasevoli, M Berk, D Castle, A de Bartolomeis

(2022), Vol. 132, pp. 289-303, Neuroscience and Biobehavioral Reviews, Amsterfam, The Netherlands, C1

Longitudinal Structural Brain Changes in Bipolar Disorder: A Multicenter Neuroimaging Study of 1232 Individuals by the ENIGMA Bipolar Disorder Working Group

C Abé, C Ching, B Liberg, A Lebedev, I Agartz, T Akudjedu, M Alda, D Alnæs, S Alonso-Lana, F Benedetti, M Berk, E Bøen, C Bonnin, F Breuer, K Brosch, R Brouwer, E Canales-Rodríguez, D Cannon, Y Chye, A Dahl, O Dandash, U Dannlowski, K Dohm, T Elvsåshagen, L Fisch, J Fullerton, J Goikolea, D Grotegerd, B Haatveit, T Hahn, T Hajek, W Heindel, M Ingvar, K Sim, T Kircher, R Lenroot, U Malt, C McDonald, S McWhinney, I Melle, T Meller, E Melloni, P Mitchell, L Nabulsi, I Nenadić, N Opel, B Overs, F Panicalli, J Pfarr, S Poletti, E Pomarol-Clotet, J Radua, J Repple, K Ringwald, G Roberts, E Rodriguez-Cano, R Salvador, K Sarink, S Sarró, S Schmitt, F Stein, C Suo, S Thomopoulos, G Tronchin, E Vieta, L Westlye, A White, L Yatham, N Zak, P Thompson, O Andreassen, M Landén

(2022), Vol. 91, pp. 582-592, Biological Psychiatry, Amsterdam. The Netherlands, C1

Neurofilament light protein as a biomarker in depression and cognitive function

N Travica, M Berk, W Marx

(2022), Vol. 35, pp. 30-37, Current Opinion in Psychiatry, Philadelphia, Pa., C1

Attentional engagement and inhibitory control according to positive and negative symptoms in schizophrenia: An emotional antisaccade task

P Navalón, R Sahuquillo-Leal, A Moreno-Giménez, L Salmerón, P Benavent, P Sierra, Y Cañada, A Cañada-Martínez, M Berk, A García-Blanco

(2022), Vol. 239, pp. 142-150, Schizophrenia Research, Amsterdam, The Netherlands, C1

Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during Infection Times - Children and Adolescents (COH-FIT-C&A)

M Solmi, A Estradé, T Thompson, A Agorastos, J Radua, S Cortese, E Dragioti, F Leisch, D Vancampfort, L Thygesen, H Aschauer, M Schloegelhofer, E Akimova, A Schneeberger, C Huber, G Hasler, P Conus, K Cuénod, R von Känel, G Arrondo, P Fusar-Poli, P Gorwood, P Llorca, M Krebs, E Scanferla, T Kishimoto, G Rabbani, K Skonieczna-Żydecka, P Brambilla, A Favaro, A Takamiya, L Zoccante, M Colizzi, J Bourgin, K Kamiński, M Moghadasin, S Seedat, E Matthews, J Wells, E Vassilopoulou, A Gadelha, K Su, J Kwon, M Kim, T Lee, O Papsuev, D Manková, A Boscutti, C Gerunda, D Saccon, E Righi, F Monaco, G Croatto, G Cereda, J Demurtas, N Brondino, N Veronese, P Enrico, P Politi, V Ciappolino, A Pfennig, A Bechdolf, A Meyer-Lindenberg, K Kahl, K Domschke, M Bauer, N Koutsouleris, S Winter, S Borgwardt, I Bitter, J Balazs, P Czobor, Z Unoka, D Mavridis, K Tsamakis, V Bozikas, C Tunvirachaisakul, M Maes, T Rungnirundorn, T Supasitthumrong, A Haque, A Brunoni, C Costardi, F Schuch, G Polanczyk, J Luiz, L Fonseca, L Aparicio, S Valvassori, M Nordentoft, P Vendsborg, S Hoffmann, J Sehli, N Sartorius, S Heuss, D Guinart, J Hamilton, J Kane, J Rubio, M Sand, Wolf Marx

(2022), Vol. 299, pp. 367-376, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

The specific phenotype of depression in recent onset schizophrenia spectrum disorders: A symptom profile and network comparison to recent onset major depressive disorder without psychotic features

S Herniman, S Wood, S Cotton, K Allott, C Davey, M Berk, L Phillips, E Liemburg, S Castelein, W Veling, R Bruggeman, H Knegtering

(2022), Vol. 240, pp. 52-60, Schizophrenia Research, Amsterdam, The Netherlands, C1

The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic

M Solmi, A Estradé, T Thompson, A Agorastos, J Radua, S Cortese, E Dragioti, F Leisch, D Vancampfort, L Thygesen, H Aschauer, M Schloegelhofer, E Akimova, A Schneeberger, C Huber, G Hasler, P Conus, K Cuénod, R von Känel, G Arrondo, P Fusar-Poli, P Gorwood, P Llorca, M Krebs, E Scanferla, T Kishimoto, G Rabbani, K Skonieczna-Żydecka, P Brambilla, A Favaro, A Takamiya, L Zoccante, M Colizzi, J Bourgin, K Kamiński, M Moghadasin, S Seedat, E Matthews, J Wells, E Vassilopoulou, A Gadelha, K Su, J Kwon, M Kim, T Lee, O Papsuev, D Manková, A Boscutti, C Gerunda, D Saccon, E Righi, F Monaco, G Croatto, G Cereda, J Demurtas, N Brondino, N Veronese, P Enrico, P Politi, V Ciappolino, A Pfennig, A Bechdolf, A Meyer-Lindenberg, K Kahl, K Domschke, M Bauer, N Koutsouleris, S Winter, S Borgwardt, I Bitter, J Balazs, P Czobor, Z Unoka, D Mavridis, K Tsamakis, V Bozikas, C Tunvirachaisakul, M Maes, T Rungnirundorn, T Supasitthumrong, A Haque, A Brunoni, C Costardi, F Schuch, G Polanczyk, J Luiz, L Fonseca, L Aparicio, S Valvassori, M Nordentoft, P Vendsborg, S Hoffmann, J Sehli, N Sartorius, S Heuss, D Guinart, J Hamilton, J Kane, J Rubio, M Sand, Michael Berk

(2022), Vol. 299, pp. 393-407, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Cocaine increases stimulation-evoked serotonin efflux in the nucleus accumbens

J Yuen, A Goyal, A Rusheen, A Kouzani, M Berk, J Kim, S Tye, C Blaha, K Bennet, K Lee, Y Oh, H Shin

(2022), Vol. 127, pp. 714-724, Journal of neurophysiology, United States, C1

Biomarkers for Deep Brain Stimulation in Animal Models of Depression.

Jason Yuen, Aaron Rusheen, Joshua Price, Abhijeet Barath, Hojin Shin, Abbas Kouzani, Michael Berk, Charles Blaha, Kendall Lee, Yoonbae Oh

(2022), Vol. 25, pp. 161-170, Neuromodulation, London, Eng., C1

Effect of Glucocorticoid and 11 beta-Hydroxysteroid-Dehydrogenase Type 1 (11 beta-HSD1) in Neurological and Psychiatric Disorders

Seetal Dodd, David Skvarc, Olivia Dean, Anna Anderson, Mark Kotowicz, Michael Berk

(2022), Vol. 25, pp. 387-398, International Journal of Neuropsychopharmacology, Oxford, Eng., C1

A systematic review of gut microbiota composition in observational studies of major depressive disorder, bipolar disorder and schizophrenia

A McGuinness, J Davis, S Dawson, A Loughman, F Collier, M O’Hely, C Simpson, J Green, W Marx, C Hair, G Guest, M Mohebbi, M Berk, D Stupart, D Watters, F Jacka

(2022), Vol. 27, pp. 1920-1935, Molecular Psychiatry, Berlin, Germany, C1

Time for united action on depression: a Lancet-World Psychiatric Association Commission

H Herrman, V Patel, C Kieling, M Berk, C Buchweitz, P Cuijpers, T Furukawa, R Kessler, B Kohrt, M Maj, P McGorry, C Reynolds, M Weissman, D Chibanda, C Dowrick, L Howard, C Hoven, M Knapp, H Mayberg, B Penninx, S Xiao, M Trivedi, R Uher, L Vijayakumar, M Wolpert

(2022), Vol. 399, pp. 957-1022, The Lancet, Amsterdam, The Netherlands, C1

Child and Parent Physical Activity, Sleep, and Screen Time During COVID-19 and Associations With Mental Health: Implications for Future Psycho-Cardiological Disease?

L Olive, E Sciberras, T Berkowitz, E Hoare, R Telford, A O'Neil, A Mikocka-Walus, S Evans, D Hutchinson, J McGillivray, M Berk, S Teague, A Wood, C Olsson, E Westrupp

(2022), Vol. 12, pp. 1-13, Frontiers in Psychiatry, Lausanne, Switzerland, C1

Childhood trauma and treatment outcomes during mood‐stabilising treatment with lithium or quetiapine among outpatients with bipolar disorder

A Wrobel, O Köhler‐Forsberg, L Sylvia, S Russell, O Dean, S Cotton, M Thase, J Calabrese, T Deckersbach, M Tohen, C Bowden, M McInnis, J Kocsis, E Friedman, T Ketter, R Shelton, M Ostacher, D Iosifescu, M Berk, A Turner, A Nierenberg

(2022), Vol. 145, pp. 615-627, Acta Psychiatrica Scandinavica, London, England, C1

Attachment insecurity partially mediates the relationship between childhood trauma and depression severity in bipolar disorder

Anna Wrobel, Samantha Russell, Anuradhi Jayasinghe, Mojtaba Lotfaliany, Alyna Turner, Olivia Dean, Sue Cotton, Claudia Diaz‐Byrd, Anastasia Yocum, Elizabeth Duval, Tobin Ehrlich, David Marshall, Michael Berk, Melvin McInnis

(2022), Vol. 145, pp. 591-603, Acta Psychiatrica Scandinavica, London, Eng., C1

A systematic review and meta-analysis of structural and functional brain alterations in individuals with genetic and clinical high-risk for psychosis and bipolar disorder

Licia Luna, Joaquim Radua, Lydia Fortea, Gisela Sugranyes, Adriana Fortea, Paolo Fusar-Poli, Lee Smith, Joseph Firth, Jae Shin, Andre Brunoni, Muhammad Husain, Muhammad Husian, Haris Sair, Walber Mendes, Luiz Uchoa, Michael Berk, Michael Maes, Zafiris Daskalakis, Sophia Frangou, Michele Fornaro, Eduard Vieta, Brendon Stubbs, Marco Solmi, Andre Carvalho

(2022), Vol. 117, pp. 1-8, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1

Supporting Dietary Change for the Treatment of Mood Disorders in Adults: How Can We Harness Digital Platforms?

Claire Young, Tetyana Rocks, Rachelle Opie, Michael Berk, Adrienne O'Neil

(2022), Vol. 52, pp. 62-66, Psychiatric Annals, Thorofore, N.J., C1

Strategies and foundations for scientific discovery in longitudinal studies of bipolar disorder

M McInnis, O Andreassen, A Andreazza, U Alon, M Berk, T Brister, K Burdick, D Cui, M Frye, M Leboyer, P Mitchell, K Merikangas, A Nierenberg, J Nurnberger, D Pham, E Vieta, L Yatham, A Young

(2022), pp. 1-10, Bipolar Disorders, London, Eng., C1

Adaptation, Transformation and Resilience in Healthcare; Comment on "Government Actions and Their Relation to Resilience in Healthcare During the COVID-19 Pandemic in New South Wales, Australia and Ontario, Canada"

David Angeler, Harris Eyre, Michael Berk, Craig Allen, William Hynes, Igor Linkov

(2022), pp. 1-4, International Journal of Health Policy and Management, Kerman, Iran, C1

N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial

J Sarris, G Byrne, D Castle, C Bousman, G Oliver, L Cribb, S Blair-West, V Brakoulias, D Camfield, C Ee, S Chamoli, M Boschen, O Dean, N Dowling, R Menon, J Murphy, N Metri, T Nguyen, A Wong, R Jordan, D Karamacoska, S Rossell, M Berk, C Ng

(2022), Vol. 117, pp. 1-9, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1

The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders

R Bradlow, M Berk, P Kalivas, S Back, R Kanaan

(2022), Vol. 36, pp. 451-482, CNS Drugs, Berlin, Germany, C1

A pragmatic preference trial of therapeutic yoga as an adjunct to group cognitive behaviour therapy versus group CBT alone for depression and anxiety

Melissa O'Shea, Hannah Capon, David Skvarc, Subhadra Evans, Shane McIver, Jill Harris, Emma Houston, Michael Berk

(2022), Vol. 307, pp. 1-10, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce

J Sarris, A Ravindran, L Yatham, W Marx, J Rucklidge, R McIntyre, S Akhondzadeh, F Benedetti, C Caneo, H Cramer, L Cribb, M de Manincor, O Dean, A Deslandes, M Freeman, B Gangadhar, B Harvey, S Kasper, J Lake, A Lopresti, L Lu, N Metri, D Mischoulon, C Ng, D Nishi, R Rahimi, S Seedat, J Sinclair, K Su, Z Zhang, M Berk

(2022), pp. 1-32, World Journal of Biological Psychiatry, London, Eng., C1

Predictors of Functional Impairment in Bipolar Disorder: Results from 13 Cohorts from Seven Countries by The Global Bipolar Cohort Collaborative

K Burdick, C Millett, A Yocum, C Altimus, O Andreassen, V Aubin, R Belzeaux, M Berk, J Biernacka, H Blumberg, A Cleare, C Diaz‐Byrd, C Dubertret, B Etain, L Eyler, B Forester, J Fullerton, M Frye, S Gard, O Godin, E Haffen, F Klaus, T Lagerberg, M Leboyer, A Martinez‐Aran, S McElroy, P Mitchell, E Olie, P Olorunfemi, C Passerieux, A Peters, D Pham, M Polosan, J Potter, M Sajatovic, L Samalin, R Schwan, M Shanahan, B Solé, R Strawbridge, A Stuart, I Torres, T Ueland, E Vieta, L Williams, A Wrobel, L Yatham, A Young, A Nierenberg, M McInnis

(2022), pp. 1-11, Bipolar Disorders, London, Eng., C1

Evaluating telehealth lifestyle therapy versus telehealth psychotherapy for reducing depression in adults with COVID-19 related distress: the curbing anxiety and depression using lifestyle medicine (CALM) randomised non-inferiority trial protocol

Lauren Young, Steve Moylan, Tayla John, Megan Turner, Rachelle Opie, Meghan Hockey, Dean Saunders, Courtney Bruscella, Felice Jacka, Megan Teychenne, Simon Rosenbaum, Khyati Banker, Sophie Mahoney, Monica Tembo, Jerry Lai, Niamh Mundell, Grace McKeon, Murat Yucel, Jane Speight, Pilvikki Absetz, Vincent Versace, Mary Chatterton, Michael Berk, Sam Manger, Mohammadreza Mohebbi, Mark Morgan, Anna Chapman, Craig Bennett, Melissa O’Shea, Tetyana Rocks, Sarah Leach, Adrienne O’Neil

(2022), Vol. 22, pp. 1-13, BMC Psychiatry, Berlin, Germany, C1

Inflammation and Nitro-oxidative Stress as Drivers of Endocannabinoid System Aberrations in Mood Disorders and Schizophrenia

G Morris, L Sominsky, K Walder, M Berk, W Marx, A Carvalho, C Bortolasci, M Maes, B Puri

(2022), Vol. 59, pp. 3485-3503, Molecular Neurobiology, Berlin, Germany, C1

Common effects of bipolar disorder medications on expression quantitative trait loci genes

T Truong, C Bortolasci, S Kidnapillai, B Spolding, B Panizzutti, Z Liu, B Watmuff, J Kim, O Dean, M Richardson, M Berk, K Walder

(2022), Vol. 150, pp. 105-112, Journal of Psychiatric Research, Amsterdam, The Netherlands, C1

What Injured Workers With Complex Claims Look For in Online Communities: Netnographic Analysis

M Hutson, S Hosking, S Mantalvanos, M Berk, J Pasco, T Dunning

(2022), Vol. 24, Journal of Medical Internet Research, Canada, C1

Co-Expression Networks Unveiled Long Non-Coding RNAs as Molecular Targets of Drugs Used to Treat Bipolar Disorder

Trang Truong, Chiara Bortolasci, Briana Spolding, Bruna Panizzutti, Zoe Liu, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Craig Smith, Olivia Dean, Jee Kim, Michael Berk, Ken Walder

(2022), Vol. 13, pp. 1-12, Frontiers in Pharmacology, Lausanne, Switzerland, C1

Bipolar disorder and bone health: A case-control study

L Williams, A Stuart, M Berk, S Brennan-Olsen, J Hodge, S Quirk, H Koivumaa-Honkanen, R Honkanen, J Heikkinen, V Chandrasekaran, J Cleminson, J Pasco

(2022), Vol. 308, pp. 39-43, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Deep Brain Stimulation for Addictive Disorders-Where Are We Now?

J Yuen, A Kouzani, M Berk, S Tye, A Rusheen, C Blaha, K Bennet, K Lee, H Shin, J Kim, Y Oh

(2022), pp. 1-23, Neurotherapeutics, Berlin, Germany, C1

Trajectories of depressive symptoms in older adults and associated health outcomes

B Agustini, M Lotfaliany, M Mohebbi, R Woods, J McNeil, M Nelson, R Shah, A Murray, C Reid, A Tonkin, J Ryan, L Williams, M Forbes, M Berk

(2022), Vol. 2, pp. 295-302, Nature Aging, Berlin, Germany, C1

Biological and practical considerations regarding circadian rhythm and mental health relationships among nurses working night shifts: a narrative review and recommendations

C Okechukwu, M Griffiths, M Carta, E Nwobodo, S Shariful Islam, M Forbes, M Berk, M Potenza, M Banach, O Amamihechineke Grace, N Nwobodo, G La Torre

(2022), Vol. 57, pp. 67-79, Rivista di psichiatria, Rome, Italy, C1

Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression

Samantha Russell, Anna Wrobel, Olivia Dean, Michael Berk, Seetal Dodd, Chee Ng, Gin Malhi, Susan Cotton, Jerome Sarris, Alyna Turner

(2022), Vol. 20, pp. 300-310, Clinical psychopharmacology and neuroscience, Seoul, Korea (South), C1

Nutrition and bipolar disorder: a systematic review

F Gabriel, M Oliveira, B Martella, M Berk, E Brietzke, F Jacka, B Lafer

(2022), Nutritional Neuroscience, England, C1

Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs

M Similon, C Paasche, F Krol, B Lerer, G Goodwin, M Berk, A Meyer-Lindenberg, T Ketter, L Yatham, J Goldberg, G Malhi, R El-Mallakh, R Licht, A Young, F Kapczinski, M Swartz, M Hagin, C Torrent, A Serretti, A Yildiz, A Martínez-Arán, S Strejilevich, J Rybakowski, G Sani, H Grunze, G Vázquez, A Pinto, J Azorin, W Nolen, O Sentissi, C López-Jaramillo, B Frey, A Nierenberg, G Parker, D Bond, A Cohen, A Tortorella, G Perugi, E Vieta, D Popovic

(2022), Vol. 60, pp. 91-99, European Neuropsychopharmacology, Netherlands, C1

Listening to the silent struggles of bipolar disorder through sonification of iMoodJournal data

D Angeler, H Eyre, M Berk

(2022), Vol. 24, pp. 689-692, Bipolar Disorders, Denmark, C1-1

Counting on U training to enhance trusting relationships and mental health literacy among business advisors: protocol for a randomised controlled trial

L Saxon, S Bromfield, S Leow-Taylor, C Vega, M Berk, A LaMontagne, A Martin, M Mohebbi, K Nielsen, N Reavley, A Walker, A Conway, A de Silva, K Memish, A Rossetto, G Tanewski, A Noblet

(2022), Vol. 22, pp. 1-12, BMC Psychiatry, London, Eng., C1

Investing in Late-Life Brain Capital

W Dawson, E Smith, L Booi, M Mosse, H Lavretsky, C Reynolds, J Cummings, P Brannally, W Hynes, E Lenze, F Manes, R Ayadi, L Frank, S Chapman, I Robertson, L Rubenstein, J Jraissati, A Ibáñez, H Fillit, D Jeste, A Rao, M Berk, E Storch, A Santuccione Chadha, H Eyre

(2022), Vol. 6, Innovation in Aging, England, C1

Risk factors for depression in Pacific adolescents in New Zealand: A network analysis

L Gossage, A Narayanan, J Dipnall, L Iusitini, A Sumich, M Berk, W Wrapson, E Tautolo, R Siegert

(2022), Vol. 311, pp. 373-382, Journal of Affective Disorders, Netherlands, C1

Effects of psychotropic drugs on ribosomal genes and protein synthesis

Zoe Liu, Trang Truong, Chiara Bortolasci, Briana Spolding, Bruna Panizzutti, Courtney Swinton, Jee Kim, Srisaiyini Kidnapillai, Mark Richardson, Laura Gray, Olivia Dean, Sean McGee, Michael Berk, Ken Walder

(2022), Vol. 23, pp. 7180-7180, International Journal of Molecular Sciences, Basel, Switzerland, C1

Brain derived neurotrophic factor in perioperative neurocognitive disorders: Current evidence and future directions

N Travica, H Aslam, A O'Neil, M Lane, M Berk, E Gamage, K Walder, Z Liu, T Segasby, W Marx

(2022), Vol. 193, pp. 107656-107656, Neurobiology of Learning and Memory, United States, C1

Integrative analyses of transcriptomes to explore common molecular effects of antipsychotic drugs

Trang Truong, Chiara Bortolasci, Srisaiyini Kidnapillai, Briana Spolding, Bruna Panizzutti, Zoe Liu, Jee Kim, Olivia Dean, Mark Richardson, Michael Berk, Ken Walder

(2022), Vol. 23, pp. 7508-7508, International Journal of Molecular Sciences, Basel, Switzerland, C1

The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study.

K Fountoulakis, G Karakatsoulis, S Abraham, K Adorjan, H Ahmed, R Alarcón, K Arai, S Auwal, M Berk, S Bjedov, J Bobes, T Bobes-Bascaran, J Bourgin-Duchesnay, C Bredicean, L Bukelskis, A Burkadze, I Abud, R Castilla-Puentes, M Cetkovich, H Colon-Rivera, R Corral, C Cortez-Vergara, P Crepin, D De Berardis, S Delgado, D De Lucena, A De Sousa, R Stefano, S Dodd, L Elek, A Elissa, B Erdelyi-Hamza, G Erzin, M Etchevers, P Falkai, A Farcas, I Fedotov, V Filatova, N Fountoulakis, I Frankova, F Franza, P Frias, T Galako, C Garay, L Garcia-Álvarez, M García-Portilla, X Gonda, T Gondek, D González, H Gould, P Grandinetti, A Grau, V Groudeva, M Hagin, T Harada, T Hasan, N Hashim, J Hilbig, S Hossain, R Iakimova, M Ibrahim, F Iftene, Y Ignatenko, M Irarrazaval, Z Ismail, J Ismayilova, A Jacobs, M Jakovljević, N Jakšić, A Javed, H Kafali, S Karia, O Kazakova, D Khalifa, O Khaustova, S Koh, S Kopishinskaia, K Kosenko, S Koupidis, I Kovacs, B Kulig, A Lalljee, J Liewig, A Majid, E Malashonkova, K Malik, N Malik, G Mammadzada, B Mandalia, D Marazziti, D Marčinko, S Martinez, E Matiekus, G Mejia, R Memon, X Martínez, D Mickevičiūtė, R Milev, M Mohammed, A Molina-López

(2022), Vol. 315, Psychiatry Research, Ireland, C1

Prediction of disability-free survival in healthy older people

J Neumann, L Thao, A Murray, E Callander, P Carr, M Nelson, R Wolfe, R Woods, C Reid, R Shah, A Newman, J Williamson, A Tonkin, J McNeil, J McNeil, A Murray, L Beilin, A Chan, J Demons, M Ernst, S Espinoza, M Goetz, C Johnston, B Kirpach, D Liew, K Margolis, F Meyskens, M Nelson, C Reid, R Shah, E Storey, A Tonkin, R Woods, J Zalcberg, M Nelson, D Ives, M Berk, W Bernstein, D Brauer, C Burns, T Chong, G Cloud, G Donnan, C Eaton, P Fitzgerald, P Gibbs, A Haydon, M Jelinek, F Macrae, S Mahady, M Malik, K Margolis, C McLean, A Murray, A Newman, L Rodriguez, S Satterfield, R Shah, E Storey, J Tie, A Tonkin, G van Londen, S Ward, J Williamson, E Wood, J Zalcberg, J Mohr, G Anderson, S Connolly, L Friedman, J Manson, M Sano, S Morrison, E Ohman, J McNeil, R Woods, W Abhayaratna, L Beilin, G Donnan, P Gibbs, C Johnston, D Liew, T Lockett, M Nelson, C Reid, N Stocks, E Storey, A Tonkin, J Zalcberg, A Murray, C Reid, W Abhayaratna, M Ernst, C Johnston, B Lewis, D Liew, K Margolis, J McNeil, M Nelson

(2022), Vol. 44, pp. 1641-1655, GeroScience, Switzerland, C1-1

Psilocybin in Neuropsychiatry: A review of its pharmacology, safety and efficacy

S Dodd, T Norman, H Eyre, S Stahl, A Phillips, A Carvalho, M Berk

(2022), CNS Spectrums, United States, C1

Associations of Cardiovascular Agents and Metformin with Depression Symptoms: A Cross-Sectional Analysis from the HUNT Study, Norway

I Bojanić, O Bjerkeset, L Williams, M Berk, E Sund, H Sletvold

(2022), Vol. 9, pp. 503-516, Drugs - Real World Outcomes, Berlin, Germany, C1

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms

Erica Neill, Susan Rossell, Caitlin Yolland, Denny Meyer, Cherrie Galletly, Anthony Harris, Dan Siskind, Michael Berk, Kiymet Bozaoglu, Frances Dark, Olivia Dean, Paul Francis, Dennis Liu, Andrea Phillipou, Jerome Sarris, David Castle

(2022), pp. 1-10, Schizophrenia Bulletin, Oxford, Eng., C1

The prescriber's guide to classic MAO-inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression

V Van Den Eynde, W Abdelmoemin, M Abraham, J Amsterdam, I Anderson, C Andrade, G Baker, A Beekman, M Berk, T Birkenhäger, B Blackwell, P Blier, M Blom, J Bodkin, C Cattaneo, B Dantz, J Davidson, B Dunlop, R Estévez, S Feinberg, J Finberg, L Fochtmann, D Gotlib, A Holt, T Insel, J Larsen, R Mago, D Menkes, J Meyer, D Nutt, G Parker, M Rego, E Richelson, H Ruhé, J Sáiz-Ruiz, S Stahl, T Steele, M Thase, S Ulrich, A Van Balkom, E Vieta, I Whyte, A Young, P Gillman

(2022), pp. 1-14, CNS Spectrums, United States, C1

Personality traits as mediators of the relationship between childhood trauma and depression severity in bipolar disorder: A structural equation model

A Wrobel, S Russell, A Jayasinghe, B Kavanagh, M Lotfaliany, A Turner, O Dean, S Cotton, C Diaz-Byrd, A Yocum, E Duval, T Ehrlich, D Marshall, M Berk, M McInnis

(2022), Australian and New Zealand Journal of Psychiatry, England, C1

Association between polarity of first episode and solar insolation in bipolar I disorder

M Bauer, T Glenn, E Achtyes, M Alda, E Agaoglu, K Altınbaş, O Andreassen, E Angelopoulos, R Ardau, M Aydin, Y Ayhan, C Baethge, R Bauer, B Baune, C Balaban, C Becerra-Palars, A Behere, P Behere, H Belete, T Belete, G Belizario, F Bellivier, R Belmaker, F Benedetti, M Berk, Y Bersudsky, Ş Bicakci, H Birabwa-Oketcho, T Bjella, C Brady, J Cabrera, M Cappucciati, A Paredes Castro, W Chen, E Cheung, S Chiesa, M Crowe, A Cuomo, S Dallaspezia, M Del Zompo, P Desai, S Dodd, B Etain, A Fagiolini, F Fellendorf, E Ferensztajn-Rochowiak, J Fiedorowicz, K Fountoulakis, M Frye, P Geoffroy, A Gonzalez-Pinto, J Gottlieb, P Grof, B Haarman, H Harima, M Hasse-Sousa, C Henry, L Høffding, J Houenou, M Imbesi, E Isometsä, M Ivkovic, S Janno, S Johnsen, F Kapczinski, G Karakatsoulis, M Kardell, L Kessing, S Kim, B König, T Kot, M Koval, M Kunz, B Lafer, M Landén, E Larsen, M Lenger, U Lewitzka, R Licht, C Lopez-Jaramillo, A MacKenzie, H Madsen, S Madsen, J Mahadevan, A Mahardika, M Manchia, W Marsh, M Martinez-Cengotitabengoa, K Martiny, Y Mashima, D McLoughlin, Y Meesters, I Melle, F Meza-Urzúa, Y Mok, S Monteith, M Moorthy, G Morken, E Mosca, A Mozzhegorov

(2022), Vol. 160, pp. 1-10, Journal of Psychosomatic Research, Amsterdam, The Netherlands, C1

Neuropsychiatric Consequences of COVID-19 Pandemic: A Synthetic Review from a Global Perspective

Seithikurippu Pandi-Perumal, Nevin Zaki, Mohammad Qasim, Nesreen Morsy, Md Manzar, Ahmed BaHammam, Haitham Jahrami, Chellamuthu Ramasubramanian, Ramanujam Karthikeyan, Thitiporn Supasitthumrong, Adam Moscovitch, Ilya Trakht, Ravi Gupta, Meera Narasimhan, Timo Partonen, Russel Reiter, Gerwyn Morris, Michael Berk, Sidney Kennedy, Dan Stein, Stephen Stahl, Dennis Charney, Mary Seeman

(2022), Vol. 23, pp. 144-154, ALPHA PSYCHIATRY, Turkey, C1

Open Innovation: The Key to Advancing Brain Health

H Eyre, J Searfoss, M Hopwood, M Berk, S Chen, J Cummings, F Veron, V Zikopolous, A Ibanez, K Kelly, J Soares, E Smith, B Gilbert

(2022), CNS Spectrums, United States, C1

Cost-Utility and Cost-effectiveness of MoodSwings 2.0, an Internet-Based Self-management Program for Bipolar Disorder: Economic Evaluation Alongside a Randomized Controlled Trial

M Chatterton, Y Lee, L Berk, M Mohebbi, M Berk, T Suppes, S Lauder, C Mihalopoulos

(2022), Vol. 9, JMIR Mental Health, Canada, C1

Depressive symptomology and cancer incidence in men and women: Longitudinal evidence from the HUNT study

S Cowdery, O Bjerkeset, E Sund, M Mohebbi, J Pasco, M Berk, L Williams

(2022), Vol. 316, pp. 1-9, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Depression, anxiety and worry in young Pacific adults in New Zealand during the COVID-19 pandemic

R Siegert, A Narayanan, J Dipnall, L Gossage, W Wrapson, A Sumich, F Merien, M Berk, J Paterson, E Tautolo

(2022), pp. 1-12, Australian and New Zealand Journal of Psychiatry, London, Eng., C1

Severe psychiatric disorders and general medical comorbidities: inflammation-related mechanisms and therapeutic opportunities

A Teixeira, L Martins, M Berk, M Bauer

(2022), Vol. 136, pp. 1257-1280, Clinical Science, London, Eng., C1

The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management

R McIntyre, M Alda, R Baldessarini, M Bauer, M Berk, C Correll, A Fagiolini, K Fountoulakis, M Frye, H Grunze, L Kessing, D Miklowitz, G Parker, R Post, A Swann, T Suppes, E Vieta, A Young, M Maj

(2022), Vol. 21, pp. 364-387, World Psychiatry, Italy, C1-1

Psychological distress in siblings of people with mental illness: A systematic review and meta-analysis

A Jayasinghe, A Wrobel, K Filia, L Byrne, G Melvin, L Berk, M Berk, S Cotton

(2022), Australian and New Zealand Journal of Psychiatry, London, Eng., C1

Renewal of academic psychiatry without addressing gender equity will render it Jurassic rather than endangered

M Galbally, K Eggleston, K Northwood, D Siskind, M Berk, S Suetani, N Gill, N O’Connor, S Harvey, S Every-Palmer

(2022), Australian and New Zealand Journal of Psychiatry, England, C1

Falls in community-dwelling women with bipolar disorder: a case-control study

A Stuart, J Pasco, M Berk, S Quirk, H Koivumaa-Honkanen, R Honkanen, M Mohebbi, L Williams

(2022), Vol. 22, BMC Psychiatry, England, C1

Assessing Suicidal Ideation in Young People With Depression: Factor Structure of the Suicidal Ideation Questionnaire

C Moller, P Badcock, S Hetrick, S Rice, M Berk, O Dean, A Chanen, C Gao, C Davey, S Cotton

(2022), Omega (United States), United States, C1

The role of metformin as a treatment for neuropsychiatric illness

S Dodd, L Sominsky, D Siskind, C Bortolasci, A Carvalho, M Maes, A Walker, K Walder, A Yung, L Williams, H Myles, T Watson, M Berk

(2022), Vol. 64, pp. 32-43, European Neuropsychopharmacology, Netherlands, C1

Isolating the impact of antipsychotic medication on metabolic health: Secondary analysis of a randomized controlled trial of antipsychotic medication versus placebo in antipsychotic medication naïve first-episode psychosis (the STAGES study)

B O'Donoghue, K Allott, S Harrigan, F Scalzo, J Ward, S Mallawaarachchi, S Whitson, L Baldwin, J Graham, E Mullen, C MacNeil, D Alexander, S Wood, M Berk, M Alvarez-Jimenez, A Thompson, A Fornito, H Yuen, B Nelson, S Francey, P McGorry

(2022), pp. 1-11, Early Intervention in Psychiatry, London, Eng., C1-1

The bidirectional association between depressive symptoms, assessed by the HADS, and albuminuria-A longitudinal populationbased cohort study with repeated measures from the HUNT2 and HUNT3 Study

L Gustad, A Holand, T Hynnekleiv, O Bjerkeset, M Berk, S Romundstad

(2022), Vol. 17, pp. e0274271-e0274271, PLoS ONE, United States, C1

Clinical guidelines for the use of lifestyle-based mental health care in major depressive disorder: World Federation of Societies for Biological Psychiatry (WFSBP) and Australasian Society of Lifestyle Medicine (ASLM) taskforce

W Marx, S Manger, M Blencowe, G Murray, F Ho, S Lawn, J Blumenthal, F Schuch, B Stubbs, A Ruusunen, H Desyibelew, T Dinan, F Jacka, A Ravindran, M Berk, A O’Neil

(2022), World Journal of Biological Psychiatry, England, C1

Coping with COVID-19: Exploring coping strategies, distress, and post-traumatic growth during the COVID-19 pandemic in Australia

B Kavanagh, J O’Donohue, M Ashton, M Lotfaliany, M McCallum, A Wrobel, S Croce, M Berk, L Saunders, J Lai, L Berk

(2022), Vol. 13, Frontiers in Psychiatry, Switzerland, C1

Anxiety and depression symptoms, albuminuria and risk of acute myocardial infarction in the Norwegian HUNT cohort study

L Gustad, T Myklebust, O Bjerkeset, L Williams, L Laugsand, H Dalen, M Berk, S Romundstad

(2022), Vol. 22, pp. 1-11, BMC Cardiovascular Disorders, London, Eng., C1

The Concept of 'Metabolic Jet Lag' in the Pathophysiology of Bipolar Disorder: Implications for Research and Clinical Care

E Koning, A McDonald, A Bambokian, F Gomes, J Vorstman, M Berk, J Fabe, R McIntyre, R Milev, R Mansur, E Brietzke

(2022), pp. 1-10, CNS Spectrums, United States, C1

Modeling psychological function in patients with schizophrenia with the PANSS: An international multi-center study

K Fountoulakis, E Dragioti, A Theofilidis, T Wiklund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L García-Alvarez, G Erzin, H Karadaǧ, A De Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M De Hert

(2021), Vol. 26, pp. 290-298, CNS Spectrums, United States, C1

Effects of psychoactive drugs on cellular bioenergetic pathways

C Bortolasci, B Spolding, S Kidnapillai, M Richardson, N Vasilijevic, S Martin, L Gray, S McGee, M Berk, K Walder

(2021), Vol. 22, pp. 79-93, World Journal of Biological Psychiatry, England, C1

How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations

M Solmi, A Miola, G Croatto, G Pigato, A Favaro, M Fornaro, M Berk, L Smith, J Quevedo, M Maes, C Correll, A Carvalho

(2021), Vol. 43, pp. 189-202, Brazilian Journal of Psychiatry, Brazil, C1

Systemic inflammation and grey matter volume in schizophrenia and bipolar disorder: Moderation by childhood trauma severity

Y Quidé, C Bortolasci, B Spolding, S Kidnapillai, O Watkeys, S Cohen-Woods, V Carr, M Berk, K Walder, M Green

(2021), Vol. 105, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1

A novel way to quantify schizophrenia symptoms in clinical trials

O Medvedev, M Berk, O Dean, E Brown, M Sandham, J Dipnall, R McNamara, A Sumich, C Krägeloh, A Narayanan, R Siegert

(2021), Vol. 51, European Journal of Clinical Investigation, England, C1

Does guideline-concordant care predict naturalistic outcomes in youth with early stage bipolar I disorder?

P Sunder, M Chia, K Filia, C Macneil, M Hasty, C Davey, P McGorry, M Berk, S Cotton, A Ratheesh

(2021), Vol. 278, pp. 23-32, Journal of affective disorders, Amsterdam, The Netherlands, C1

Mood disorder and cancer onset: Evidence from a population-based sample of australian women

S Cowdery, A Stuart, J Pasco, M Berk, D Campbell, O Bjerkeset, L Williams

(2021), Vol. 43, pp. 355-361, Brazilian Journal of Psychiatry, Brazil, C1

A Systematic Review of Nutraceuticals for the Treatment of Bipolar Disorder

M Ashton, B Kavanagh, W Marx, M Berk, J Sarris, C Ng, M Hopwood, L Williams, O Dean

(2021), Vol. 66, pp. 262-273, Canadian Journal of Psychiatry, United States, C1

Cumulative Cardiovascular Disease Risk and Triglycerides Differentially Relate to Subdomains of Executive Function in Bipolar Disorder; preliminary findings

T Van Rheenen, R McIntyre, V Balanzá-Martínez, M Berk, S Rossell

(2021), Vol. 278, pp. 556-562, Journal of Affective Disorders, Netherlands, C1

Clinical and demographic characteristics of people who smoke versus inject crystalline methamphetamine in Australia: Findings from a pharmacotherapy trial

R McKETIN, B Quinn, P Higgs, M Berk, O Dean, A Turner, P Kelly, D Lubman, G Carter, A Baker, V Manning, T Thomas, R Bathish, D Raftery, L Saunders, A Wrobel, A Meehan, B Sinclair, D Reid, S Arunogiri, H Hill, F Cordaro, P Dietze

(2021), Vol. 40, pp. 1249-1255, Drug and Alcohol Review, Australia, C1

Trace amine-associated receptor 1 (TAAR1): a new drug target for psychiatry?

S Dodd, A Carvalho, B Puri, M Maes, C Bortolasci, G Morris, M Berk

(2021), Vol. 120, pp. 537-541, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

Preventing the development of severe COVID-19 by modifying immunothrombosis

G Morris, C Bortolasci, B Puri, L Olive, W Marx, A O'Neil, E Athan, A Carvalho, M Maes, K Walder, M Berk

(2021), Vol. 264, Life Sciences, Netherlands, C1

Minocycline as adjunctive treatment for major depressive disorder: Pooled data from two randomized controlled trials

R Zazula, M Husain, M Mohebbi, A Walker, I Chaudhry, A Khoso, M Ashton, B Agustini, N Husain, J Deakin, A Young, M Berk, B Kanchanatawan, C Ng, M Maes, L Berk, A Singh, G Malhi, O Dean

(2021), Vol. 55, pp. 784-798, Australian and New Zealand Journal of Psychiatry, England, C1

Diet and depression: exploring the biological mechanisms of action

W Marx, M Lane, M Hockey, H Aslam, M Berk, K Walder, A Borsini, J Firth, C Pariante, K Berding, J Cryan, G Clarke, J Craig, K Su, D Mischoulon, F Gomez-Pinilla, J Foster, P Cani, S Thuret, H Staudacher, A Sánchez-Villegas, H Arshad, T Akbaraly, A O’Neil, T Segasby, F Jacka

(2021), Vol. 26, pp. 134-150, Molecular Psychiatry, England, C1

Ultraprocessed food and chronic noncommunicable diseases: A systematic review and meta-analysis of 43 observational studies

M Lane, J Davis, S Beattie, C Gómez-Donoso, A Loughman, A O'Neil, F Jacka, M Berk, R Page, W Marx, T Rocks

(2021), Vol. 22, Obesity Reviews, England, C1

Systematic review and meta-analysis of the role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders

B Kavanagh, M Ashton, S Cowdery, O Dean, A Turner, M Berk, S Gwini, S Brennan-Olsen, H Koivumaa-Honkanen, A Chanen, L Williams

(2021), Vol. 279, pp. 711-721, Journal of affective disorders, Amsterdam, The Netherlands, C1

The effect of concomitant benzodiazepine use on neurocognition in stable, long-term patients with bipolar disorder

Y Cañada, A Sabater, P Sierra, V Balanzá-Martínez, M Berk, S Dodd, P Navalón, L Livianos, A García-Blanco

(2021), Vol. 55, pp. 1005-1016, Australian and New Zealand Journal of Psychiatry, England, C1

Design of a brief psychological intervention for youth who self-harm: A formative study in India

S Aggarwal, G Patton, M Berk, V Patel

(2021), Vol. 24, pp. E2-, Evidence-Based Mental Health, England, C1

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies

W Marx, A McGuinness, T Rocks, A Ruusunen, J Cleminson, A Walker, S Gomes-da-Costa, M Lane, M Sanches, A Diaz, P Tseng, P Lin, M Berk, G Clarke, A O’Neil, F Jacka, B Stubbs, A Carvalho, J Quevedo, J Soares, B Fernandes

(2021), Vol. 26, pp. 4158-4178, Molecular Psychiatry, England, C1

Relationships Between Different Dimensions of Social Support and Suicidal Ideation in Young People with Major Depressive Disorder

C Moller, S Cotton, P Badcock, S Hetrick, M Berk, O Dean, A Chanen, C Davey

(2021), Vol. 281, pp. 714-720, Journal of Affective Disorders, Netherlands, C1

Genetics of methamphetamine use disorder: a systematic review and meta-analyses of gene association studies

A Guerin, E Nestler, M Berk, A Lawrence, S Rossell, J Kim

(2021), Vol. 120, pp. 48-74, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

The prevalence, odds and predictors of lifespan comorbid eating disorder among people with a primary diagnosis of bipolar disorders, and vice-versa: Systematic review and meta-analysis

M Fornaro, F Daray, F Hunter, A Anastasia, B Stubbs, D De Berardis, J Shin, M Husain, E Dragioti, P Fusar-Poli, M Solmi, M Berk, E Vieta, A Carvalho

(2021), Vol. 280, pp. 409-431, Journal of Affective Disorders, Netherlands, C1

A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?

S Dodd, M Bauer, A Carvalho, H Eyre, M Fava, S Kasper, S Kennedy, J Khoo, C Lopez Jaramillo, G Malhi, R McIntyre, P Mitchell, A Castro, A Ratheesh, E Severus, T Suppes, M Trivedi, M Thase, L Yatham, A Young, M Berk

(2021), Vol. 22, pp. 483-494, World Journal of Biological Psychiatry, England, C1

Measuring fatigue: a meta-review

M Machado, N Kang, F Tai, R Sambhi, M Berk, A Carvalho, L Chada, J Merola, V Piguet, A Alavi

(2021), Vol. 60, pp. 1053-1069, International Journal of Dermatology, England, C1

Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia: A 24-Week Double-blind, Randomized, Placebo Controlled Efficacy Trial: Péricarpe d'appoint Garcinia mangostana Linn (mangoustan) pour la schizophrénie : un essai d'efficacité de 24 semaines, à double insu, randomisé et contrôlé par placebo

A Turner, A Baker, O Dean, A Walker, S Dodd, S Cotton, J Scott, B Kavanagh, M Ashton, E Brown, J McGrath, M Berk

(2021), Vol. 66, pp. 354-366, Canadian Journal of Psychiatry, United States, C1

Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry

G Morris, A Walker, K Walder, M Berk, W Marx, A Carvalho, M Maes, B Puri

(2021), Vol. 58, pp. 2158-2182, Molecular Neurobiology, United States, C1

The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress

G Raghu, M Berk, P Campochiaro, H Jaeschke, G Marenzi, L Richeldi, F Wen, F Nicoletti, P Calverley

(2021), Vol. 19, pp. 1202-1224, Current neuropharmacology, United Arab Emirates, C1

Psychosocial interventions for self-harm in low-income and middle-income countries: systematic review and theory of change

S Aggarwal, G Patton, M Berk, V Patel

(2021), Vol. 56, pp. 1729-1750, Social Psychiatry and Psychiatric Epidemiology, Germany, C1

The mental health and lifestyle impacts of COVID-19 on bipolar disorder

James Karantonis, Susan Rossell, Michael Berk, Tamsyn Van Rheenen

(2021), Vol. 282, pp. 442-447, Journal of Affective Disorders, Aamsterdam, The Netherlands, C1

Prebiotic and probiotic supplementation and the tryptophan-kynurenine pathway: a systematic review and meta analysis

T Purton, L Staskova, M Lane, S Dawson, M West, J Firth, G Clarke, J Cryan, M Berk, A O'Neil, O Dean, A Hadi, C Honan, W Marx

(2021), Vol. 123, pp. 1-13, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

Nutrition-based interventions for mood disorders

L Martins, J Braga Tibães, M Sanches, F Jacka, M Berk, A Teixeira

(2021), Vol. 21, pp. 303-315, Expert Review of Neurotherapeutics, England, C1

Inflammatory versus anti-inflammatory profiles in major depressive disorders-the role of il-17, il-21, il-23, il-35 and foxp3

M Gałecka, K Bliźniewska-Kowalska, A Orzechowska, J Szemraj, M Maes, M Berk, K Su, P Gałecki

(2021), Vol. 11, pp. 1-14, Journal of Personalized Medicine, Switzerland, C1

Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial

M Berk, B Agustini, R Woods, M Nelson, R Shah, C Reid, E Storey, S Fitzgerald, J Lockery, R Wolfe, M Mohebbi, S Dodd, A Murray, N Stocks, P Fitzgerald, C Mazza, J McNeil

(2021), Vol. 26, pp. 5161-5170, Molecular Psychiatry, England, C1

Optimizing engagement in an online dietary intervention for depression (My food & mood version 3.0): Cohort study

C Young, M Mohebbi, H Staudacher, F Kay-Lambkin, M Berk, F Jacka, A O'Neil

(2021), Vol. 8, JMIR Mental Health, Canada, C1

Short-term neuropsychiatric outcomes and quality of life in COVID-19 survivors

R Méndez, V Balanzá-Martínez, S Luperdi, I Estrada, A Latorre, P González-Jiménez, L Feced, L Bouzas, K Yépez, A Ferrando, D Hervás, E Zaldívar, S Reyes, M Berk, R Menéndez

(2021), Vol. 290, pp. 621-631, Journal of Internal Medicine, England, C1

The effects of childhood emotional maltreatment and alexithymia on depressive and manic symptoms and suicidal ideation in females with bipolar disorder: emotion dysregulation as a mediator

Vahid Khosravani, Michael Berk, Farangis Sharifi Bastan, Seyed Samimi Ardestani, Anna Wrobel

(2021), Vol. 25, pp. 90-102, International journal of psychiatry in clinical practice, Abingdon, Eng., C1

Anticonvulsant use and bone health in a population-based study of men and women: cross-sectional data from the Geelong Osteoporosis Study

V Chandrasekaran, J Pasco, A Stuart, S Brennan-Olsen, M Berk, J Hodge, R Samarasinghe, L Williams

(2021), Vol. 22, BMC Musculoskeletal Disorders, England, C1

Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les médicaments à base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une méta-revue des méta-analyses d'essais randomisés contrôlés

J Sarris, W Marx, M Ashton, C Ng, N Galvao-Coelho, Z Ayati, Z Zhang, S Kasper, A Ravindran, B Harvey, A Lopresti, D Mischoulon, J Amsterdam, L Yatham, M Berk

(2021), Vol. 66, pp. 849-862, Canadian Journal of Psychiatry, United States, C1

Cognitive ability and metabolic physical health in first-episode psychosis

S Whitson, B O'Donoghue, R Hester, L Baldwin, S Harrigan, S Francey, J Graham, B Nelson, A Ratheesh, M Alvarez-Jimenez, A Fornito, C Pantelis, H Yuen, A Thompson, M Kerr, M Berk, S Wood, P McGorry, K Allott

(2021), Vol. 24, Schizophrenia Research: Cognition, United States, C1

Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: A Meta-Analysis of Mood Effects

T Cartmill, D Skvarc, R Bittar, J McGillivray, M Berk, L Byrne

(2021), Vol. 31, pp. 385-401, Neuropsychology Review, United States, C1

The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders

Gerwyn Morris, B Puri, C Bortolasci, Andre Carvalho, M Berk, K Walder, E Moreira, M Maes

(2021), Vol. 125, pp. 244-263, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

Age as a predictor of quit attempts and quit success in smoking cessation: findings from the International Tobacco Control Four-Country survey (2002-14)

L Arancini, R Borland, M Le Grande, M Mohebbi, S Dodd, O Dean, M Berk, A McNeill, G Fong, K Cummings

(2021), Vol. 116, pp. 2509-2520, Addiction, England, C1

Psychometric properties of the chinese version of the bipolar depression rating scale for bipolar disorder

J Chen, L Yin, H Xu, S Zhang, W Huang, H Li, B Li, K Yang, Q Li, M Berk, Y Su

(2021), Vol. 17, pp. 787-795, Neuropsychiatric Disease and Treatment, New Zealand, C1

Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm

D Perkins, J Sarris, S Rossell, Y Bonomo, D Forbes, C Davey, D Hoyer, C Loo, G Murray, S Hood, V Schubert, N Galvão-Coelho, M O’Donnell, O Carter, P Liknaitzky, M Williams, D Siskind, D Penington, M Berk, D Castle

(2021), Vol. 55, pp. 1127-1133, Australian and New Zealand Journal of Psychiatry, England, C1

Trajectories of change in depression symptoms and suicidal ideation over the course of evidence-based treatment for depression: Secondary analysis of a randomised controlled trial of cognitive behavioural therapy plus fluoxetine in young people

K Witt, T Madsen, M Berk, O Dean, A Chanen, P McGorry, S Cotton, C Davey, S Hetrick

(2021), Vol. 55, pp. 506-516, Australian and New Zealand Journal of Psychiatry, England, C1

Synthesizing the evidence for ketamine and esketamine in treatment-resistant depression: An international expert opinion on the available evidence and implementation

R McIntyre, J Rosenblat, C Nemeroff, G Sanacora, J Murrough, M Berk, E Brietzke, S Dodd, P Gorwood, R Ho, D Iosifescu, C Jaramillo, S Kasper, K Kratiuk, J Lee, Y Lee, L Lui, R Mansur, G Papakostas, M Subramaniapillai, M Thase, E Vieta, A Young, C Zarate, S Stahl

(2021), Vol. 178, pp. 383-399, American Journal of Psychiatry, Washington, D.C., C1

Risk of cancer in bipolar disorder and the potential role of lithium: International collaborative systematic review and meta-analyses

G Anmella, G Fico, M Lotfaliany, D Hidalgo-Mazzei, Ó Soto-Angona, A Giménez-Palomo, S Amoretti, A Murru, J Radua, A Solanes, I Pacchiarotti, N Verdolini, S Cowdery, S Dodd, L Williams, M Mohebbi, A Carvalho, L Kessing, E Vieta, M Berk

(2021), Vol. 126, pp. 529-541, Neuroscience and Biobehavioral Reviews, United States, C1

The Added Burden of Personality Disorder on Subsidized Australian Health Service Utilization Among Women With Mental State Disorder

Bianca Kavanagh, Stella Gwini, Julie Pasco, Amanda Stuart, Shae Quirk, James Gaston, Kara Holloway-Kew, Alyna Turner, Michael Berk, Olivia Dean, Andrew Chanen, Heli Koivumaa-Honkanen, Paul Moran, Rohan Borschmann, Lana Williams

(2021), Vol. 2, pp. 1-8, Frontiers in Global Women's Health, Lausanne, Switzerland, C1

Miniature FSCV Devices: A Review

D Corva, S Adams, K Bennet, M Berk, A Kouzani

(2021), Vol. 21, pp. 13006-13018, IEEE Sensors Journal, C1

Associations between dairy consumption and constipation in adults: A cross-sectional study

H Aslam, M Mohebbi, A Ruusunen, S Dawson, L Williams, M Berk, K Holloway-Kew, F Collier, A Loughman, J Pasco, F Jacka

(2021), pp. 1-9, Nutrition and Health, London, Eng., C1

The Dietary Inflammatory Index and Human Health: An Umbrella Review of Meta-Analyses of Observational Studies

W Marx, N Veronese, J Kelly, L Smith, M Hockey, S Collins, G Trakman, E Hoare, S Teasdale, A Wade, M Lane, H Aslam, J Davis, A O'neil, N Shivappa, J Hebert, L Blekkenhorst, M Berk, T Segasby, F Jacka

(2021), Vol. 12, pp. 1681-1690, Advances in Nutrition, United States, C1

Major depressive disorder in older patients as an inflammatory disorder: implications for the pharmacological management of geriatric depression

M Forbes, A O'Neil, M Lane, B Agustini, N Myles, M Berk

(2021), Vol. 38, pp. 451-467, Drugs and aging, Cham, Switzerland, C1

Influence of childhood trauma on the treatment outcomes of pharmacological and/or psychological interventions for adolescents and adults with bipolar disorder: protocol for a systematic review and meta-analysis

A Wrobel, S Russell, O Dean, S Cotton, M Berk, A Turner

(2021), Vol. 11, pp. 1-8, BMJ open, London, Eng., C1

Building brain capital

H Eyre, R Ayadi, W Ellsworth, G Aragam, E Smith, W Dawson, A Ibanez, C Altimus, M Berk, H Manji, E Storch, M Leboyer, N Kawaguchi, M Freeman, P Brannelly, F Manes, S Chapman, J Cummings, C Graham, B Miller, Z Sarnyai, R Meyer, W Hynes

(2021), Vol. 109, pp. 1430-1432, Neuron, Amsterdam, The Netherlands, C1

Translational evidence for the Inflammatory Response System (IRS)/Compensatory Immune Response System (CIRS) and neuroprogression theory of major depression

M Debnath, M Berk, M Maes

(2021), Vol. 111, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1

A review of the global impact of the covid-19 pandemic on public mental health, with a comparison between the usa, australia, and poland with taiwan and thailand

K Blizniewska-Kowalska, A Halaris, S Wang, K Su, M Maes, M Berk, P Galecki

(2021), Vol. 27, Medical Science Monitor, United States, C1

Assessing the feasibility of an m-Health intervention for changing diet quality and mood in individuals with depression: the My Food & Mood program

C Young, M Mohebbi, H Staudacher, M Berk, F Jacka, A O’Neil

(2021), Vol. 33, pp. 266-279, International Review of Psychiatry, London, Eng., C1

Preventive psychiatry: a blueprint for improving the mental health of young people

P Fusar-Poli, C Correll, C Arango, M Berk, V Patel, J Ioannidis

(2021), Vol. 20, pp. 200-221, World psychiatry, Chichester, Eng., C1

Polyphenols as adjunctive treatments in psychiatric and neurodegenerative disorders: Efficacy, mechanisms of action, and factors influencing inter-individual response

G Morris, E Gamage, N Travica, M Berk, F Jacka, A O'Neil, B Puri, A Carvalho, C Bortolasci, K Walder, W Marx

(2021), Vol. 172, pp. 101-122, Free radical biology and medicine, Amsterdam, The Netherlands, C1

The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all?

G Morris, C Bortolasci, B Puri, W Marx, A O'Neil, E Athan, K Walder, M Berk, L Olive, A Carvalho, M Maes

(2021), Vol. 144, Cytokine, England, C1

Hospital-in-the-Home as a Model for Mental Health Care Delivery: A Narrative Review

M Towicz, W Yang, S Moylan, R Tindall, M Berk

(2021), Vol. 72, pp. 1415-1427, Psychiatric services (Washington, D.C.), United States, C1

The lipid paradox in neuroprogressive disorders: causes and consequences

Gerwyn Morris, M Berk, K Walder, A O'Neil, M Maes, B Puri

(2021), Vol. 128, pp. 35-57, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

The endocannabinoidome in neuropsychiatry: Opportunities and potential risks

G Morris, K Walder, S Kloiber, P Amminger, M Berk, C Bortolasci, M Maes, B Puri, A Carvalho

(2021), Vol. 170, Pharmacological Research, Netherlands, C1

Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force

R Kupka, A Duffy, J Scott, J Almeida, V Balanzá-Martínez, B Birmaher, D Bond, E Brietzke, I Chendo, B Frey, I Grande, D Hafeman, T Hajek, M Hillegers, M Kauer-Sant’Anna, R Mansur, A van der Markt, R Post, M Tohen, H Tremain, G Vazquez, E Vieta, L Yatham, M Berk, M Alda, F Kapczinski

(2021), Vol. 23, pp. 659-678, Bipolar Disorders, Denmark, C1

The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial

W Marx, D Skvarc, M Mohebbi, A Walker, A Meehan, A Turner, A Baker, S Dodd, S Cotton, J Scott, B Kavanagh, M Ashton, E Brown, J McGrath, M Berk, O Dean

(2021), Vol. 12, Frontiers in Psychiatry, Switzerland, C1

Treatment of Refractory Obsessive-Compulsive Disorder with Nutraceuticals (TRON): A 20-week, open label pilot study

J Sarris, G Byrne, G Oliver, L Cribb, S Blair-West, D Castle, O Dean, D Camfield, V Brakoulias, C Bousman, N Dowling, C Ee, J Murphy, R Menon, M Berk, S Chamoli, M Boschen, C Ng

(2021), CNS Spectrums, United States, C1

Transcriptional modulation of the hippo signaling pathway by drugs used to treat bipolar disorder and schizophrenia

B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, G Morris, L Gray, J Kim, O Dean, M Berk, K Walder

(2021), Vol. 22, International Journal of Molecular Sciences, Switzerland, C1

Statins: Neurobiological underpinnings and mechanisms in mood disorders

A Walker, Y Kim, I Borissiouk, R Rehder, S Dodd, G Morris, A Nierenberg, M Maes, B Fernandes, O Dean, L Williams, H Eyre, S Kim, S Zoungas, A Carvalho, M Berk

(2021), Vol. 128, pp. 693-708, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

Cocaine-Induced Changes in Tonic Dopamine Concentrations Measured Using Multiple-Cyclic Square Wave Voltammetry in vivo

J Yuen, A Goyal, A Rusheen, A Kouzani, M Berk, J Kim, S Tye, C Blaha, K Bennet, D Jang, K Lee, H Shin, Y Oh

(2021), Vol. 12, Frontiers in Pharmacology, Switzerland, C1

A proof-of-concept study of maternal immune activation mediated induction of Toll-like receptor (TLR) and inflammasome pathways leading to neuroprogressive changes and schizophrenia-like behaviours in offspring

P Talukdar, F Abdul, M Maes, M Berk, G Venkatasubramanian, B Kutty, M Debnath

(2021), Vol. 52, pp. 48-61, European Neuropsychopharmacology, Amsterdam, The Netherlands, C1

The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment

A Giménez-Palomo, S Dodd, G Anmella, A Carvalho, G Scaini, J Quevedo, I Pacchiarotti, E Vieta, M Berk

(2021), Vol. 12, Frontiers in Psychiatry, Switzerland, C1

N-acetylcysteine (NAC) for methamphetamine dependence: A randomised controlled trial

R McKetin, O Dean, A Turner, P Kelly, B Quinn, D Lubman, P Dietze, G Carter, P Higgs, B Sinclair, D Reid, A Baker, V Manning, N Pas, T Thomas, R Bathish, D Raftery, A Wrobel, L Saunders, S Arunogiri, F Cordaro, H Hill, S Hall, P Clare, M Mohebbi, M Berk

(2021), Vol. 38, eClinicalMedicine, England, C1

Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability

M Solmi, M Suresh Sharma, E Osimo, M Fornaro, B Bortolato, G Croatto, A Miola, E Vieta, C Pariante, L Smith, P Fusar-Poli, J Shin, M Berk, A Carvalho

(2021), Vol. 97, pp. 193-203, Brain, Behavior, and Immunity, Netherlands, C1

Diabetes and mood disorders: shared mechanisms and therapeutic opportunities

L Martins, J Braga Tibães, M Berk, A Teixeira

(2021), pp. 1-13, International Journal of Psychiatry in Clinical Practice, London, Eng., C1

Mood Regulatory Actions of Active and Sham Nucleus Accumbens Deep Brain Stimulation in Antidepressant Resistant Rats

R Kale, T Nguyen, J Price, N Yates, K Walder, M Berk, R Sillitoe, A Kouzani, S Tye

(2021), Vol. 15, Frontiers in Human Neuroscience, Switzerland, C1

Baseline serum amino acid levels predict treatment response to augmentation with N-acetylcysteine (NAC) in a bipolar disorder randomised trial

C Bortolasci, A Turner, M Mohebbi, Z Liu, M Ashton, L Gray, W Marx, A Walker, G Kowalski, F Jacka, M Berk, O Dean, K Walder

(2021), Vol. 142, pp. 376-383, Journal of Psychiatric Research, England, C1

An Investigation Into Miniaturised Closed-Loop DBS Devices

Dean Corva, Scott Adams, Kevin Bennet, Parastoo Hashemi, Michael Berk, Abbas Kouzani

(2021), Vol. 3, pp. 671-680, IEEE Transactions on Medical Robotics and Bionics, Piscataway, N.J., C1

Anticonvulsant use and fracture: A case-control study

V Chandrasekaran, A Stuart, J Pasco, S Brennan-Olsen, M Berk, J Hodge, R Samarasinghe, L Williams

(2021), Vol. 21, pp. 422-428, Journal of Musculoskeletal Neuronal Interactions, Kifissia, Greece, C1

Gender, age at onset and duration of being ill as predictors for the long-term course and outcome of Schizophrenia: An international multi-center study

K Fountoulakis, E Dragioti, A Theofilidis, T Wiklund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L García-Alvarez, G Erzin, H Karadağ, A de Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M de Hert

(2021), CNS Spectrums, United States, C1

Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder

M Bauer, T Glenn, E Achtyes, M Alda, E Agaoglu, K Altınbaş, O Andreassen, E Angelopoulos, R Ardau, E Vares, M Aydin, Y Ayhan, C Baethge, R Bauer, B Baune, C Balaban, C Becerra-Palars, A Behere, P Behere, H Belete, T Belete, G Belizario, F Bellivier, R Belmaker, F Benedetti, M Berk, Y Bersudsky, Ş Bicakci, H Birabwa-Oketcho, T Bjella, C Brady, J Cabrera, M Cappucciati, A Castro, W Chen, E Cheung, S Chiesa, M Crowe, A Cuomo, S Dallaspezia, M Del Zompo, P Desai, S Dodd, M Donix, B Etain, A Fagiolini, F Fellendorf, E Ferensztajn-Rochowiak, J Fiedorowicz, K Fountoulakis, M Frye, P Geoffroy, A Gonzalez-Pinto, J Gottlieb, P Grof, B Haarman, H Harima, M Hasse-Sousa, C Henry, L Høffding, J Houenou, M Imbesi, E Isometsä, M Ivkovic, S Janno, S Johnsen, F Kapczinski, G Karakatsoulis, M Kardell, L Kessing, S Kim, B König, T Kot, M Koval, M Kunz, B Lafer, M Landén, E Larsen, M Lenger, U Lewitzka, R Licht, C Lopez-Jaramillo, A MacKenzie, H Madsen, S Madsen, J Mahadevan, A Mahardika, M Manchia, W Marsh, M Martinez-Cengotitabengoa, K Martiny, Y Mashima, D McLoughlin, Y Meesters, I Melle, F Meza-Urzúa, M Ming, S Monteith, M Moorthy, G Morken

(2021), Vol. 9, International Journal of Bipolar Disorders, Germany, C1

Biological mechanism(S) underpinning the association between antipsychotic drugs and weight gain

B Panizzutti, C Bortolasci, B Spolding, S Kidnapillai, T Connor, M Richardson, T Truong, Z Liu, L Gray, J Kim, O Dean, M Berk, K Walder

(2021), Vol. 10, Journal of Clinical Medicine, Switzerland, C1

Implications of the COVID-19 pandemic for people with bipolar disorders: A scoping review

M Fornaro, M De Prisco, M Billeci, E Ermini, A Young, B Lafer, J Soares, E Vieta, J Quevedo, A de Bartolomeis, K Sim, L Yatham, M Bauer, D Stein, M Solmi, M Berk, A Carvalho

(2021), Vol. 295, pp. 740-751, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Increased maternal mental health burden in a representative longitudinal community cohort coinciding with COVID-19 lockdown

A Loughman, J Hedley, C Olsson, M Berk, S Moylan, R Saffery, P Sly, M Tang, A Ponsonby, P Vuillermin

(2021), Vol. 73, pp. 578-585, Australian Journal of Psychology, London, England, C1

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations

L Yatham, T Chakrabarty, D Bond, A Schaffer, S Beaulieu, S Parikh, R McIntyre, R Milev, M Alda, G Vazquez, A Ravindran, B Frey, V Sharma, B Goldstein, S Rej, C O’Donovan, V Tourjman, J Kozicky, M Kauer-Sant’Anna, G Malhi, T Suppes, E Vieta, F Kapczinski, S Kanba, R Lam, S Kennedy, J Calabrese, M Berk, R Post

(2021), Vol. 23, pp. 767-788, Bipolar Disorders, Denmark, C1

A placebo-controlled, randomised pilot trial of N-acetylcysteine or placebo for cessation of tobacco smoking

L Arancini, M Mohebbi, M Berk, O Dean, C Bortolasci, B Spolding, R Zazula, S Dodd

(2021), Vol. 53, pp. 120-126, European Neuropsychopharmacology, Amsterdam, The Netherlands, C1

Deep learning for neuroimaging-based diagnosis and rehabilitation of Autism Spectrum Disorder: A review

M Khodatars, A Shoeibi, D Sadeghi, N Ghaasemi, M Jafari, P Moridian, A Khadem, R Alizadehsani, A Zare, Y Kong, A Khosravi, S Nahavandi, S Hussain, U Acharya, M Berk

(2021), Vol. 139, Computers in Biology and Medicine, United States, C1

Universal depression prevention: An umbrella review of meta-analyses

E Hoare, S Collins, W Marx, E Callaly, R Moxham-Smith, P Cuijpers, A Holte, A Nierenberg, N Reavley, H Christensen, C Reynolds, A Carvalho, F Jacka, M Berk

(2021), Vol. 144, pp. 483-493, Journal of Psychiatric Research, Amsterdam, The Netherlands, C1

Dietary quality and nutrient intake in adults with obsessive-compulsive disorder

T Nguyen, L Cribb, C Ng, G Byrne, D Castle, V Brakoulias, S Blair-West, G Oliver, C Ee, O Dean, D Camfield, C Bousman, N Dowling, R Roy, M Berk, J Sarris

(2021), Vol. 7, BJPsych Open, C1

Mindfulness-Based Online Intervention to Improve Quality of Life in Late-Stage Bipolar Disorder: A Randomized Clinical Trial

G Murray, N Thomas, E Michalak, S Jones, S Lapsley, S Bowe, F Foley, K Fletcher, T Perich, S Johnson, S Cotton, L Berk, C Mihalopoulos, M Kyrios, M Berk

(2021), Vol. 89, pp. 830-844, Journal of Consulting and Clinical Psychology, Washington, D.C., C1

Microdialysis and microperfusion electrodes in neurologic disease monitoring

L Stangler, A Kouzani, K Bennet, L Dumee, M Berk, G Worrell, S Steele, T Burns, C Howe

(2021), Vol. 18, Fluids and Barriers of the CNS, England, C1

Exploring interleukin-6, lipopolysaccharide binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression

K Hasebe, M Mohebbi, L Gray, A Walker, C Bortolasci, A Turner, M Berk, K Walder, M Maes, B Kanchanatawan, M Ashton, L Berk, C Ng, G Malhi, A Singh, O Dean

(2021), Vol. 34, Acta Neuropsychiatrica, England, C1

Social isolation, social support and loneliness as predictors of cardiovascular disease incidence and mortality

R Freak-Poli, J Ryan, J Neumann, A Tonkin, C Reid, R Woods, M Nelson, N Stocks, M Berk, J McNeil, C Britt, A Owen

(2021), Vol. 21, BMC Geriatrics, England, C1

Effect of Vitamin D Supplementation on Outcomes in People with Early Psychosis: The DFEND Randomized Clinical Trial

F Gaughran, D Stringer, G Wojewodka, S Landau, S Smith, P Gardner-Sood, D Taylor, H Jordan, E Whiskey, A Krivoy, S Ciufolini, B Stubbs, C Casetta, J Williams, S Moore, L Allen, S Rathod, A Boardman, R Khalifa, M Firdosi, P McGuire, M Berk, J McGrath

(2021), Vol. 4, JAMA Network Open, United States, C1

The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder

S Kidnapillai, C Bortolasci, M Udawela, B Panizzutti, B Spolding, T Connor, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, E Scarr, M Leboyer, B Dean, M Berk, K Walder

(2020), Vol. 21, pp. 775-783, World Journal of Biological Psychiatry, England, C1

Fermented foods, the gut and mental health: a mechanistic overview with implications for depression and anxiety

H Aslam, J Green, F Jacka, F Collier, M Berk, J Pasco, S Dawson

(2020), Vol. 23, pp. 659-671, Nutritional Neuroscience, England, C1

Personality disorder and functioning in major depressive disorder: a nested study within a randomized controlled trial

Bianca Kavanagh, Lana Williams, Michael Berk, Alyna Turner, Henry Jackson, Mohammadreza Mohebbi, Buranee Kanchanatawan, Melanie Ashton, Chee Ng, Michael Maes, Lesley Berk, Gin Malhi, Nathan Dowling, Ajeet Singh, Olivia Dean

(2020), Vol. 42, pp. 14-21, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1

Unravelled facets of milk derived opioid peptides: a focus on gut physiology, fractures and obesity

Hajara Aslam, Anu Ruusunen, Michael Berk, Amy Loughman, Leni Rivera, Julie Pasco, Felice Jacka

(2020), Vol. 71, pp. 36-49, International journal of food sciences and nutrition, Abingdon, Eng., C1

Are remitted affective disorders and familial risk of affective disorders associated with metabolic syndrome, inflammation and oxidative stress? - A monozygotic twin study

N Ottesen, I Meluken, R Frikke-Schmidt, P Plomgaard, T Scheike, B Fernandes, M Berk, H Poulsen, L Kessing, K Miskowiak, M Vinberg

(2020), pp. 1-10, Psychological Medicine, Cambridge, Eng., C1

EPA and DHA as markers of nutraceutical treatment response in major depressive disorder

K van der Burg, L Cribb, J Firth, D Karmacoska, D Mischoulon, G Byrne, C Bousman, C Stough, J Murphy, G Oliver, M Berk, C Ng, J Sarris

(2020), Vol. 59, pp. 2439-2447, European Journal of Nutrition, Germany, C1

Impact of antipsychotic medication on IL-6/STAT3 signaling axis in peripheral blood mononuclear cells of drug-naive schizophrenia patients

M Subbanna, V Shivakumar, D Venugopal, J Narayanaswamy, M Berk, S Varambally, G Venkatasubramanian, M Debnath

(2020), Vol. 74, pp. 64-69, Psychiatry and clinical neurosciences, Chichester, Eng., C1

Opportunities in the Australian national education initiative for promoting mental health in schools

E Hoare, A Thorp, N Bartholomeusz-Raymond, A McCoy, M Berk

(2020), Vol. 4, pp. 11-13, The Lancet Child and Adolescent Health, England, C1

Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive N-acetylcysteine and mitochondrial agents in adults with bipolar disorder: a sub-study of a randomised placebo-controlled trial

M Ashton, O Dean, W Marx, M Mohebbi, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, K Faye-Chauhan, Y Kim, S Dash, F Jacka, N Shivappa, J Hebert, A Turner

(2020), Vol. 54, pp. 159-172, Australian and New Zealand journal of psychiatry, London, Eng., C1

The effect of emerging nutraceutical interventions for clinical and biological outcomes in multiple sclerosis: A systematic review

W Marx, M Hockey, A McGuinness, M Lane, J Christodoulou, I van der Mei, M Berk, O Dean, B Taylor, S Broadley, J Lechner-Scott, F Jacka, R Lucas, A Ponsonby

(2020), Vol. 37, Multiple Sclerosis and Related Disorders, Netherlands, C1

Differences in the immune-inflammatory profiles of unipolar and bipolar depression

A Brunoni, T Supasitthumrong, A Teixeira, E Vieira, W Gattaz, I Benseñor, P Lotufo, B Lafer, M Berk, A Carvalho, M Maes

(2020), Vol. 262, pp. 8-15, Journal of Affective Disorders, Netherlands, C1

S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial

J Sarris, J Murphy, C Stough, D Mischoulon, C Bousman, P MacDonald, L Adams, S Nazareth, G Oliver, L Cribb, K Savage, R Menon, S Chamoli, M Berk, C Ng, G Byrne

(2020), Vol. 237, pp. 209-218, Psychopharmacology, Berlin, Germany, C1

Depression, stress and vascular function from childhood to adolescence: a longitudinal investigation

L Olive, W Abhayaratna, D Byrne, R Telford, M Berk, R Telford

(2020), Vol. 62, pp. 6-12, General hospital psychiatry, Amsterdam, The Netherlands, C1

Depression in the medically ill

J Rosenblat, P Kurdyak, F Cosci, M Berk, M Maes, A Brunoni, M Li, G Rodin, R McIntyre, A Carvalho

(2020), Vol. 54, pp. 346-366, Australian and New Zealand Journal of Psychiatry, London, Eng., C1

Physical activity as a predictor of clinical trial outcomes in bipolar depression: a subanalysis of a mitochondrial-enhancing nutraceutical randomized controlled trial

M Ashton, M Mohebbi, A Turner, W Marx, M Berk, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, M Hopwood, B Stubbs, O Dean

(2020), Vol. 65, pp. 306-318, Canadian journal of psychiatry, London, Eng., C1

Meta-analysis of randomised controlled trials with N-acetylcysteine in the treatment of schizophrenia

C Yolland, D Hanratty, E Neill, S Rossell, M Berk, O Dean, D Castle, E Tan, A Phillipou, A Harris, A Barreiros, A Hansen, D Siskind

(2020), Vol. 54, pp. 453-466, Australian and New Zealand journal of psychiatry, London, Eng., C1

Vitamin D supplementation compared to placebo in people with First Episode psychosis - Neuroprotection Design (DFEND): A protocol for a randomised, double-blind, placebo-controlled, parallel-group trial

F Gaughran, D Stringer, M Berk, S Smith, D Taylor, E Whiskey, S Landau, R Murray, P McGuire, P Gardner-Sood, G Wojewodka, S Ciufolini, H Jordan, J Clarke, L Allen, A Krivoy, B Stubbs, P Lowe, M Arbuthnott, S Rathod, A Boardman, M Firdosi, J McGrath

(2020), Vol. 21, Trials, England, C1

Drugs used to treat bipolar disorder act via microRNAs to regulate expression of genes involved in neurite outgrowth

S Kidnapillai, B Wade, C Bortolasci, B Panizzutti, B Spolding, T Connor, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder

(2020), Vol. 34, pp. 370-379, Journal of Psychopharmacology, United States, C1

The role of microglia in neuroprogressive disorders: mechanisms and possible neurotherapeutic effects of induced ketosis

G Morris, B Puri, M Maes, L Olive, M Berk, A Carvalho

(2020), Vol. 99, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1

Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): A randomised clinical trial of rosuvastatin and aspirin

M Berk, M Mohebbi, O Dean, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Weller, A MacKinnon, F Giorlando, S Baird, L Incerti, R Brodie, N Ferguson, S Rice, M Schäfer, E Mullen, S Hetrick, M Kerr, S Harrigan, A Quinn, C Mazza, P McGorry, C Davey

(2020), Vol. 18, BMC Medicine, England, C1

TinyFSCV: FSCV for the Masses

S Adams, E Doeven, S Tye, K Bennet, M Berk, A Kouzani

(2020), Vol. 28, pp. 133-142, IEEE Transactions on Neural Systems and Rehabilitation Engineering, Piscataway, N.J., C1

Risk of dementia in bipolar disorder and the interplay of lithium: a systematic review and meta-analyses

J Velosa, A Delgado, E Finger, M Berk, F Kapczinski, T de Azevedo Cardoso

(2020), Vol. 141, pp. 510-521, Acta Psychiatrica Scandinavica, United States, C1

Clozapine and the Course of Bipolar Disorder in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

M Costa, M Kunz, A Nierenberg, T Deckersbach, M Berk, P Magalhaes

(2020), Vol. 65, pp. 245-252, Canadian Journal of Psychiatry, United States, C1

Mental, behavioral and neurodevelopmental disorders in the ICD-11: An international perspective on key changes and controversies

D Stein, P Szatmari, W Gaebel, M Berk, E Vieta, M Maj, Y De Vries, A Roest, P De Jonge, A Maercker, C Brewin, K Pike, C Grilo, N Fineberg, P Briken, P Cohen-Kettenis, G Reed

(2020), Vol. 18, BMC Medicine, England, C1

A multi-national, multi-disciplinary Delphi consensus study on using omega-3 polyunsaturated fatty acids (n-3 PUFAs) for the treatment of major depressive disorder

T Guu, D Mischoulon, J Sarris, J Hibbeln, R McNamara, K Hamazaki, M Freeman, M Maes, Y Matsuoka, R Belmaker, W Marx, C Pariante, M Berk, F Jacka, K Su

(2020), Vol. 265, pp. 233-238, Journal of affective disorders, Amsterdam, The Netherlands, C1

The association of antihypertensive use and depressive symptoms in a large older population with hypertension living in Australia and the United States: a cross-sectional study

B Agustini, M Mohebbi, R Woods, J McNeil, M Nelson, R Shah, A Murray, M Ernst, C Reid, A Tonkin, J Lockery, M Berk

(2020), Vol. 34, pp. 787-794, Journal of Human Hypertension, England, C1

The effect of combined treatment with SSRIs and renin-angiotensin system (RAS) drugs: A propensity score matched cohort study

O Köhler-Forsberg, L Petersen, M Berk, C Gasse, S Østergaard

(2020), Vol. 32, pp. 120-130, European Neuropsychopharmacology, Netherlands, C1

Neurodevelopmental pathways in bipolar disorder

S Kloiber, J Rosenblat, M Husain, A Ortiz, M Berk, J Quevedo, E Vieta, M Maes, B Birmaher, J Soares, A Carvalho

(2020), Vol. 112, pp. 213-226, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?

G Morris, B Puri, A Carvalho, M Maes, M Berk, A Ruusunen, L Olive

(2020), Vol. 23, pp. 366-384, International Journal of Neuropsychopharmacology, England, C1

Bone health in bipolar disorder: A study protocol for a case-control study in Australia

L Williams, A Stuart, M Berk, S Brennan-Olsen, J Hodge, S Cowdery, V Chandrasekaran, J Pasco

(2020), Vol. 10, BMJ Open, England, C1

Nutritional ketosis as an intervention to relieve astrogliosis: Possible therapeutic applications in the treatment of neurodegenerative and neuroprogressive disorders

G Morris, M Maes, M Berk, A Carvalho, B Puri

(2020), Vol. 63, European Psychiatry, England, C1

Minocycline for the treatment of mental health and neurological conditions: study protocol of a systematic review and meta-analysis

C Bortolasci, W Marx, A Walker, K Hasebe, B Kavanagh, M Morris, M Mohebbi, A Turner, L Gray, L Berk, K Walder, M Berk, O Dean

(2020), Vol. 10, pp. e035080-, BMJ open, England, C1

Depression Heterogeneity and Its Biological Underpinnings: Toward Immunometabolic Depression

Y Milaneschi, F Lamers, M Berk, B Penninx

(2020), Vol. 88, pp. 369-380, Biological Psychiatry, New York, N.Y., C1

Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats

J Lotter, M Möller, O Dean, M Berk, B Harvey

(2020), Vol. 11, Frontiers in Psychiatry, Switzerland, C1

Neurovegetative symptom subtypes in young people with major depressive disorder and their structural brain correlates

Y Toenders, L Schmaal, B Harrison, R Dinga, M Berk, C Davey

(2020), Vol. 10, Translational Psychiatry, United States, C1

Patterns of Association between Depressive Symptoms and Chronic Medical Morbidities in Older Adults

B Agustini, M Lotfaliany, R Woods, J McNeil, M Nelson, R Shah, A Murray, M Ernst, C Reid, A Tonkin, J Lockery, L Williams, M Berk, M Mohebbi

(2020), Vol. 68, pp. 1834-1841, Journal of the American Geriatrics Society, Chichester, Eng., C1

Evidence-based umbrella review of 162 peripheral biomarkers for major mental disorders

A Carvalho, M Solmi, M Sanches, M Machado, B Stubbs, O Ajnakina, C Sherman, Y Sun, C Liu, A Brunoni, G Pigato, B Fernandes, B Bortolato, M Husain, E Dragioti, J Firth, T Cosco, M Maes, M Berk, K Lanctôt, E Vieta, D Pizzagalli, L Smith, P Fusar-Poli, P Kurdyak, M Fornaro, J Rehm, N Herrmann

(2020), Vol. 10, Translational Psychiatry, United States, C1

Precision psychiatry with immunological and cognitive biomarkers: a multi-domain prediction for the diagnosis of bipolar disorder or schizophrenia using machine learning

B Fernandes, C Karmakar, R Tamouza, T Tran, J Yearwood, N Hamdani, H Laouamri, J Richard, R Yolken, M Berk, S Venkatesh, M Leboyer

(2020), Vol. 10, Translational Psychiatry, United States, C1

Effect of aspirin vs placebo on the prevention of depression in older people: a randomized clinical trial

M Berk, R Woods, M Nelson, R Shah, C Reid, E Storey, S Fitzgerald, J Lockery, R Wolfe, M Mohebbi, S Dodd, A Murray, N Stocks, P Fitzgerald, C Mazza, B Agustini, J McNeil

(2020), Vol. 77, pp. 1012-1020, JAMA psychiatry, Chicago, Ill., C1

Lithium therapy and its interactions

G Malhi, E Bell, T Outhred, M Berk

(2020), Vol. 43, pp. 91-93, Australian Prescriber, Deakin West, A.C.T., C1

Genetic gateways to COVID-19 infection: implications for risk, severity, and outcomes

M Debnath, M Banerjee, M Berk

(2020), Vol. 34, pp. 8787-8795, FASEB journal, Chichester, Eng., C1

A Randomized Controlled Trial of Transcultural Validation of Group-Based Psychosocial Intervention for Patients with Bipolar Disorder

C Lin, Y Huang, K Huang, S Wu, Y Chang, H Yeh, C Chang, I Lin, H Huang, F Sun, M Berk, S Liu

(2020), Vol. 290, Psychiatry Research, Ireland, C1

Interleukin-6 and total antioxidant capacity levels following N-acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder

C Bortolasci, C Voigt, A Turner, M Mohebbi, L Gray, S Dodd, K Walder, M Berk, S Cotton, G Malhi, C Ng, N Dowling, J Sarris, O Dean

(2020), Vol. 32, pp. 313-320, Acta Neuropsychiatrica, England, C1

The influence of stage of illness on functional outcomes after psychological treatment in bipolar disorder: a systematic review

H Tremain, K Fletcher, J Scott, C McEnery, M Berk, G Murray

(2020), Vol. 22, pp. 666-692, Bipolar disorders, Chichester, Eng., C1

Explanatory style in youth self-harm: an Indian qualitative study to inform intervention design

S Aggarwal, G Patton, D Bahl, N Shah, M Berk, V Patel

(2020), Vol. 23, pp. 100-106, Evidence-based mental health, London, Eng., C1

Personality disorder increases risk of low quality of life among women with mental state disorders

B Kavanagh, A Stuart, M Berk, A Turner, O Dean, J Pasco, H Jackson, H Koivumaa-Honkanen, A Chanen, L Williams

(2020), Vol. 102, Comprehensive Psychiatry, United States, C1

The pathophysiology of SARS-CoV-2: A suggested model and therapeutic approach

G Morris, C Bortolasci, B Puri, L Olive, W Marx, A O'Neil, E Athan, A Carvalho, M Maes, K Walder, M Berk

(2020), Vol. 258, Life Sciences, Netherlands, C1

A multi-centre, double-blind, 12-week, randomized, placebo-controlled trial to assess the efficacy of adjunctive N-Acetylcysteine for treatment-resistant PTSD: A study protocol

A Maier, A Dharan, G Oliver, M Berk, S Redston, S Back, P Kalivas, C Ng, R Kanaan

(2020), Vol. 20, BMC Psychiatry, England, C1

Validity of self-reported cancer: Comparison between self-report versus cancer registry records in the Geelong Osteoporosis Study

S Cowdery, A Stuart, J Pasco, M Berk, D Campbell, L Williams

(2020), Vol. 68, Cancer Epidemiology, Netherlands, C1

The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials

M Fornaro, A Carvalho, A Fusco, A Anastasia, M Solmi, M Berk, K Sim, E Vieta, A de Bartolomeis

(2020), Vol. 276, pp. 970-983, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Promoting tech transfer between space and global mental health

D Chang, E Storch, L Black, M Berk, N Pellis, H Lavretsky, J Sutton, K Ternes, M Shepanek, E Smith, R Abbott, H Eyre

(2020), Vol. 91, pp. 737-745, Aerospace Medicine and Human Performance, United States, C1

Antihypertensive Drugs and Risk of Depression: A Nationwide Population-Based Study

L Kessing, H Rytgaard, C Ekstrøm, C Torp-Pedersen, M Berk, T Gerds

(2020), Vol. 76, pp. 1263-1279, Hypertension, United States, C1

Prebiotics, probiotics, fermented foods and cognitive outcomes: A meta-analysis of randomized controlled trials

Wolfgang Marx, Andrew Scholey, Joseph Firth, Nathan D’Cunha, Melissa Lane, Meghan Hockey, Melanie Ashton, John Cryan, A O'Neil, Nenad Naumovski, Michael Berk, Olivia Dean, Felice Jacka

(2020), Vol. 118, pp. 472-484, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1

Antidiabetes agents and incident depression: A nationwide population-based study

L Kessing, H Rytgaard, C Ekstrøm, F Knop, M Berk, T Gerds

(2020), Vol. 43, pp. 3050-3060, Diabetes Care, United States, C1

Non-alcoholic fatty liver disease (NAFLD) as a neglected metabolic companion of psychiatric disorders: Common pathways and future approaches

Ó Soto-Angona, G Anmella, M Valdés-Florido, N De Uribe-Viloria, A Carvalho, B Penninx, M Berk

(2020), Vol. 18, BMC Medicine, England, C1

The associations between dairy product consumption and biomarkers of inflammation, adipocytokines, and oxidative stress in children: A cross-sectional study

H Aslam, F Jacka, W Marx, K Karatzi, C Mavrogianni, E Karaglani, M Mohebbi, J Pasco, A O’neil, M Berk, T Nomikos, S Kanellakis, O Androutsos, Y Manios, G Moschonis

(2020), Vol. 12, pp. 1-15, Nutrients, Switzerland, C1

Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?

G Morris, E Athan, K Walder, C Bortolasci, A O'Neil, W Marx, M Berk, A Carvalho, M Maes, B Puri

(2020), Vol. 262, Life Sciences, Netherlands, C1

Endothelial dysfunction in neuroprogressive disorders-causes and suggested treatments

G Morris, B Puri, L Olive, A Carvalho, M Berk, K Walder, L Gustad, M Maes

(2020), Vol. 18, BMC Medicine, England, C1

Dietary tryptophan and bone health: a cross-sectional, population-based study

J Cleminson, A Stuart, J Pasco, J Hodge, M Berk, R Samarasinghe, L Williams

(2020), Vol. 15, Archives of Osteoporosis, England, C1

Transcriptional effects of psychoactive drugs on genes involved in neurogenesis

C Bortolasci, B Spolding, S Kidnapillai, T Connor, T Truong, Z Liu, B Panizzutti, M Richardson, L Gray, M Berk, O Dean, K Walder

(2020), Vol. 21, pp. 1-19, International Journal of Molecular Sciences, Switzerland, C1

Effect of Sodium Benzoate vs Placebo Among Individuals With Early Psychosis: A Randomized Clinical Trial

J Scott, A Baker, C Lim, S Foley, F Dark, A Gordon, D Ward, D Richardson, G Bruxner, K Beckmann, S Hatherill, S Stathis, K Dixon, A Ryan, B McWhinney, J Ungerer, M Berk, O Dean, S Saha, J McGrath

(2020), Vol. 3, pp. e2024335-, JAMA network open, United States, C1

Bipolar disorders

R McIntyre, M Berk, E Brietzke, B Goldstein, C López-Jaramillo, L Kessing, G Malhi, A Nierenberg, J Rosenblat, A Majeed, E Vieta, M Vinberg, A Young, R Mansur

(2020), Vol. 396, pp. 1841-1856, The Lancet, England, C1

The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary

G Malhi, E Bell, P Boyce, D Bassett, M Berk, R Bryant, M Gitlin, A Hamilton, P Hazell, M Hopwood, B Lyndon, R McIntyre, G Morris, R Mulder, R Porter, A Singh, L Yatham, A Young, G Murray

(2020), Vol. 22, pp. 805-821, Bipolar Disorders, London, Eng., C1

Study protocol for the systematic review and meta-analyses of the association between schizophrenia and bone fragility

B Azimi Manavi, A Stuart, J Pasco, J Hodge, K Corney, M Berk, L Williams

(2020), Vol. 10, BMJ Open, England, C1

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders: Major depression summary

G Malhi, E Bell, A Singh, D Bassett, M Berk, P Boyce, R Bryant, M Gitlin, A Hamilton, P Hazell, M Hopwood, B Lyndon, R McIntyre, G Morris, R Mulder, R Porter, L Yatham, A Young, G Murray

(2020), Vol. 22, pp. 788-804, Bipolar Disorders, London, Eng., C1

Efficacy and safety of fecal microbiota transplantation for the treatment of diseases other than Clostridium difficile infection: a systematic review and meta-analysis

J Green, J Davis, M Berk, C Hair, A Loughman, D Castle, E Athan, A Nierenberg, J Cryan, F Jacka, W Marx

(2020), Vol. 12, pp. 1-25, Gut Microbes, United States, C1

Personality Disorder and Physical Health Comorbidities: A Link With Bone Health?

L Williams, S Quirk, H Koivumaa-Honkanen, R Honkanen, J Pasco, A Stuart, B Kavanagh, J Heikkinen, M Berk

(2020), Vol. 11, Frontiers in Psychiatry, Switzerland, C1

Psychosocial Intervention With or Without Antipsychotic Medication for First-Episode Psychosis: A Randomized Noninferiority Clinical Trial

Shona Francey, Brian O’Donoghue, Barnaby Nelson, Jessica Graham, Lara Baldwin, Hok Yuen, Melissa Kerr, Aswin Ratheesh, Kelly Allott, Mario Alvarez-Jimenez, Alex Fornito, Susy Harrigan, Andrew Thompson, Stephen Wood, Michael Berk, Patrick McGorry

(2020), Vol. 1, pp. 1-11, Schizophrenia Bulletin Open, Oxford, Eng., C1

Exploring A-Acetylcysteine in Psychiatry

A Gimenez-Palomo, S Dodd, O Dean, C Bortolasci, M Berk

(2020), Vol. 37, pp. 48-51, Psychiatric Times, Santa Ana, Calif., C1-1

The role of depression pharmacogenetic decision support tools in shared decision making

K Arandjelovic, H Eyre, E Lenze, A Singh, M Berk, C Bousman

(2019), Vol. 126, pp. 87-94, Journal of Neural Transmission, Austria, C1

A randomized controlled trial of MoodSwings 2.0: An internet-based self-management program for bipolar disorder

E Gliddon, V Cosgrove, L Berk, S Lauder, M Mohebbi, D Grimm, S Dodd, C Coulson, K Raju, T Suppes, M Berk

(2019), Vol. 21, pp. 28-39, Bipolar Disorders, London, Eng., C1

Could Alzheimer's Disease Originate in the Periphery and If So How So?

G Morris, M Berk, M Maes, B Puri

(2019), Vol. 56, pp. 406-434, Molecular Neurobiology, United States, C1

Does N-acetylcysteine improve behaviour in children with autism?: A mixed-methods analysis of the effects of N-acetylcysteine

O Dean, K Gray, S Dodd, K Villagonzalo, E Brown, B Tonge, M Berk, L Byrne

(2019), Vol. 44, pp. 474-480, Journal of Intellectual and Developmental Disability, C1

Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants

B O'Donoghue, S Francey, B Nelson, A Ratheesh, K Allott, J Graham, L Baldwin, M Alvarez-Jimenez, A Thompson, A Fornito, A Polari, M Berk, C Macneil, K Crisp, C Pantelis, H Yuen, S Harrigan, P McGorry

(2019), Vol. 13, pp. 953-960, Early Intervention in Psychiatry, Australia, C1

Association of depression with mortality in an elderly treated hypertensive population

E Chowdhury, M Berk, M Nelson, L Wing, C Reid

(2019), Vol. 31, pp. 371-381, International Psychogeriatrics, England, C1

New drug candidates for depression - a nationwide population-based study

L Kessing, H Rytgaard, T Gerds, M Berk, C Ekstrøm, P Andersen

(2019), Vol. 139, pp. 68-77, Acta Psychiatrica Scandinavica, United States, C1

Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial

Melanie Ashton, Michael Berk, Chee Ng, Malcolm Hopwood, Seetal Dodd, Alyna Turner, Ellie Brown, Felice Jacka, Susan Cotton, Jon-Paul Khoo, Mary Chatterton, Bianca Kavanagh, Sarah Nadjidai, Samantha Lo Monaco, Brian Harvey, Jerome Sarris, Gin Malhi, Nathan Dowling, Olivia Dean

(2019), Vol. 41, pp. 245-253, Brazilian journal of psychiatry, Sao Paulo, Brazil, C1

The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: An integrative review of evidence, mechanisms, and clinical implications

M Fornaro, A Anastasia, S Novello, A Fusco, R Pariano, D De Berardis, M Solmi, N Veronese, B Stubbs, E Vieta, M Berk, A de Bartolomeis, A Carvalho

(2019), Vol. 139, pp. 494-502, Pharmacological Research, Netherlands, C1

Nutraceuticals for major depressive disorder- more is not merrier: An 8-week double-blind, randomised, controlled trial

J Sarris, G Byrne, C Stough, C Bousman, D Mischoulon, J Murphy, P Macdonald, L Adams, S Nazareth, G Oliver, L Cribb, K Savage, R Menon, S Chamoli, M Berk, C Ng

(2019), Vol. 245, pp. 1007-1015, Journal of Affective Disorders, Netherlands, C1

Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: Consensus definition

D Hidalgo-Mazzei, M Berk, A Cipriani, A Cleare, A Florio, D Dietch, J Geddes, G Goodwin, H Grunze, J Hayes, I Jones, S Kasper, K Macritchie, R McAllister-Williams, R Morriss, S Nayrouz, S Pappa, J Soares, D Smith, T Suppes, P Talbot, E Vieta, S Watson, L Yatham, A Young, P Stokes

(2019), Vol. 214, pp. 27-35, British Journal of Psychiatry, England, C1

WFSBP guidelines on how to grade treatment evidence for clinical guideline development

A Hasan, B Bandelow, L Yatham, M Berk, P Falkai, H Möller, S Kasper

(2019), Vol. 20, pp. 2-16, World Journal of Biological Psychiatry, England, C1

Association between childhood trauma exposure and pro-inflammatory cytokines in schizophrenia and bipolar-I disorder

Y Quidé, C Bortolasci, B Spolding, S Kidnapillai, O Watkeys, S Cohen-Woods, M Berk, V Carr, K Walder, M Green

(2019), Vol. 49, pp. 2736-2744, Psychological Medicine, England, C1

The efficacy of adjunctive N-acetylcysteine in acute bipolar depression: A randomized placebo-controlled study

P Ellegaard, R Licht, R Nielsen, O Dean, M Berk, H Poulsen, M Mohebbi, C Nielsen

(2019), Vol. 245, pp. 1043-1051, Journal of Affective Disorders, Netherlands, C1

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: Mitochondrial agents, N-acetylcysteine, and placebo

M Berk, A Turner, G Malhi, C Ng, S Cotton, S Dodd, Y Samuni, M Tanious, C McAulay, N Dowling, J Sarris, L Owen, A Waterdrinker, D Smith, O Dean

(2019), Vol. 17, BMC Medicine, England, C1

The impact of urbanization on mood disorders: an update of recent evidence

Erin Hoare, Felice Jacka, Michael Berk

(2019), Vol. 32, pp. 198-203, Current opinion in psychiatry, Philadelphia, Pa., C1

Socioeconomic Deprivation, Adverse Childhood Experiences and Medical Disorders in Adulthood: Mechanisms and Associations

G Morris, M Berk, M Maes, A Carvalho, B Puri

(2019), Vol. 56, pp. 5866-5890, Molecular Neurobiology, United States, C1

Putative neuroprotective pharmacotherapies to target the staged progression of mental illness

O Robertson, N Coronado, R Sethi, M Berk, S Dodd

(2019), Vol. 13, pp. 1032-1049, Early Intervention in Psychiatry, Australia, C1

Improving functional outcomes in early-stage bipolar disorder: The protocol for the REsearch into COgnitive and behavioural VERsatility trial

S Cotton, M Berk, H Jackson, G Murray, K Filia, M Hasty, A Chanen, C Davey, B Nelson, A Ratheesh, C MacNeil

(2019), Vol. 13, pp. 1470-1479, Early Intervention in Psychiatry, Australia, C1

Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop?

Gerwyn Morris, Michael Maes, Michael Berk, Basant Puri

(2019), Vol. 34, pp. 385-415, Metabolic brain disease, New York, N.Y., C1

Bipolar disorder and bone health: a systematic review

Vinoomika Chandrasekaran, Sharon Brennan-Olsen, Amanda Stuart, Julie Pasco, Michael Berk, Jason Hodge, Lana Williams

(2019), Vol. 249, pp. 262-269, Journal of affective disorders, Amsterdam, The Netherlands, C1

Development of a miniature device for emerging deep brain stimulation paradigms

S Adams, K Bennet, S Tye, M Berk, A Kouzani

(2019), Vol. 14, PLoS ONE, United States, C1

Buffering against maladaptive perfectionism in bipolar disorder: the role of self-compassion

Kathryn Fletcher, Yan Yang, Sheri Johnson, Michael Berk, Tania Perich, Sue Cotton, Steven Jones, Sara Lapsley, Erin Michalak, Greg Murray

(2019), Vol. 250, pp. 132-139, Journal of affective disorders, Amsterdam, The Netherlands, C1

Association between solar insolation and a history of suicide attempts in bipolar I disorder

M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, Y Ayhan, C Baethge, R Bauer, B Baune, C Becerra-Palars, F Bellivier, R Belmaker, M Berk, Y Bersudsky, Ş Bicakci, H Birabwa-Oketcho, T Bjella, J Cabrera, E Wo Cheung, M Del Zompo, S Dodd, M Donix, B Etain, A Fagiolini, K Fountoulakis, M Frye, A Gonzalez-Pinto, J Gottlieb, P Grof, H Harima, C Henry, E Isometsä, S Janno, F Kapczinski, M Kardell, S Khaldi, S Kliwicki, B König, T Kot, R Krogh, M Kunz, B Lafer, M Landén, E Larsen, U Lewitzka, R Licht, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, F Meza-Urzúa, M Ming, S Monteith, G Morken, E Mosca, A Mozzhegorov, R Munoz, S Mythri, F Nacef, R Nadella, F Nery, R Nielsen, C O'Donovan, A Omrani, Y Osher, H Sørensen, U Ouali, Y Ruiz, M Pilhatsch, M Pinna, F da Ponte, D Quiroz, R Ramesar, N Rasgon, M Reddy, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Raghuraman, Â Scippa, E Severus, C Simhandl, P Stackhouse, D Stein, S Strejilevich, M Subramaniam, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, L Tondo, C Torrent, A Vaaler, E Vares, J Veeh, E Vieta

(2019), Vol. 113, pp. 1-9, Journal of Psychiatric Research, England, C1

Statins and inflammation: New therapeutic opportunities in psychiatry

S Kim, H Kang, M Jhon, J Kim, J Lee, A Walker, B Agustini, J Kim, M Berk

(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1

New drug candidates for bipolar disorder-A nation-wide population-based study

L Kessing, H Rytgaard, T Gerds, M Berk, C Ekstrøm, P Andersen

(2019), Vol. 21, pp. 410-418, Bipolar Disorders, Denmark, C1

The therapeutic potential of mangosteen pericarp as an adjunctive therapy for bipolar disorder and schizophrenia

M Ashton, O Dean, A Walker, C Bortolasci, C Ng, M Hopwood, B Harvey, M Möller, J McGrath, W Marx, A Turner, S Dodd, J Scott, J Khoo, K Walder, J Sarris, M Berk

(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1

Protocol and rationale: a 24-week double-blind, randomized, placebo controlled trial of the efficacy of adjunctive garcinia mangostanaLinn. (mangosteen) pericarp for schizophrenia

Alyna Turner, John McGrath, Olivia Dean, Seetal Dodd, Andrea Baker, Susan Cotton, James Scott, Bianca Kavanagh, Melanie Ashton, Adam Walker, Ellie Brown, Michael Berk

(2019), Vol. 17, pp. 297-307, Clinical psychopharmacology and neuroscience, Seoul, South Korea, C1

Nutraceuticals and nutritional supplements for the treatment of bipolar disorder: Protocol for a systematic review

M Ashton, M Berk, C Ng, M Hopwood, B Kavanagh, L Williams, J Sarris, O Dean

(2019), Vol. 9, BMJ Open, England, C1

Protocol update and statistical analysis plan for CADENCE-BZ: A randomized clinical trial to assess the efficacy of sodium benzoate as an adjunctive treatment in early psychosis

C Lim, A Baker, S Saha, S Foley, A Gordon, D Ward, B Burgher, F Dark, M Beckmann, S Stathis, G Bruxner, A Ryan, D Richardson, S Hatherill, M Berk, O Dean, J McGrath, J Chapman, S Patterson, S Singh, B Mowry, L Tracy, M Duhig, A Machin, E Troman, S Suetani, T Dinala, L Burton, P Cosgrove, C Gamble, J Scott

(2019), Vol. 20, Trials, England, C1

Childbirth and prevention of bipolar disorder: an opportunity for change

V Sharma, V Bergink, M Berk, P Chandra, T Munk-Olsen, A Viguera, L Yatham

(2019), Vol. 6, pp. 786-792, The Lancet Psychiatry, England, C1

Prevalence of depressive symptoms and its associated factors among healthy community-dwelling older adults living in Australia and the United States

M Mohebbi, B Agustini, R Woods, J McNeil, M Nelson, R Shah, V Nguyen, E Storey, A Murray, C Reid, B Kirpach, R Wolfe, J Lockery, M Berk

(2019), Vol. 34, pp. 1208-1216, International Journal of Geriatric Psychiatry, England, C1

Supporting engagement, adherence, and behavior change in online dietary interventions

Claire Young, Sara Campolonghi, Stephanie Ponsonby, Samantha Dawson, Adrienne O'Neil, Frances Kay-Lambkin, Sarah McNaughton, Michael Berk, Felice Jacka

(2019), Vol. 51, pp. 719-739, Journal of nutrition education and behavior, Amsterdam, The Netherlands, C1

Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: A protocol for a systematic review and meta-analysis

B Kavanagh, S Brennan-Olsen, A Turner, O Dean, M Berk, M Ashton, H Koivumaa-Honkanen, L Williams

(2019), Vol. 9, BMJ Open, England, C1

Co-occurrence of depression with chronic diseases among the older population living in low- and middle-income countries: a compound health challenge

Mojtaba Lotfaliany, Bruno Agustini, Paul Kowal, Michael Berk, Mohammadreza Mohebbi

(2019), Vol. 31, pp. 95-105, Annals of clinical psychiatry, Montvale, N.J., C1

Association Between Statin Use and Depressive Symptoms in a Large Community-Dwelling Older Population Living in Australia and the USA: A Cross-Sectional Study

B Agustini, M Mohebbi, R Woods, J McNeil, M Nelson, R Shah, A Murray, M Ernst, C Reid, A Tonkin, J Lockery, M Berk

(2019), Vol. 33, pp. 685-694, CNS Drugs, New Zealand, C1

Supporting Self-Management in Bipolar Disorder: Mixed-Methods Knowledge Translation Study

Erin Michalak, Emma Morton, Steven Barnes, Rachelle Hole, Greg Murray

(2019), Vol. 6, JMIR MENTAL HEALTH, Canada, C1

Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis

Wolfgang Marx, Melissa Lane, Tetyana Rocks, Anu Ruusunen, Amy Loughman, Adrian Lopresti, Skye Marshall, Michael Berk, Felice Jacka, Olivia Dean

(2019), Vol. 77, pp. 557-571, Nutrition reviews, Oxford, Eng., C1

The potential of carnosine in brain-related disorders: A comprehensive review of current evidence

M Schön, A Mousa, M Berk, W Chia, J Ukropec, A Majid, B Ukropcová, B De Courten

(2019), Vol. 11, Nutrients, Switzerland, C1

Does stage of illness influence recovery-focused outcomes after psychological treatment in bipolar disorder? A systematic review protocol

H Tremain, K Fletcher, J Scott, C McEnery, M Berk, G Murray

(2019), Vol. 8, Systematic Reviews, England, C1

A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine ("ice") dependence

R McKetin, O Dean, A Turner, P Kelly, B Quinn, D Lubman, P Dietze, G Carter, P Higgs, A Baker, B Sinclair, D Reid, V Manning, N Te Pas, W Liang, T Thomas, R Bathish, M Kent, D Raftery, S Arunogiri, F Cordaro, H Hill, M Berk

(2019), Vol. 20, Trials, England, C1

Lessons from Iceland: developing scalable and sustainable community approaches for the prevention of mental disorders in young Australians

E Hoare, I Thorisdóttir, A Kristjansson, I Sigfusdóttir, J Hayward, S Allender, C Strugnell, N Reavley, G Patton, M Berk, F Jacka

(2019), Vol. 15, pp. 1-4, Mental health and prevention, Amsterdam, The Netherlands, C1

Sample selection and reasons for non-participation in the predictors and outcomes of incident FRACtures (PROFRAC) study

A Stuart, J Pasco, S Brennan-Olsen, M Berk, A Betson, K Bennett, E Timney, L Williams

(2019), Vol. 8, pp. 50-55, Journal of Public Health Research, United States, C1

A Neuroethics Framework for the Australian Brain Initiative

J Kennett, A Carter, J Bourne, W Hall, N Levy, J Mattingley, A Lawrence, C Forlini, L Malcolm, N Vincent, L Richards, G Egan, M Breakspear, K Cornish, G Halliday, L Poole-Warren, S Sriram, T Soulis, B Fitzgibbon, I Kiral-Kornek, D Badcock, B Balleine, J Bekkers, M Berk, A Bradley, A Brichta, O Carter, A Castles, J Clements, J Cornish, G de Zubicaray, P Enticott, A Fornito, L Griffiths, J Gullifer, A Hannan, S Harrer, A Harvey, I Hickie, L Jazwinska, M Kiernan, T Kilpatrick, R Leventer, J Licinio, N Lovell, G Mackellar, S Medland, P Michie, J Nithianantharajah, J Parker, J Payne, S Rossell, P Sah, Z Sarnyai, P Schofield, D Shum, T Silk, M Slee, G Stuart, J Tapson, A van Schaik, B Vissel, A Waters, D Apthorp, S Cohen-Woods, S Conn, M Korgaonkar, A Mason, M Azghadi, O Shimoni, A Smith, M Thompson

(2019), Vol. 101, pp. 365-369, Neuron, United States, C1

The case for improved care and provision of treatment for people with first-episode mania

S Jauhar, A Ratheesh, C Davey, L Yatham, P McGorry, P McGuire, M Berk, A Young

(2019), Vol. 6, pp. 869-876, The Lancet Psychiatry, England, C1

Has the sun set for seasonal affective disorder and HPA axis studies? A systematic review and future prospects

B Agustini, M Bocharova, A Walker, M Berk, A Young, M Juruena

(2019), Vol. 256, pp. 584-593, Journal of affective disorders, Amsterdam, The Netherlands, C1

Beyond evidence-based treatment of bipolar disorder: rational pragmatic approaches to management

R Post, L Yatham, E Vieta, M Berk, A Nierenberg

(2019), Vol. 21, pp. 650-659, Bipolar disorders, Chichester, Eng., C1

The compensatory antioxidant response system with a focus on neuroprogressive disorders

G Morris, B Puri, A Walker, M Berk, K Walder, C Bortolasci, W Marx, A Carvalho, M Maes

(2019), Vol. 95, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial

C Davey, A Chanen, S Hetrick, S Cotton, A Ratheesh, G Amminger, J Koutsogiannis, M Phelan, E Mullen, B Harrison, S Rice, A Parker, O Dean, A Weller, M Kerr, A Quinn, L Catania, N Kazantzis, P McGorry, M Berk

(2019), Vol. 6, pp. 735-744, The Lancet Psychiatry, England, C1

Early intervention for bipolar disorder - Do current treatment guidelines provide recommendations for the early stages of the disorder?

M Chia, S Cotton, K Filia, M Phelan, P Conus, S Jauhar, S Marwaha, P McGorry, C Davey, M Berk, A Ratheesh

(2019), Vol. 257, pp. 669-677, Journal of Affective Disorders, Netherlands, C1

A case of antibiotic-associated mania in a 67-year-old woman

P Navalón, Y Cañada, M Merizalde, P Sierra, A García-Blanco, A Domínguez-Carabantes, M Berk

(2019), Vol. 21, pp. 670-672, Bipolar Disorders, Denmark, C1

Emerging role of innate B1 cells in the pathophysiology of autoimmune and neuroimmune diseases: Association with inflammation, oxidative and nitrosative stress and autoimmune responses

G Morris, B Puri, L Olive, A Carvalho, M Berk, M Maes

(2019), Vol. 148, Pharmacological Research, Netherlands, C1

International society for nutritional psychiatry research practice guidelines for Omega-3 fatty acids in the treatment of major depressive disorder

T Guu, D Mischoulon, J Sarris, J Hibbeln, R McNamara, K Hamazaki, M Freeman, M Maes, Y Matsuoka, R Belmaker, F Jacka, C Pariante, M Berk, W Marx, K Su

(2019), Vol. 88, pp. 263-273, Psychotherapy and psychosomatics, Basel, Switzerland, C1

Mapping Cancer incidence across Western Victoria: The association with age, accessibility, and socioeconomic status among men and women

S Cowdery, M Sajjad, K Holloway-Kew, M Mohebbi, L Williams, M Kotowicz, P Livingston, M Khasraw, S Hakkennes, T Dunning, S Brumby, R Page, A Sutherland, S Brennan-Olsen, M Berk, D Campbell, J Pasco

(2019), Vol. 19, BMC Cancer, England, C1

An international society of bipolar disorders task force report: precursors and prodromes of bipolar disorder

Gianni Faedda, Ross Baldessarini, Ciro Marangoni, Andreas Bechdolf, Michael Berk, Boris Birmaher, Philippe Conus, Melissa DelBello, Anne Duffy, Manon Hillegers, Andrea Pfennig, Robert Post, Martin Preisig, Aswin Ratheesh, Paola Salvatore, Mauricio Tohen, Gustavo Vazquez, Eduard Vieta, Lakshmi Yatham, Eric Youngstrom, Anna Van Meter, Christoph Correll

(2019), Vol. 21, pp. 720-740, Bipolar disorders, Chichester, Eng., C1

N-acetylcysteine for cessation of tobacco smoking: Rationale and study protocol for a randomised controlled trial

L Arancini, C Bortolasci, S Dodd, O Dean, M Berk

(2019), Vol. 20, Trials, England, C1

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders

R Sethi, N Gómez-Coronado, A Walker, O Robertson, B Agustini, M Berk, S Dodd

(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1

Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities

G Morris, B Puri, A Walker, M Maes, A Carvalho, K Walder, C Mazza, M Berk

(2019), Vol. 148, Pharmacological Research, Netherlands, C1

The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials

J Firth, S Teasdale, K Allott, D Siskind, W Marx, J Cotter, N Veronese, F Schuch, L Smith, M Solmi, A Carvalho, D Vancampfort, M Berk, B Stubbs, J Sarris

(2019), Vol. 18, pp. 308-324, World psychiatry, Chichester, Eng., C1

Drugs used in the treatment of bipolar disorder and their effects on cholesterol biosynthesis - a possible therapeutic mechanism

S Kidnapillai, C Bortolasci, B Panizzutti, B Spolding, T Connor, K Bonifacio, A Sanigorski, O Dean, T Crowley, S Jamain, L Gray, M Leboyer, M Berk, K Walder

(2019), Vol. 20, pp. 766-777, World Journal of Biological Psychiatry, London, Eng., C1

Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders

G Morris, B Puri, A Walker, M Maes, A Carvalho, C Bortolasci, K Walder, M Berk

(2019), Vol. 107, pp. 862-882, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

Promotion of Wellbeing for Children of Parents With Mental Illness: A Model Protocol for Research and Intervention

C Reedtz, K van Doesum, G Signorini, C Lauritzen, T van Amelsvoort, F van Santvoort, A Young, P Conus, R Musil, T Schulze, M Berk, A Stringaris, G Piché, G de Girolamo

(2019), Vol. 10, Frontiers in Psychiatry, Switzerland, C1

Staging of Schizophrenia with the Use of PANSS: An International Multi-Center Study

K Fountoulakis, E Dragioti, A Theofilidis, T Wikilund, X Atmatzidis, I Nimatoudis, E Thys, M Wampers, L Hranov, T Hristova, D Aptalidis, R Milev, F Iftene, F Spaniel, P Knytl, P Furstova, T From, H Karlsson, M Walta, R Salokangas, J Azorin, J Bouniard, J Montant, G Juckel, I Haussleiter, A Douzenis, I Michopoulos, P Ferentinos, N Smyrnis, L Mantonakis, Z Nemes, X Gonda, D Vajda, A Juhasz, A Shrivastava, J Waddington, M Pompili, A Comparelli, V Corigliano, E Rancans, A Navickas, J Hilbig, L Bukelskis, L Injac Stevovic, S Vodopic, O Esan, O Oladele, C Osunbote, J Rybakowski, P Wojciak, K Domowicz, M Figueira, L Linhares, J Crawford, A Panfil, D Smirnova, O Izmailova, D Lecic-Tosevski, H Temmingh, F Howells, J Bobes, M Garcia-Portilla, L García-Alvarez, G Erzin, H Karadaǧ, A De Sousa, A Bendre, C Hoschl, C Bredicean, I Papava, O Vukovic, B Pejuskovic, V Russell, L Athanasiadis, A Konsta, D Stein, M Berk, O Dean, R Tandon, S Kasper, M De Hert

(2019), Vol. 22, pp. 681-697, International Journal of Neuropsychopharmacology, Oxford, Eng., C1

An immune gate of depression - early neuroimmune development in the formation of the underlying depressive disorder

M Kowalczyk, J Szemraj, K Bliźniewska, M Maes, M Berk, K Su, P Gałecki

(2019), Vol. 71, pp. 1299-1307, Pharmacological reports, Amsterdam, The Netherlands, C1

ENACT: A protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

S Cotton, M Berk, A Watson, S Wood, K Allott, C Bartholomeusz, C Bortolasci, K Walder, B O'Donoghue, O Dean, A Chanen, G Amminger, P McGorry, A Burnside, J Uren, A Ratheesh, S Dodd

(2019), Vol. 20, Trials, England, C1

Variation in the prevalence of depression and patterns of association, sociodemographic and lifestyle factors in community-dwelling older adults in six low- and middle-income countries

M Lotfaliany, E Hoare, F Jacka, P Kowal, M Berk, M Mohebbi

(2019), Vol. 251, pp. 218-226, Journal of Affective Disorders, Netherlands, C1

Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorder

S Dodd, A Walker, A Brnabic, N Hong, A Burns, M Berk

(2019), Vol. 21, pp. 142-150, Bipolar Disorders, Denmark, C1

Falls and Depression in Men: A Population-Based Study

A Stuart, J Pasco, F Jacka, M Berk, L Williams

(2018), Vol. 12, pp. 14-18, American Journal of Men's Health, United States, C1

Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin

A Quinn, O Dean, C Davey, M Kerr, S Harrigan, S Cotton, A Chanen, S Dodd, A Ratheesh, G Amminger, M Phelan, A Williams, A Mackinnon, F Giorlando, S Baird, S Rice, M O'Shea, M Schäfer, E Mullen, S Hetrick, P McGorry, M Berk

(2018), Vol. 12, pp. 45-54, Early Intervention in Psychiatry, Australia, C1

A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?

G Morris, M Berk, B Puri

(2018), Vol. 55, pp. 3592-3609, Molecular Neurobiology, United States, C1

The limitations of using randomised controlled trials as a basis for developing treatment guidelines

R Mulder, A Singh, A Hamilton, P Das, T Outhred, G Morris, D Bassett, B Baune, M Berk, P Boyce, B Lyndon, G Parker, G Malhi

(2018), Vol. 21, pp. 4-6, Evidence-Based Mental Health, England, C1

Interactions between pro-inflammatory cytokines and statins on depression in patients with acute coronary syndrome

S Kim, H Kang, K Bae, I Shin, Y Hong, Y Ahn, M Jeong, M Berk, J Yoon, J Kim

(2018), Vol. 80, pp. 250-254, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1

Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials

D Brownstein, E Salagre, C Köhler, B Stubbs, J Vian, C Pereira, V Chavarria, C Karmakar, A Turner, J Quevedo, A Carvalho, M Berk, B Fernandes

(2018), Vol. 52, pp. 24-38, Australian and New Zealand Journal of Psychiatry, England, C1

Pre-onset risk characteristics for mania among young people at clinical high risk for psychosis

A Ratheesh, S Cotton, C Davey, A Lin, S Wood, H Yuen, A Bechdolf, P McGorry, A Yung, M Berk, B Nelson

(2018), Vol. 192, pp. 345-350, Schizophrenia Research, Netherlands, C1-1

The role of hypernitrosylation in the pathogenesis and pathophysiology of neuroprogressive diseases

G Morris, K Walder, A Carvalho, S Tye, K Lucas, M Berk, M Maes

(2018), Vol. 84, pp. 453-469, Neuroscience and Biobehavioral Reviews, United States, C1

Cognition in depression: can we THINC-it better?

B Baune, G Malhi, G Morris, T Outhred, A Hamilton, P Das, D Bassett, M Berk, P Boyce, B Lyndon, R Mulder, G Parker, A Singh

(2018), Vol. 225, pp. 559-562, Journal of affective disorders, Amsterdam, The Netherlands, C1

Psychometric properties of a short form of the Center for Epidemiologic Studies Depression (CES-D-10) scale for screening depressive symptoms in healthy community dwelling older adults

M Mohebbi, V Nguyen, J McNeil, R Woods, M Nelson, R Shah, E Storey, A Murray, C Reid, B Kirpach, R Wolfe, J Lockery, M Berk

(2018), Vol. 51, pp. 118-125, General Hospital Psychiatry, United States, C1

A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression

C Roomruangwong, G Anderson, M Berk, D Stoyanov, A Carvalho, M Maes

(2018), Vol. 81, pp. 262-274, Progress in Neuro-Psychopharmacology and Biological Psychiatry, England, C1

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement

S Dodd, P Mitchell, M Bauer, L Yatham, A Young, S Kennedy, L Williams, T Suppes, C Lopez Jaramillo, M Trivedi, M Fava, A Rush, R McIntyre, M Thase, R Lam, E Severus, S Kasper, M Berk

(2018), Vol. 19, pp. 330-348, World Journal of Biological Psychiatry, England, C1

Cell death pathways: a novel therapeutic approach for neuroscientists

G Morris, A Walker, M Berk, M Maes, B Puri

(2018), Vol. 55, pp. 5767-5786, Molecular neurobiology, New York, N.Y., C1

Garcinia mangostana Linn displays antidepressant-like and pro-cognitive effects in a genetic animal model of depression: a bio-behavioral study in the Flinders Sensitive Line rat

I Oberholzer, M Möller, B Holland, O Dean, M Berk, B Harvey

(2018), Vol. 33, pp. 467-480, Metabolic Brain Disease, United States, C1

Post-operative cognitive dysfunction: an exploration of the inflammatory hypothesis and novel therapies

D Skvarc, M Berk, L Byrne, O Dean, S Dodd, M Lewis, A Marriott, E Moore, G Morris, R Page, L Gray

(2018), Vol. 84, pp. 116-133, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

Distinguishing transient versus stable aspects of depression in New Zealand Pacific Island children using generalizability theory

J Paterson, O Medvedev, A Sumich, E Tautolo, C Krägeloh, R Sisk, R McNamara, M Berk, A Narayanan, R Siegert

(2018), Vol. 227, pp. 698-704, Journal of affective disorders, Amsterdam, The Netherlands, C1

Nutritional deficiencies and clinical correlates in first-episode psychosis: A systematic review and meta-analysis

J Firth, R Carney, B Stubbs, S Teasdale, D Vancampfort, P Ward, M Berk, J Sarris

(2018), Vol. 44, pp. 1275-1292, Schizophrenia Bulletin, United States, C1

Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking

N Gómez-Coronado, A Walker, M Berk, S Dodd

(2018), Vol. 38, pp. 235-258, Pharmacotherapy, United States, C1

Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases

G Morris, M Berk, A Carvalho, M Maes, A Walker, B Puri

(2018), Vol. 341, pp. 154-175, Behavioural brain research, Amsterdam, The Netherlands, C1

Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis

G Morris, E Reiche, A Murru, A Carvalho, M Maes, M Berk, B Puri

(2018), Vol. 55, pp. 6282-6306, Molecular Neurobiology, United States, C1

Gender-specific risk factors for low bone mineral density in patients taking antipsychotics for psychosis

M Jhon, T Yoo, J Lee, S Kim, J Kim, I Shin, L Williams, M Berk, J Yoon, S Kim

(2018), Vol. 33, Human Psychopharmacology, England, C1

Early intervention in Bipolar Disorder

Eduard Vieta, Estela Salagre, Iria Grande, André Carvalho, Brisa Fernandes, Michael Berk, Boris Birmaher, Mauricio Tohen, Trisha Suppes

(2018), Vol. 175, pp. 411-426, American journal of psychiatry, Arlington, Va., C1

An update on adjunctive treatment options for bipolar disorder

O Dean, E Gliddon, T Van Rheenen, F Giorlando, S Davidson, M Kaur, T Ngo, L Williams

(2018), Vol. 20, pp. 87-96, Bipolar Disorders, Denmark, C1

An investigation into closed-loop treatment of neurological disorders based on sensing mitochondrial dysfunction

S Adams, A Kouzani, S Tye, K Bennet, M Berk

(2018), Vol. 15, Journal of NeuroEngineering and Rehabilitation, England, C1

Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men

L Williams, M Berk, J Hodge, M Kotowicz, A Stuart, V Chandrasekaran, J Cleminson, J Pasco

(2018), Vol. 103, pp. 125-130, Calcified Tissue International, United States, C1

Mechanisms underpinning the polypharmacy effects of medications in psychiatry

C Bortolasci, B Spolding, E Callaly, S Martin, B Panizzutti, S Kidnapillai, T Connor, K Hasebe, M Mohebbi, O Dean, S McGee, S Dodd, L Gray, M Berk, K Walder

(2018), Vol. 21, pp. 582-591, International Journal of Neuropsychopharmacology, England, C1

N-acetylcysteine for major mental disorders: a systematic review and meta-analysis of randomized controlled trials

W Zheng, Q Zhang, D Cai, X Yang, Y Qiu, G Ungvari, C Ng, M Berk, Y Ning, Y Xiang

(2018), Vol. 137, pp. 391-400, Acta Psychiatrica Scandinavica, United States, C1

The subjective wellbeing profile of the 'pretiree' demographic: A cross-sectional study

J Pasco, K Holloway, A Stuart, L Williams, S Brennan-Olsen, M Berk

(2018), Vol. 110, pp. 111-117, Maturitas, Ireland, C1

Bipolar disorders

E Vieta, M Berk, T Schulze, A Carvalho, T Suppes, J Calabrese, K Gao, K Miskowiak, I Grande

(2018), Vol. 4, Nature Reviews Disease Primers, England, C1

Association between vitamin D insufficiency and metabolic syndrome in patients with psychotic disorders

T Yoo, W Choi, J-H Hong, J-Y Lee, J-M Kim, I-S Shin, S Yang, P Amminger, M Berk, J-S Yoon, S-W Kim

(2018), Vol. 15, pp. 396-401, Psychiatry Investigation, Soeul, South Korea, C1

Differential effect of quetiapine and lithium on functional connectivity of the striatum in first episode mania

O Dandash, M Yücel, R Daglas, C Pantelis, P McGorry, M Berk, A Fornito

(2018), Vol. 8, Translational Psychiatry, United States, C1

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

L Yatham, S Kennedy, S Parikh, A Schaffer, D Bond, B Frey, V Sharma, B Goldstein, S Rej, S Beaulieu, M Alda, G MacQueen, R Milev, A Ravindran, C O'Donovan, D McIntosh, R Lam, G Vazquez, F Kapczinski, R McIntyre, J Kozicky, S Kanba, B Lafer, T Suppes, J Calabrese, E Vieta, G Malhi, R Post, M Berk

(2018), Vol. 20, pp. 97-170, Bipolar Disorders, Denmark, C1

Mitochondrial agents for bipolar disorder

C Pereira, V Chavarria, J Vian, M Ashton, M Berk, W Marx, O Dean

(2018), Vol. 21, pp. 550-569, International Journal of Neuropsychopharmacology, England, C1

The Endoplasmic Reticulum Stress Response in Neuroprogressive Diseases: Emerging Pathophysiological Role and Translational Implications

G Morris, B Puri, K Walder, M Berk, B Stubbs, M Maes, A Carvalho

(2018), Vol. 55, pp. 8765-8787, Molecular Neurobiology, United States, C1

Lithium and nephrotoxicity: Unravelling the complex pathophysiological threads of the lightest metal

J Davis, M Desmond, M Berk

(2018), Vol. 23, pp. 897-903, Nephrology, Australia, C1

Add-on treatment with N-acetylcysteine for bipolar depression: a 24-week randomized double-blind parallel group placebo-controlled multicentre trial (NACOS-study protocol)

P Ellegaard, R Licht, H Poulsen, R Nielsen, M Berk, O Dean, M Mohebbi, C Nielsen

(2018), Vol. 6, International Journal of Bipolar Disorders, Germany, C1

Bioenergetics and synaptic plasticity as potential targets for individualizing treatment for depression

J Price, Carrie Bronars, Sophie Erhardt, Kathyrn Cullen, Lilly Schwieler, Michael Berk, Ken Walder, Sean McGee, Mark Frye, Susannah Tye

(2018), Vol. 90, pp. 212-220, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

The putative role of oxidative stress and inflammation in the pathophysiology of sleep dysfunction across neuropsychiatric disorders: Focus on chronic fatigue syndrome, bipolar disorder and multiple sclerosis

G Morris, B Stubbs, C Köhler, K Walder, A Slyepchenko, M Berk, A Carvalho

(2018), Vol. 41, pp. 255-265, Sleep Medicine Reviews, England, C1

Economic evaluation of a dietary intervention for adults with major depression (the "SMILES" trial)

M Chatterton, C Mihalopoulos, A O'Neil, C Itsiopoulos, R Opie, D Castle, S Dash, L Brazionis, M Berk, F Jacka

(2018), Vol. 18, BMC Public Health, England, C1

Patient centric measures for a patient centric era: Agreement and convergent between ratings on The Patient Global Impression of Improvement (PGI-I) scale and the Clinical Global Impressions - Improvement (CGI-S) scale in bipolar and major depressive disorder

M Mohebbi, S Dodd, O Dean, M Berk

(2018), Vol. 53, pp. 17-22, European Psychiatry, England, C1

Ketamine and rapidly acting antidepressants: Breaking the speed of sound or light?

M Berk, C Loo, C Davey, B Harvey

(2018), Vol. 52, pp. 1026-1029, Australian and New Zealand Journal of Psychiatry, England, C1

Psychopathological features of bipolar depression: Italian validation of the Bipolar Depression Rating Scale (I-BDRS)

A Bruschi, M Mazza, G Camardese, S Calò, C Palumbo, L Mandelli, A Callea, A Gori, M Di Nicola, G Marano, M Berk, G di Sciascio, L Janiri

(2018), Vol. 9, Frontiers in Psychology, Switzerland, C1

Mediator effects of parameters of inflammation and neurogenesis from a N-acetyl cysteine clinical-trial for bipolar depression

B Panizzutti, C Bortolasci, K Hasebe, S Kidnapillai, L Gray, K Walder, M Berk, M Mohebbi, S Dodd, C Gama, P Magalhães, S Cotton, F Kapczinski, A Bush, G Malhi, O Dean

(2018), Vol. 30, pp. 334-341, Acta Neuropsychiatrica, England, C1

Web-based intervention to improve quality of life in late stage bipolar disorder (ORBIT): Randomised controlled trial protocol

K Fletcher, F Foley, N Thomas, E Michalak, L Berk, M Berk, S Bowe, S Cotton, L Engel, S Johnson, S Jones, M Kyrios, S Lapsley, C Mihalopoulos, T Perich, G Murray

(2018), Vol. 18, BMC Psychiatry, England, C1

Efficacy of online lifestyle interventions targeting lifestyle behaviour change in depressed populations: A systematic review

C Young, K Trapani, S Dawson, A O’Neil, F Kay-Lambkin, M Berk, F Jacka

(2018), Vol. 52, pp. 834-846, Australian and New Zealand Journal of Psychiatry, England, C1

Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial

J Sarris, G Byrne, C Bousman, C Stough, J Murphy, P MacDonald, L Adams, S Nazareth, G Oliver, L Cribb, K Savage, R Menon, S Chamoli, M Berk, C Ng, D Mischoulon

(2018), Vol. 28, pp. 1126-1136, European Neuropsychopharmacology, Netherlands, C1

Role of IL-6/RORC/IL-22 axis in driving Th17 pathway mediated immunopathogenesis of schizophrenia

M Subbanna, V Shivakumar, P Talukdar, J Narayanaswamy, D Venugopal, M Berk, S Varambally, G Venkatasubramanian, M Debnath

(2018), Vol. 111, pp. 112-118, Cytokine, England, C1

A review of the neurobiological underpinning of comorbid substance use and mood disorders

N Gómez-Coronado, R Sethi, C Bortolasci, L Arancini, M Berk, S Dodd

(2018), Vol. 241, pp. 388-401, Journal of Affective Disorders, Netherlands, C1

Mental health information online: What we have learned from social media metrics in BuzzFeed's mental health week

T Martini, L Czepielewski, D Baldez, E Gliddon, C Kieling, L Berk, M Berk, M Kauer-Sant’anna

(2018), Vol. 40, pp. 326-336, Trends in Psychiatry and Psychotherapy, Brazil, C1

Internet use by older adults with bipolar disorder: international survey results

R Bauer, T Glenn, S Strejilevich, J Conell, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, A Castro, E Cheung, C Chillotti, S Choppin, A Cuomo, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, M Fernández Hernandez, J Garnham, J Geddes, J Gildebro, M Gitlin, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, A Lund, V Kapur, G Kunigiri, B Lafer, E Larsen, U Lewitzka, R Licht, B Misiak, P Piotrowski, Â Miranda-Scippa, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O’Donovan, Y Okamura, Y Osher, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, J Veeh, E Vieta, M Vinberg, B Viswanath, M Zetin, P Whybrow, M Bauer

(2018), Vol. 6, International Journal of Bipolar Disorders, Germany, C1

The impact of substance use disorders on recovery from bipolar depression: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder psychosocial treatment trial

A Gold, A Peters, M Otto, L Sylvia, P Magalhaes, M Berk, D Dougherty, D Miklowitz, E Frank, A Nierenberg, T Deckersbach

(2018), Vol. 52, pp. 847-855, Australian and New Zealand Journal of Psychiatry, England, C1

Leaky brain in neurological and psychiatric disorders: drivers and consequences

Gerwyn Morris, Brisa Fernandes, Basant Puri, Adam Walker, Andre Carvalho, Michael Berk

(2018), Vol. 52, pp. 924-948, Australian and New Zealand journal of psychiatry, London, Eng., C1

Effect of aspirin on all-cause mortality in the healthy elderly

J McNeil, M Nelson, R Woods, J Lockery, R Wolfe, C Reid, B Kirpach, R Shah, D Ives, E Storey, J Ryan, A Tonkin, A Newman, J Williamson, K Margolis, M Ernst, W Abhayaratna, N Stocks, S Fitzgerald, S Orchard, R Trevaks, L Beilin, G Donnan, P Gibbs, C Johnston, B Radziszewska, R Grimm, A Murray

(2018), Vol. 379, pp. 1519-1528, New England Journal of Medicine, United States, C1

Effect of aspirin on disability-free survival in the healthy elderly

J McNeil, R Woods, M Nelson, C Reid, B Kirpach, R Wolfe, E Storey, R Shah, J Lockery, A Tonkin, A Newman, J Williamson, K Margolis, M Ernst, W Abhayaratna, N Stocks, S Fitzgerald, S Orchard, R Trevaks, L Beilin, G Donnan, P Gibbs, C Johnston, J Ryan, B Radziszewska, R Grimm, A Murray

(2018), Vol. 379, pp. 1499-1508, New England Journal of Medicine, United States, C1

Effect of aspirin on cardiovascular events and bleeding in the healthy elderly

John McNeil, Rory Wolfe, Robyn Woods, Andrew Tonkin, Geoffrey Donnan, Mark Nelson, Christopher Reid, Jessica Lockery, Brenda Kirpach, Elsdon Storey, Raj Shah, Jeff Williamson, Karen Margolis, Michael Ernst, Walter Abhayaratna, Nigel Stocks, Sharyn Fitzgerald, Suzanne Orchard, Ruth Trevaks, Lawrence Beilin, Colin Johnston, Joanne Ryan, Barbara Radziszewska, Michael Jelinek, Mobin Malik, Charles Eaton, Donna Brauer, Geoff Cloud, Erica Wood, Suzanne Mahady, Suzanne Satterfield, Richard Grimm, Anne Murray, Michael Berk

(2018), Vol. 379, pp. 1509-1518, New England journal of medicine, Waltham, Mass., C1

Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project

G Parker, G Tavella, G Macqueen, M Berk, H Grunze, T Deckersbach, D Dunner, M Sajatovic, J Amsterdam, T Ketter, L Yatham, L Kessing, D Bassett, M Zimmerman, K Fountoulakis, A Duffy, M Alda, C Calkin, V Sharma, A Anand, M Singh, T Hajek, P Boyce, B Frey, D Castle, A Young, E Vieta, J Rybakowski, H Swartz, A Schaffer, G Murray, A Bayes, R Lam, E Bora, R Post, M Ostacher, B Lafer, A Cleare, K Burdick, C O’Donovan, A Ortiz, C Henry, S Kanba, J Rosenblat, S Parikh, D Bond, M Grunebaum, S Frangou, J Goldberg, M Orum, D Osser, M Frye, R McIntyre, A Fagiolini, V Manicavasagar, G Carlson, G Malhi

(2018), Vol. 52, pp. 1173-1182, Australian and New Zealand Journal of Psychiatry, England, C1

Lithium and nephrotoxicity: A literature review of approaches to clinical management and risk stratification

J Davis, M Desmond, M Berk

(2018), Vol. 19, BMC Nephrology, England, C1

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0

E Salagre, S Dodd, A Aedo, A Rosa, S Amoretti, J Pinzon, M Reinares, M Berk, F Kapczinski, E Vieta, I Grande

(2018), Vol. 9, Frontiers in Psychiatry, Switzerland, C1

Pretiree lifestyles in relation to musculoskeletal health: cross-sectional data from the Geelong Osteoporosis Study

Julie Pasco, K Holloway-Kew, N Hyde, Monica Tembo, Pamela Rufus, Sophia Sui, Michael Berk, Mark Kotowicz

(2018), Vol. 3, pp. 1-12, JCSM Clinical Reports, London, Eng., C1

The MHC/HLA gene complex in major psychiatric disorders: emerging roles and implications

M Debnath, M Berk, M Leboyer, R Tamouza

(2018), Vol. 5, pp. 179-188, Current behavioral neuroscience reports, New York, N.Y.g, C1

Depression and chronic diseases: Co-occurrence and communality of risk factors

M Lotfaliany, S Bowe, P Kowal, L Orellana, M Berk, M Mohebbi

(2018), Vol. 241, pp. 461-468, Journal of Affective Disorders, Netherlands, C1

Ethical considerations in preventive interventions for bipolar disorder

A Ratheesh, S Cotton, C Davey, S Adams, A Bechdolf, C Macneil, M Berk, P McGorry

(2017), Vol. 11, pp. 104-112, Early Intervention in Psychiatry, Australia, C1

A potential role for N-acetylcysteine in the management of methamphetamine dependence

R McKetin, O Dean, A Baker, G Carter, A Turner, P Kelly, M Berk

(2017), Vol. 36, pp. 153-159, Drug and Alcohol Review, Australia, C1

The prevalence, age distribution and comorbidity of personality disorders in Australian women

S Quirk, M Berk, J Pasco, S Brennan-Olsen, A Chanen, H Koivumaa-Honkanen, L Burke, H Jackson, C Hulbert, C A Olsson, P Moran, A Stuart, L Williams

(2017), Vol. 51, pp. 141-150, Australian and New Zealand Journal of Psychiatry, England, C1

A randomised, double blind, placebo-controlled trial of a fixed dose of N -acetyl cysteine in children with autistic disorder

O Dean, K Gray, K Villagonzalo, S Dodd, M Mohebbi, T Vick, B Tonge, M Berk

(2017), Vol. 51, pp. 241-249, Australian and New Zealand Journal of Psychiatry, England, C1

Nitrosative Stress, Hypernitrosylation, and Autoimmune Responses to Nitrosylated Proteins: New Pathways in Neuroprogressive Disorders Including Depression and Chronic Fatigue Syndrome

G Morris, M Berk, H Klein, K Walder, P Galecki, M Maes

(2017), Vol. 54, pp. 4271-4291, Molecular Neurobiology, United States, C1

The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease

G Morris, M Berk, A Carvalho, J Caso, Y Sanz, K Walder, M Maes

(2017), Vol. 54, pp. 4432-4451, Molecular Neurobiology, United States, C1

Beyond the therapeutic shackles of the monoamines: new mechanisms in bipolar disorder biology

J Data-Franco, A Singh, D Popovic, M Ashton, M Berk, E Vieta, M Figueira, O Dean

(2017), Vol. 72, pp. 73-86, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1

Do sleep disturbances predict or moderate the response to psychotherapy in bipolar disorder?

L Sylvia, S Salcedo, A Peters, P Da Silva Magalhães, E Frank, D Miklowitz, M Otto, M Berk, A Nierenberg, T Deckersbach

(2017), Vol. 205, pp. 196-202, Journal of Nervous and Mental Disease, United States, C1

Predictors for clinical deterioration of mental state in patients assessed by telephone-based mental health triage

N Sands, S Elsom, R Corbett, S Keppich-Arnold, R Prematunga, M Berk, J Considine

(2017), Vol. 26, pp. 226-237, International journal of mental health nursing, Milton, Qld., C1

Why so GLUMM? Detecting depression clusters through graphing lifestyle-environs using machine-learning methods (GLUMM)

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2017), Vol. 39, pp. 40-50, European Psychiatry, England, C1

Concordance between actual and pharmacogenetic predicted desvenlafaxine dose needed to achieve remission in major depressive disorder: A 10-week open-label study

C Bousman, D Müller, C Ng, K Byron, M Berk, A Singh

(2017), Vol. 27, pp. 1-6, Pharmacogenetics and Genomics, United States, C1

Hierarchical estimation of neural activity through explicit identification of temporally synchronous spikes

R Veerabhadrappa, A Bhatti, M Berk, S Tye, S Nahavandi

(2017), Vol. 249, pp. 299-313, Neurocomputing, C1

Cognitive effects of adjunctive N-acetyl cysteine in psychosis

M Rapado-Castro, S Dodd, A Bush, G Malhi, D Skvarc, Z On, M Berk, O Dean

(2017), Vol. 47, pp. 866-876, Psychological Medicine, England, C1

Functional implications of the IL-23/IL-17 immune axis in schizophrenia

M Debnath, M Berk

(2017), Vol. 54, pp. 8170-8178, Molecular neurobiology, Berlin, Germany, C1

Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms

S de Campos-Carli, M Araújo, A de Oliveira Silveira, V de Rezende, N Rocha, R Ferretjans, R Ribeiro-Santos, A Teixeira-Carvalho, O Martins-Filho, M Berk, J Salgado, A Teixeira

(2017), Vol. 87, pp. 44-52, Journal of Psychiatric Research, England, C1

A systematic review and meta-analysis of prospective transition from major depression to bipolar disorder

A Ratheesh, C Davey, S Hetrick, M Alvarez-Jimenez, C Voutier, A Bechdolf, P McGorry, J Scott, M Berk, S Cotton

(2017), Vol. 135, pp. 273-284, Acta psychiatrica Scandinavica, London, Eng., C1

A model of the mitochondrial basis of bipolar disorder

G Morris, K Walder, S McGee, O Dean, S Tye, M Maes, M Berk

(2017), Vol. 74, pp. 1-20, Neuroscience and Biobehavioral Reviews, United States, C1

Towards recovery-oriented psychosocial interventions for bipolar disorder: quality of life outcomes, stage-sensitive treatments, and mindfulness mechanisms

G Murray, N Leitan, N Thomas, E Michalak, S Johnson, S Jones, T Perich, L Berk, M Berk

(2017), Vol. 52, pp. 148-163, Clinical psychology review, Amsterdam, The Netherlands, C1

Neuroprotection after a first episode of mania: A randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume

M Berk, O Dandash, R Daglas, S Cotton, K Allott, A Fornito, C Suo, P Klauser, B Liberg, L Henry, C Macneil, M Hasty, P McGorry, C Pantelis, M Yöcel

(2017), Vol. 7, Translational Psychiatry, United States, C1

A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial)

F Jacka, A O'Neil, R Opie, C Itsiopoulos, S Cotton, M Mohebbi, D Castle, S Dash, C Mihalopoulos, M Chatterton, L Brazionis, O Dean, A Hodge, M Berk

(2017), Vol. 15, BMC Medicine, England, C1

A review of the theoretical and biological understanding of the nocebo and placebo phenomena

S Dodd, O Dean, J Vian, M Berk

(2017), Vol. 39, pp. 469-476, Clinical therapeutics, Amsterdam, The Netherlands, C1

Antidepressant prescribing in the precision medicine era: A prescriber's primer on pharmacogenetic tools

C Bousman, M Forbes, M Jayaram, H Eyre, C Reynolds, M Berk, M Hopwood, C Ng

(2017), Vol. 17, BMC Psychiatry, England, C1

The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis

J Firth, B Stubbs, J Sarris, S Rosenbaum, S Teasdale, M Berk, A Yung

(2017), Vol. 47, pp. 1515-1527, Psychological medicine, Cambridge, Eng., C1

Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: Network meta-analysis

M Chatterton, E Stockings, M Berk, J Barendregt, R Carter, C Mihalopoulos

(2017), Vol. 210, pp. 333-341, British Journal of Psychiatry, England, C1

The placebo and nocebo phenomena: their clinical management and impact on treatment outcomes

V Chavarria, J Vian, C Pereira, J Data-Franco, B Fernandes, M Berk, S Dodd

(2017), Vol. 39, pp. 477-486, Clinical therapeutics, New York, N.Y., C1

Quetiapine v. lithium in the maintenance phase following a first episode of mania: Randomised controlled trial

M Berk, R Daglas, O Dandash, M Yücel, L Henry, K Hallam, C Macneil, M Hasty, C Pantelis, B Murphy, L Kader, S Damodaran, M Wong, P Conus, A Ratheesh, P McGorry, S Cotton

(2017), Vol. 210, pp. 413-421, British Journal of Psychiatry, England, C1

Progressing MoodSwings. The upgrade and evaluation of MoodSwings 2.0: an online intervention for bipolar disorder

S Lauder, V Cosgrove, E Gliddon, D Grimm, S Dodd, L Berk, D Castle, T Suppes, M Berk

(2017), Vol. 56, pp. 18-24, Contemporary clinical trials, Amsterdam, The Netherlands, C1

Adjunctive N-acetylcysteine in depression: Exploration of interleukin-6, C-reactive protein and brain-derived neurotrophic factor

K Hasebe, L Gray, C Bortolasci, B Panizzutti, M Mohebbi, S Kidnapillai, B Spolding, K Walder, M Berk, G Malhi, S Dodd, O Dean

(2017), Vol. 29, pp. 337-346, Acta Neuropsychiatrica, England, C1

Do Statins Have Antidepressant Effects?

O Köhler-Forsberg, C Gasse, M Berk, S Østergaard

(2017), Vol. 31, pp. 335-343, CNS Drugs, New Zealand, C1

Homocysteine as a peripheral biomarker in bipolar disorder: A meta-analysis

E Salagre, A Vizuete, M Leite, D Brownstein, A McGuinness, F Jacka, S Dodd, B Stubbs, C Köhler, E Vieta, A Carvalho, M Berk, B Fernandes

(2017), Vol. 43, pp. 81-91, European Psychiatry, England, C1

The efficacy of sodium benzoate as an adjunctive treatment in early psychosis - CADENCE-BZ: Study protocol for a randomized controlled trial

A Ryan, A Baker, F Dark, S Foley, A Gordon, S Hatherill, S Stathis, S Saha, G Bruxner, M Beckman, D Richardson, M Berk, O Dean, J McGrath, C Group, J Scott

(2017), Vol. 18, Trials, England, C1

Youth self-harm in low- and middle-income countries: systematic review of the risk and protective factors

S Aggarwal, G Patton, N Reavley, S Sreenivasan, M Berk

(2017), Vol. 63, pp. 359-375, International journal of social psychiatry, London, Eng., C1

the effect of n-acetylcysteine (nac) on human cognition - a systematic review

D Skvarc, O Dean, L Byrne, L Gray, S Lane, M Lewis, B Fernandes, M Berk, A Marriott

(2017), Vol. 78, pp. 44-56, Neuroscience & Biobehavioral Reviews, Amsterdam, The Netherlands, C1

Impact of irritability: a 2-year observational study of outpatients with bipolar I or schizoaffective disorder

L Berk, K Hallam, K Venugopal, A Lewis, D Austin, J Kulkarni, S Dodd, A de Castella, P Fitzgerald, M Berk

(2017), Vol. 19, pp. 184-197, Bipolar disorders, Hoboken, N.J., C1

Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses

B Bortolato, C Köhler, E Evangelou, J León-Caballero, M Solmi, B Stubbs, L Belbasis, I Pacchiarotti, L Kessing, M Berk, E Vieta, A Carvalho

(2017), Vol. 19, pp. 84-96, Bipolar Disorders, Denmark, C1

Perturbations in the apoptotic pathway and mitochondrial network dynamics in peripheral blood mononuclear cells from bipolar disorder patients

G Scaini, G Fries, S Valvassori, C Zeni, G Zunta-Soares, M Berk, J Soares, J Quevedo

(2017), Vol. 7, pp. e1111-, Translational psychiatry, United States, C1

Evaluation of modified patient health questionnaire-9 teen in South African adolescents

S Aggarwal, L Taljard, Z Wilson, M Berk

(2017), Vol. 39, pp. 143-145, Indian Journal of Psychological Medicine, Mumbai, India, C1

Pattern of psychotropic medication use over two decades in Australian women

A Stuart, M Mohebbi, J Pasco, S Quirk, S Brennan-Olsen, M Berk, L Williams

(2017), Vol. 51, pp. 1212-1219, Australian and New Zealand Journal of Psychiatry, England, C1

Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial

O Dean, B Kanchanatawan, M Ashton, M Mohebbi, C Ng, M Maes, L Berk, A Sughondhabirom, S Tangwongchai, A Singh, H McKenzie, D Smith, G Malhi, N Dowling, M Berk

(2017), Vol. 51, pp. 829-840, Australian and New Zealand Journal of Psychiatry, England, C1

Social and academic premorbid adjustment domains predict different functional outcomes among youth with first episode mania

A Ratheesh, C Davey, R Daglas, C Macneil, M Hasty, K Filia, P McGorry, M Berk, P Conus, S Cotton

(2017), Vol. 219, pp. 133-140, Journal of affective disorders, Amsterdam, The Netherlands, C1

Defining melancholia: A core mood disorder

G Parker, D Bassett, T Outhred, G Morris, A Hamilton, P Das, B Baune, M Berk, P Boyce, B Lyndon, R Mulder, A Singh, G Malhi

(2017), Vol. 19, pp. 235-237, Bipolar Disorders, Denmark, C1

Psychotropic pharmacogenetics - distraction or destiny?

A Singh, B Baune, A Hamilton, P Das, T Outhred, G Morris, D Bassett, M Berk, P Boyce, B Lyndon, R Mulder, G Parker, G Malhi

(2017), Vol. 51, pp. 665-667, Australian & New Zealand journal of psychiatry, London, Eng., C1

International multi-site survey on the use of online support groups in bipolar disorder

R Bauer, J Conell, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Castro, E Cheung, C Chillotti, S Choppin, M Zompo, R Dias, S Dodd, A Duffy, B Etain

(2017), Vol. 71, pp. 473-476, Nordic Journal of Psychiatry, Abingdon, Eng, C1

Indices of insulin resistance and glucotoxicity are not associated with bipolar disorder or major depressive disorder, but are differently associated with inflammatory, oxidative and nitrosative biomarkers

K Landucci Bonifácio, D Sabbatini Barbosa, E Gastaldello Moreira, C de Farias, L Higachi, A Camargo, J Favaro Soares, H Odebrecht Vargas, S Nunes, M Berk, S Dodd, M Maes

(2017), Vol. 222, pp. 185-194, Journal of Affective Disorders, Netherlands, C1

Solar insolation in springtime influences age of onset of bipolar I disorder

M Bauer, T Glenn, M Alda, M Aleksandrovich, O Andreassen, E Angelopoulos, R Ardau, Y Ayhan, C Baethge, S Bharathram, R Bauer, B Baune, C Becerra-Palars, F Bellivier, R Belmaker, M Berk, Y Bersudsky, Bicakci, H Birabwa-Oketcho, T Bjella, L Bossini, J Cabrera, E Cheung, M Del Zompo, S Dodd, M Donix, B Etain, A Fagiolini, K Fountoulakis, M Frye, A Gonzalez-Pinto, J Gottlieb, P Grof, H Harima, C Henry, E Isometsä, S Janno, F Kapczinski, M Kardell, S Khaldi, S Kliwicki, B König, T Kot, R Krogh, M Kunz, B Lafer, M Landén, E Larsen, U Lewitzka, R Licht, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, F Meza-Urzúa, M Yee Ming, S Monteith, G Morken, E Mosca, R Munoz, S Mythri, F Nacef, R Nadella, F Nery, R Nielsen, C O'Donovan, A Omrani, Y Osher, H Østermark Sørensen, U Ouali, Y Pica Ruiz, M Pilhatsch, M Pinna, F da Ponte, D Quiroz, R Ramesar, N Rasgon, M Reddy, A Reif, P Ritter, J Rybakowski, K Sagduyu, M Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, M Subramaniam, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, L Tondo, C Torrent, A Vaaler, J Veeh, E Vieta, B Viswanath

(2017), Vol. 136, pp. 571-582, Acta Psychiatrica Scandinavica, United States, C1

Mixed mood: the not so united states?

G Malhi, M Berk, G Morris, A Hamilton, T Outhred, P Das, D Bassett, B Baune, P Boyce, B Lyndon, R Mulder, G Parker, A Singh

(2017), Vol. 19, pp. 242-245, Bipolar Disorders, Hoboken, N. J., C1

The renin-angiotensin system: A possible new target for depression

J Vian, C Pereira, V Chavarria, C Köhler, B Stubbs, J Quevedo, S Kim, A Carvalho, M Berk, B Fernandes

(2017), Vol. 15, BMC Medicine, England, C1

Online ethics: where will the interface of mental health and the internet lead us?

V Cosgrove, E Gliddon, L Berk, D Grimm, S Lauder, S Dodd, M Berk, T Suppes

(2017), Vol. 5, International Journal of Bipolar Disorders, Germany, C1

Plasma levels of tumor necrosis factor superfamily molecules are increased in bipolar disorder

I Barbosa, G Vaz, N Rocha, R Machado-Vieira, M Ventura, R Huguet, M Bauer, M Berk, A Teixeira

(2017), Vol. 15, pp. 269-275, Clinical Psychopharmacology and Neuroscience, Korea (South), C1

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: A 7-year longitudinal study

M Berger, S Smesny, S Kim, C Davey, S Rice, Z Sarnyai, M Schlögelhofer, M Schäfer, M Berk, P McGorry, G Amminger

(2017), Vol. 7, pp. 1-6, Translational Psychiatry, United States, C1

Getting RID of the blues: Formulating a Risk Index for Depression (RID) using structural equation modeling

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2017), Vol. 51, pp. 1121-1133, Australian and New Zealand Journal of Psychiatry, England, C1

Personality disorder is an excess risk factor for physical multimorbidity among women with mental state disorders

S Quirk, A Stuart, M Berk, J Pasco, S Brennan Olsen, H Koivumaa-Honkanen, R Honkanen, P Lukkala, A Chanen, M Kotowicz, L Williams

(2017), Vol. 257, pp. 546-549, Psychiatry Research, Ireland, C1

N-acetylcysteine in the treatment of craving in substance use disorders: Systematic review and meta-analysis

M Duailibi, Q Cordeiro, E Brietzke, M Ribeiro, S LaRowe, M Berk, A Trevizol

(2017), Vol. 26, pp. 660-666, American Journal on Addictions, England, C1

Staging in bipolar disorder: from theoretical framework to clinical utility

M Berk, R Post, A Ratheesh, E Gliddon, A Singh, E Vieta, A Carvalho, M Ashton, L Berk, S Cotton, P McGorry, B Fernandes, L Yatham, S Dodd

(2017), Vol. 16, pp. 236-244, World psychiatry, Chichester, Eng., C1

Validation of a Portable Low-Power Deep Brain Stimulation Device Through Anxiolytic Effects in a Laboratory Rat Model

A Kouzani, R Kale, P Zarate-Garza, M Berk, K Walder, S Tye

(2017), Vol. 25, pp. 1365-1374, IEEE Transactions on Neural Systems and Rehabilitation Engineering, United States, C1

Nutritional psychiatry: the present state of the evidence

W Marx, G Moseley, M Berk, F Jacka

(2017), Vol. 76, pp. 427-436, Proceedings of the Nutrition Society, Cambridge, Eng., C1

Cognitive functioning following stabilisation from first episode mania

R Daglas, K Allott, M Yücel, L Henry, C Macneil, M Hasty, M Berk, S Cotton

(2017), Vol. 5, International Journal of Bipolar Disorders, Germany, C1

Mitochondrial modifying nutrients in treating chronic fatigue syndrome: a 16-week open-label pilot study

R Menon, L Cribb, J Murphy, M Ashton, G Oliver, N Dowling, A Turner, O Dean, M Berk, C Ng, J Sarris

(2017), Vol. 4, pp. 109-114, Advances in integrative medicine, Amsterdam, The Netherlands, C1

Emergency Department Youth Patients With Suicidal Ideation or Attempts: Predicting Suicide Attempts Through 18Months of Follow-Up

Joan Asarnow, Michele Berk, Lily Zhang, Peter Wang, Lingqi Tang

(2017), Vol. 47, pp. 551-566, SUICIDE AND LIFE-THREATENING BEHAVIOR, England, C1

Cardiovascular efficacy and safety of bococizumab in high-risk patients

P Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, M Flather, R Glynn, J Gregoire, J Jukema, Y Karpov, J Kastelein, W Koenig, A Lorenzatti, P Manga, U Masiukiewicz, M Miller, A Mosterd, J Murin, J Nicolau, S Nissen, P Ponikowski, R Santos, P Schwartz, H Soran, H White, R Wright, M Vrablik, C Yunis, C Shear, J Tardif, D Conde, D Colquhoun, L Missault, J Grégoire, R Gao, M Urina, M Solar, H Jensen, D Grobbee, M Savolainen, F Schiele, G Montalescot, I Edes, G Blake, C Lotan, A Maggioni, S Savonitto, C Lee, J Leiva Pons, G Dan, J Cortada, L Mellbin, T Kahan, S Noble, J Hwang, P Sritara, L Tökgozoğlu, L Tarasenko, J Borer, H Black, R Carmena, K Furie, J McMurray, J Neaton, F Zannad, B O’Neill, F Welty, R McNamara, H Chun, J Abbott, D Jacoby, C McPherson, F Jadbabaie, D Pinto, L McCullough, I Silverman, L Sansing, J Dearborn-Tomazos, J Foody, J Schindler, G Piazza, A Chakrabarti, Y Pride, E Gelfand, D Baultrukonis, S Chaudhuri, R Frederich, M Johnson, K Mridha, C Powell, E Wang, C Wei, P Anderson, M Buonanno, C Epsley, B Evans, M Frolova, M Goetsch, D Hessinger, M Berk

(2017), Vol. 376, pp. 1527-1539, New England journal of medicine, Boston, Mass., C1

Steroidogenic Metabolism of Galeterone Reveals a Diversity of Biochemical Activities

Mohammad Alyamani, Zhenfei Li, Michael Berk, Jianneng Li, Jingjie Tang, Sunil Upadhyay, Richard Auchus, Nima Sharifi

(2017), Vol. 24, pp. 825-+, CELL CHEMICAL BIOLOGY, United States, C1

Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer

Jianneng Li, Mohammad Alyamani, Ao Zhang, Kai-Hsiung Chang, Michael Berk, Zhenfei Li, Ziqi Zhu, Marianne Petro, Cristina Magi-Galluzzi, Mary-Ellen Taplin, Jorge Garcia, Kevin Courtney, Eric Klein, Nima Sharifi

(2017), Vol. 6, ELIFE, England, C1

Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial

S Rice, I Hickie, A Yung, A Mackinnon, M Berk, C Davey, D Hermens, S Hetrick, A Parker, M Schäfer, P McGorry, G Amminger

(2016), Vol. 10, pp. 290-299, Early Intervention in Psychiatry, Australia, C1

The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases

G Morris, M Berk, P Galecki, K Walder, M Maes

(2016), Vol. 53, pp. 1195-1219, Molecular Neurobiology, United States, C1

Toward Omics-Based, Systems Biomedicine, and Path and Drug Discovery Methodologies for Depression-Inflammation Research

M Maes, G Nowak, J Caso, J Leza, C Song, M Kubera, H Klein, P Galecki, C Noto, E Glaab, R Balling, M Berk

(2016), Vol. 53, pp. 2927-2935, Molecular Neurobiology, United States, C1

The Putative Role of Viruses, Bacteria, and Chronic Fungal Biotoxin Exposure in the Genesis of Intractable Fatigue Accompanied by Cognitive and Physical Disability

G Morris, M Berk, K Walder, M Maes

(2016), Vol. 53, pp. 2550-2571, Molecular Neurobiology, United States, C1

C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: Meta-analysis and implications

B Fernandes, J Steiner, H Bernstein, S Dodd, J Pasco, O Dean, P Nardin, C Gonçalves, M Berk

(2016), Vol. 21, pp. 554-564, Molecular Psychiatry, England, C1

The deleterious effects of oxidative and nitrosative stress on palmitoylation, membrane lipid rafts and lipid-based cellular signalling : new drug targets in neuroimmune disorders

G Morris, K Walder, B Puri, M Berk, M Maes

(2016), Vol. 53, pp. 4638-4658, Molecular neurobiology, New York, N.Y., C1

Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways

M Martin-Subero, G Anderson, B Kanchanatawan, M Berk, M Maes

(2016), Vol. 21, pp. 184-198, CNS Spectrums, Cambridge, Eng., C1

Citalopram and sertraline exposure compromises embryonic bone development

D Fraher, J Hodge, F Collier, J McMillan, R Kennedy, M Ellis, G Nicholson, K Walder, S Dodd, M Berk, J Pasco, L Williams, Y Gibert

(2016), Vol. 21, pp. 656-664, Molecular Psychiatry, England, C1

Bipolar disorder

I Grande, M Berk, B Birmaher, E Vieta

(2016), Vol. 387, pp. 1561-1572, The Lancet, England, C1

Autobiographical memory dysfunctions in depressive disorders

M Talarowska, M Berk, M Maes, P Gałecki

(2016), Vol. 70, pp. 100-108, Psychiatry and Clinical Neurosciences, Australia, C1

The prevalence and age of onset of psychiatric disorders in Australian men

L Williams, F Jacka, J Pasco, C Coulson, S Quirk, A Stuart, M Berk

(2016), Vol. 50, pp. 678-684, Australian and New Zealand Journal of Psychiatry, England, C1

Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression

B Fernandes, J Hodge, J Pasco, M Berk, L Williams

(2016), Vol. 33, pp. 21-25, Drugs and Aging, New Zealand, C1

Theory of mind in major depressive disorder: A meta-analysis

E Bora, M Berk

(2016), Vol. 191, pp. 49-55, Journal of Affective Disorders, Netherlands, C1

A single-blind, randomised controlled trial on the effects of lithium and quetiapine monotherapy on the trajectory of cognitive functioning in first episode mania: A 12-month follow-up study

R Daglas, S Cotton, K Allott, M Yücel, C Macneil, M Hasty, B Murphy, C Pantelis, K Hallam, L Henry, P Conus, A Ratheesh, L Kader, M Wong, P McGorry, M Berk

(2016), Vol. 31, pp. 20-28, European Psychiatry, England, C1

The trajectory of cognitive functioning following first episode mania: A 12-month follow-up study

R Daglas, K Allott, M Yücel, C Pantelis, C Macneil, M Berk, S Cotton

(2016), Vol. 50, pp. 1186-1197, Australian and New Zealand Journal of Psychiatry, England, C1

Depression as a risk factor for fracture in women: A 10 year longitudinal study

L Williams, J Pasco, H Jackson, L Kiropoulos, A Stuart, F Jacka, M Berk

(2016), Vol. 192, pp. 34-40, Journal of Affective Disorders, Netherlands, C1

DNA methylation and the social gradient of osteoporotic fracture: A conceptual model

S Brennan-Olsen, R Page, M Berk, J Riancho, W Leslie, S Wilson, K Saban, L Janusek, J Pasco, J Hodge, S Quirk, N Hyde, S Hosking, L Williams

(2016), Vol. 84, pp. 204-212, Bone, United States, C1

Regulators of mitochondrial complex I activity: A review of literature and evaluation in postmortem prefrontal cortex from patients with bipolar disorder

A Duong, Y Che, D Ceylan, A Pinguelo, A Andreazza, L Trevor Young, M Berk

(2016), Vol. 236, pp. 148-157, Psychiatry Research, Ireland, C1

Population Prevalence of Personality Disorder and Associations with Physical Health Comorbidities and Health Care Service Utilization: A Review

S Quirk, M Berk, A Chanen, H Koivumaa-Honkanen, S Brennan-Olsen, J Pasco, L Williams

(2016), Vol. 7, pp. 136-146, Personality Disorders: Theory, Research, and Treatment, United States, C1

SPECIFIC MOOD SYMPTOMS CONFER RISK FOR SUBSEQUENT SUICIDAL IDEATION IN BIPOLAR DISORDER WITH AND WITHOUT SUICIDE ATTEMPT HISTORY: MULTI-WAVE DATA FROM STEP-BD

J Stange, E Kleiman, L Sylvia, P Magalhães, M Berk, A Nierenberg, T Deckersbach

(2016), Vol. 33, pp. 464-472, Depression and Anxiety, United States, C1

Cognitive remission: A novel objective for the treatment of major depression?

B Bortolato, K Miskowiak, C Köhler, M Maes, B Fernandes, M Berk, A Carvalho

(2016), Vol. 14, BMC Medicine, England, C1

Bias in Peripheral Depression Biomarkers

A Carvalho, C Köhler, A Brunoni, K Miskowiak, N Herrmann, K Lanctôt, T Hyphantis, J Quevedo, B Fernandes, M Berk

(2016), Vol. 85, pp. 81-90, Psychotherapy and Psychosomatics, Switzerland, C1

Affective instability and the course of bipolar depression: Results from the STEP-BD randomised controlled trial of psychosocial treatment

J Stange, L Sylvia, P Da Silva Magalhães, D Miklowitz, M Otto, E Frank, C Yim, M Berk, D Dougherty, A Nierenberg, T Deckersbach

(2016), Vol. 208, pp. 352-358, British Journal of Psychiatry, England, C1

Statin and Aspirin Use and the Risk of Mood Disorders among Men

L Williams, J Pasco, M Mohebbi, F Jacka, A Stuart, K Venugopal, A O'Neil, M Berk

(2016), Vol. 19, pp. 1-4, International Journal of Neuropsychopharmacology, England, C1

Harnessing the potential of community-based participatory research approaches in bipolar disorder

E Michalak, S Jones, F Lobban, G Algorta, S Barnes, L Berk, M Berk, R Hole, S Lapsley, V Maxwell, R Milev, J McManamy, G Murray, M Tohen, S Tse, M Sanchez de Carmona, S Johnson

(2016), Vol. 4, pp. 1-9, International Journal of Bipolar Disorders, Germany, C1

Fusing data mining, machine learning and traditional statistics to detect biomarkers associated with depression

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2016), Vol. 11, PLoS ONE, United States, C1

Niacin skin sensitivity is increased in adolescents at ultra-high risk for psychosis

G Berger, S Smesny, M Schäfer, B Milleit, K Langbein, U Hipler, C Milleit, C Klier, M Schlögelhofer, M Holub, I Holzer, M Berk, P McGorry, H Sauer, G Amminger

(2016), Vol. 11, PLoS ONE, United States, C1

Trajectory and predictors of quality of life in first episode psychotic mania

M Oldis, G Murray, C Macneil, M Hasty, R Daglas, M Berk, P Conus, S Cotton

(2016), Vol. 195, pp. 148-155, Journal of Affective Disorders, Netherlands, C1

T helper 17 cells may drive neuroprogression in major depressive disorder: Proposal of an integrative model

A Slyepchenko, M Maes, C Köhler, G Anderson, J Quevedo, G Alves, M Berk, B Fernandes, A Carvalho

(2016), Vol. 64, pp. 83-100, Neuroscience and Biobehavioral Reviews, United States, C1

The putative use of lithium in alzheimer's disease

G Morris, M Berk

(2016), Vol. 13, pp. 853-861, Current alzheimer research, Bussum, Netherlands, C1

Depression is a risk factor for incident coronary heart disease in women: An 18-year longitudinal study

A O'Neil, A Fisher, K Kibbey, F Jacka, M Kotowicz, L Williams, A Stuart, M Berk, P Lewandowski, C Taylor, J Pasco

(2016), Vol. 196, pp. 117-124, Journal of Affective Disorders, Netherlands, C1

The addition of depression to the Framingham Risk Equation model for predicting coronary heart disease risk in women

A O'Neil, A Fisher, K Kibbey, F Jacka, M Kotowicz, L Williams, A Stuart, M Berk, P Lewandowski, J Atherton, C Taylor, J Pasco

(2016), Vol. 87, pp. 115-120, Preventive Medicine, United States, C1

Physical health comorbidities in women with personality disorder: Data from the Geelong Osteoporosis Study

S Quirk, A Stuart, S Brennan-Olsen, J Pasco, M Berk, A Chanen, H Koivumaa-Honkanen, M Kotowicz, P Lukkala, L Williams

(2016), Vol. 34, pp. 29-35, European Psychiatry, England, C1

Fibromyalgia and bipolar disorder: Emerging epidemiological associations and shared pathophysiology

B Bortolato, M Berk, M Maes, R McIntyre, A Carvalho

(2016), Vol. 16, pp. 119-136, Current Molecular Medicine, Netherlands, C1

Relationship between erythrocyte fatty acid composition and psychopathology in the Vienna omega-3 study

S Kim, M Jhon, J Kim, S Smesny, S Rice, M Berk, C Klier, P McGorry, M Schäfer, G Amminger

(2016), Vol. 11, PLoS ONE, United States, C1

Anti-inflammatory agents in the treatment of bipolar depression: A systematic review and meta-analysis

J Rosenblat, R Kakar, M Berk, L Kessing, M Vinberg, B Baune, R Mansur, E Brietzke, B Goldstein, R Mcintyre

(2016), Vol. 18, pp. 89-101, Bipolar Disorders, Denmark, C1

Mental health for all Australians

M Berk

(2016), Vol. 50, pp. 301-302, Australian and New Zealand Journal of Psychiatry, England, C1

Leptin in bipolar disorder: A systematic review and meta-analysis

B Fernandes, S Dash, F Jacka, S Dodd, A Carvalho, C Köhler, J Steiner, M da Graça Cantarelli, P Nardin, C Gonçalves, M Berk

(2016), Vol. 35, pp. 1-7, European Psychiatry, England, C1

A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis

J Davis, H Eyre, F Jacka, S Dodd, O Dean, S McEwen, M Debnath, J McGrath, M Maes, P Amminger, P McGorry, C Pantelis, M Berk

(2016), Vol. 65, pp. 185-194, Neuroscience and Biobehavioral Reviews, United States, C1

Associations between DNA damage, DNA base excision repair gene variability and Alzheimer's disease risk

D Kwiatkowski, P Czarny, M Toma, N Jurkowska, A Sliwinska, J Drzewoski, A Bachurska, J Szemraj, M Maes, M Berk, K Su, P Galecki, T Sliwinski

(2016), Vol. 41, pp. 152-171, Dementia and Geriatric Cognitive Disorders, Switzerland, C1

Areas of controversy in neuroprogression in bipolar disorder

I Passos, B Mwangi, E Vieta, M Berk, F Kapczinski

(2016), Vol. 134, pp. 91-103, Acta Psychiatrica Scandinavica, United States, C1

Adjunctive nutraceuticals for depression: a systematic review and meta-analyses

J Sarris, J Murphy, D Mischoulon, G Papakostas, M Fava, M Berk, C Ng

(2016), Vol. 173, pp. 575-587, American journal of psychiatry, Arlington, Va., C1

Antioxidant treatments for schizophrenia

P Magalhães, O Dean, A Andreazza, M Berk, F Kapczinski

(2016), Vol. 2016, Cochrane Database of Systematic Reviews, England, C1

N-acetylcysteine in depressive symptoms and functionality: A systematic review and meta-analysis

B Fernandes, O Dean, S Dodd, G Malhi, M Berk

(2016), Vol. 77, pp. e457-e466, Journal of Clinical Psychiatry, United States, C1

Integrating early intervention for borderline personality disorder and mood disorders

A Chanen, M Berk, K Thompson

(2016), Vol. 24, pp. 330-341, Harvard Review of Psychiatry, United States, C1

Statins for the treatment of depression: a meta-analysis of randomized, double-blind, placebo-controlled trials

E Salagre, B Fernandes, S Dodd, D Brownstein, M Berk

(2016), Vol. 200, pp. 235-242, Journal of affective disorders, Amsterdam, The Netherlands, C1

Mental health system development in Asia: Does Australia have a role?

K Arandjelovic, H Eyre, M Forbes, R Bauer, S Aggarwal, A Singh, B Baune, I Everall, M Berk, C Ng

(2016), Vol. 50, pp. 834-841, Australian and New Zealand Journal of Psychiatry, England, C1

Bias in emerging biomarkers for bipolar disorder

A Carvalho, C Köhler, B Fernandes, J Quevedo, K Miskowiak, A Brunoni, R Machado-Vieira, M Maes, E Vieta, M Berk

(2016), Vol. 46, pp. 2287-2297, Psychological Medicine, England, C1

Is there a nexus between mental and bone health?

L Williams, J Pasco, J Hodge, M Berk

(2016), Vol. 50, pp. 829-830, Australian and New Zealand Journal of Psychiatry, England, C1

A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: results from STEP-BD

T Deckersbach, A Peters, L Sylvia, A Gold, P Da Silva Magalhaes, D Henry, E Frank, M Otto, M Berk, D Dougherty, A Nierenberg, D Miklowitz

(2016), Vol. 203, pp. 152-157, Journal of affective disorders, Amsterdam, The Netherlands, C1

Nucleus accumbens deep-brain stimulation efficacy in ACTH-pretreated rats: alterations in mitochondrial function relate to antidepressant-like effects

Y Kim, S McGee, J Czeczor, A Walker, R Kale, A Kouzani, K Walder, M Berk, S Tye

(2016), Vol. 6, pp. e842-, Translational psychiatry, United States, C1

Unified selective sorting approach to analyse multi-electrode extracellular data

R Veerabhadrappa, C Lim, T Nguyen, M Berk, S Tye, P Monaghan, S Nahavandi, A Bhatti

(2016), Vol. 6, Scientific Reports, England, C1

Study protocol for a systematic review of evidence for lifestyle interventions targeting smoking, sleep, alcohol/other drug use, physical activity, and healthy diet in people with bipolar disorder

F Kay-Lambkin, L Thornton, J Lappin, T Hanstock, L Sylvia, F Jacka, A Baker, M Berk, P Mitchell, R Callister, N Rogers, S Webster, S Dennis, C Oldmeadow, A MacKinnon, C Doran, A Turner, S Hunt

(2016), Vol. 5, Systematic Reviews, England, C1

Internet use by patients with bipolar disorder: Results from an international multisite survey

R Bauer, J Conell, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Castro, E Cheung, C Chillotti, S Choppin, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, M Hernandez, J Garnham, J Geddes, J Gildebro, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, V Kapur, G Kunigiri, B Lafer, E Larsen, U Lewitzka, R Licht, A Lund, B Misiak, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O'Donovan, Y Okamura, Y Osher, P Piotrowski, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, Â Scippa, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, E Vieta, M Vinberg, B Viswanath, J Volkert, M Zetin, P Whybrow, M Bauer

(2016), Vol. 242, pp. 388-394, Psychiatry Research, Ireland, C1

Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications

G Scaini, G Rezin, A Carvalho, E Streck, M Berk, J Quevedo

(2016), Vol. 68, pp. 694-713, Neuroscience and Biobehavioral Reviews, United States, C1

Predicting Risk of Suicide Attempt Using History of Physical Illnesses From Electronic Medical Records

C Karmakar, W Luo, T Tran, M Berk, S Venkatesh

(2016), Vol. 3, JMIR Mental Health, Canada, C1

Medical burden, body mass index and the outcome of psychosocial interventions for bipolar depression

A Peters, L Shesler, L Sylvia, P Da Silva Magalhaes, D Miklowitz, M Otto, E Frank, M Berk, D Dougherty, A Nierenberg, T Deckersbach

(2016), Vol. 50, pp. 667-677, Australian and New Zealand journal of psychiatry, London, Eng., C1

Effect of adjunctive raloxifene therapy on severity of refractory schizophrenia in women: a randomized clinical trial

J Kulkarni, E Gavrilidis, S Gwini, R Worsley, J Grigg, A Warren, C Gurvich, H Gilbert, M Berk, S Davis

(2016), Vol. 73, pp. 947-954, JAMA psychiatry, Chicago, Ill., C1

ASPREE-D: Aspirin for the prevention of depression in the elderly

M Berk, R Woods, M Nelson, R Shah, C Reid, E Storey, S Fitzgerald, J Lockery, R Wolfe, M Mohebbi, A Murray, B Kirpach, R Grimm, J McNeil

(2016), Vol. 28, pp. 1741-1748, International Psychogeriatrics, England, C1

The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: Study protocol for a randomised controlled trial

D Skvarc, O Dean, L Byrne, L Gray, K Ives, S Lane, M Lewis, C Osborne, R Page, D Stupart, A Turner, M Berk, A Marriott

(2016), Vol. 17, Trials, England, C1

Online information seeking by patients with bipolar disorder: results from an international multisite survey

J Conell, R Bauer, T Glenn, M Alda, R Ardau, B Baune, M Berk, Y Bersudsky, A Bilderbeck, A Bocchetta, L Bossini, A Paredes Castro, E Cheung, C Chillotti, S Choppin, M Del Zompo, R Dias, S Dodd, A Duffy, B Etain, A Fagiolini, J Garnham, J Geddes, J Gildebro, A Gonzalez-Pinto, G Goodwin, P Grof, H Harima, S Hassel, C Henry, D Hidalgo-Mazzei, V Kapur, G Kunigiri, B Lafer, C Lam, E Larsen, U Lewitzka, R Licht, A Lund, B Misiak, P Piotrowski, S Monteith, R Munoz, T Nakanotani, R Nielsen, C O’Donovan, Y Okamura, Y Osher, A Reif, P Ritter, J Rybakowski, K Sagduyu, B Sawchuk, E Schwartz, Â Scippa, C Slaney, A Sulaiman, K Suominen, A Suwalska, P Tam, Y Tatebayashi, L Tondo, E Vieta, M Vinberg, B Viswanath, J Volkert, M Zetin, I Zorrilla, P Whybrow, M Bauer

(2016), Vol. 4, International Journal of Bipolar Disorders, Germany, C1

The impact of HLA-G 3′ UTR variants and sHLA-G on risk and clinical correlates of schizophrenia

A Rajasekaran, V Shivakumar, S Kalmady, J Narayanaswamy, M Subbana, D Venugopal, A Amaresha, G Venkatasubramanian, M Berk, M Debnath

(2016), Vol. 77, pp. 1166-1171, Human Immunology, United States, C1

N-acetylcysteine (NAC) in schizophrenia resistant to clozapine: A double blind randomised placebo controlled trial targeting negative symptoms

S Rossell, P Francis, C Galletly, A Harris, D Siskind, M Berk, K Bozaoglu, F Dark, O Dean, D Liu, D Meyer, E Neill, A Phillipou, J Sarris, D Castle

(2016), Vol. 16, BMC Psychiatry, England, C1

An ISBD perspective on the sociocultural challenges of managing bipolar disorder: A content analysis

C Oedegaard, L Berk, M Berk, S Dilsaver, R Belmaker, K Oedegaard, O Fasmer, I Engebretsen, E Youngstrom

(2016), Vol. 50, pp. 1096-1103, Australian and New Zealand Journal of Psychiatry, England, C1

Shortened telomere length in bipolar disorder: A comparison of the early and late stages of disease

F Barbé-Tuana, M Parisi, B Panizzutti, G Fries, L Grun, F Guma, F Kapczinski, M Berk, C Gama, A Rosa

(2016), Vol. 38, pp. 281-286, Revista Brasileira de Psiquiatria, Brazil, C1

Immuno-psychiatry: An agenda for clinical practice and innovative research

M Leboyer, M Berk, R Yolken, R Tamouza, D Kupfer, L Groc

(2016), Vol. 14, BMC Medicine, England, C1

C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis

B Fernandes, J Steiner, M Molendijk, S Dodd, P Nardin, C Gonçalves, F Jacka, C Köhler, C Karmakar, A Carvalho, M Berk

(2016), Vol. 3, pp. 1147-1156, The Lancet Psychiatry, England, C1

Gut Microbiota, Bacterial Translocation, and Interactions with Diet: Pathophysiological Links between Major Depressive Disorder and Non-Communicable Medical Comorbidities

A Slyepchenko, M Maes, F Jacka, C Köhler, T Barichello, R McIntyre, M Berk, I Grande, J Foster, E Vieta, A Carvalho

(2016), Vol. 86, pp. 31-46, Psychotherapy and Psychosomatics, Switzerland, C1

Single-nucleotide polymorphisms of genes involved in repair of oxidative DNA damage and the risk of recurrent depressive disorder

P Czarny, D Kwiatkowski, M Toma, P Gałecki, A Orzechowska, K Bobińska, A Bielecka-Kowalska, J Szemraj, M Berk, G Anderson, T Śliwiński

(2016), Vol. 22, pp. 4455-4474, Medical Science Monitor, United States, C1-1

Guidelines for developing and reporting machine learning predictive models in biomedical research: A multidisciplinary view

W Luo, D Phung, T Tran, S Gupta, S Rana, C Karmakar, A Shilton, J Yearwood, N Dimitrova, T Ho, S Venkatesh, M Berk

(2016), Vol. 18, Journal of Medical Internet Research, Canada, C1

Into the bowels of depression: Unravelling medical symptoms associated with depression by applying machine-learning techniques to a community based population sample

J Dipnall, J Pasco, M Berk, L Williams, S Dodd, F Jacka, D Meyer

(2016), Vol. 11, PLoS ONE, United States, C1

The gut-brain axis, including the microbiome, leaky gut and bacterial translocation: Mechanisms and pathophysiological role in alzheimer's disease

C Köhler, M Maes, A Slyepchenko, M Berk, M Solmi, K Lanctôt, A Carvalho

(2016), Vol. 22, pp. 6152-6166, Current Pharmaceutical Design, United Arab Emirates, C1

Intestinal dysbiosis, gut hyperpermeability and bacterial translocation: Missing links between depression, obesity and type 2 diabetes?

A Slyepchenko, M Maes, R Machado-Vieira, G Anderson, M Solmik, Y Sanz, M Berk, C Köhlerp, A Carvalhop

(2016), Vol. 22, pp. 6087-6106, Current Pharmaceutical Design, United Arab Emirates, C1

Gut permeability and microbiota in parkinson's disease: Role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways

G Anderson, M Seo, M Berk, A Carvalho, M Maes

(2016), Vol. 22, pp. 6142-6151, Current Pharmaceutical Design, United Arab Emirates, C1

The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimmune processes with an emphasis on inflammatory bowel disease type 1 diabetes and chronic fatigue syndrome

G Morris, M Berk, A Carvalho, J Caso, Y Sanz, M Maes

(2016), Vol. 22, pp. 6058-6075, Current pharmaceutical design, Beijing, China, C1

Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of child-bearing age

J Kulkarni, E Gavrilidis, Wang, W, R Worsley, P Fitzgerald, C Gurvich, T Van Rheenen, M Berk, H Burger

(2015), Vol. 20, pp. 695-702, Molecular psychiatry, Basingstoke, Eng., C1

Towards stage specific treatments: Effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia.

M Rapado-Castro, M Berk, K Venugopal, A Bush, S Dodd, O Dean

(2015), Vol. 57, pp. 69-75, Progress in Neuro-Psychopharmacology and Biological Psychiatry, Amsterdam, The Netherlands, C1

Personality disorders and physical comorbidities in adults from the United States: data from the National Epidemiologic Survey on Alcohol and Related Conditions

S Quirk, R El-Gabalawy, S Brennan, J Bolton, J Sareen, M Berk, A Chanen, J Pasco, L Williams

(2015), Vol. 50, pp. 807-820, Social Psychiatry and Psychiatric Epidemiology, Germany, C1

A randomized head to head trial of MoodSwings.net.au: an internet based self-help program for bipolar disorder

S Lauder, A Chester, D Castle, S Dodd, E Gliddon, L Berk, J Chamberlain, B Klein, M Gilbert, D Austin, M Berk

(2015), Vol. 171, pp. 13-21, Journal of affective disorders, Amsterdam, The Netherlands, C1

Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications

B Fernandes, J Steiner, M Berk, M Molendijk, A Gonzalez-Pinto, C Turck, P Nardin, C Gonçalves

(2015), Vol. 20, pp. 1108-1119, Molecular Psychiatry, London, Eng., C1

The association between attributions of responsibility for motor vehicle accidents and patient satisfaction: a study within a no-fault injury compensation system

J Thompson, M Berk, M O'Donnell, L Stafford, T Nordfjaern

(2015), Vol. 29, pp. 500-508, Clinical rehabilitation, London, Eng., C1

The relationships between insomnia, sleep apnoea and depression: findings from the American national health and nutrition examination survey, 2005-2008

A Hayley, L Williams, K Venugopal, G Kennedy, M Berk, J Pasco

(2015), Vol. 49, pp. 156-170, Australian & New Zealand journal of psychiatry, London, England, C1

Towards a classification of biomarkers of neuropsychiatric disease: From encompass to compass

J Davis, M Maes, A Andreazza, J McGrath, S Tye, M Berk

(2015), Vol. 20, pp. 152-153, Molecular Psychiatry, England, C1

Atherogenic index of plasma and atherogenic coefficient are increased in major depression and bipolar disorder, especially when comorbid with tobacco use disorder

S Nunes, L Piccoli de Melo, M Pizzo de Castro, D Barbosa, H Vargas, M Berk, M Maes

(2015), Vol. 172, pp. 55-62, Journal of affective disorders, Amsterdam, The Netherlands, C1

A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: results from the second Australian national psychosis survey

S Mancuso, V Morgan, P Mitchell, M Berk, A Young, D Castle

(2015), Vol. 172, pp. 30-37, Journal of affective disorders, Amsterdam, The Netherlands, C1

The gut microbiome and diet in psychiatry: focus on depression

S Dash, G Clarke, M Berk, F Jacka

(2015), Vol. 28, pp. 1-6, Current opinion in psychiatry, Philadelphia, Pa., C1

Restless leg syndrome associated with atypical antipsychotics : current status, pathophysiology, and clinical implications

S Aggarwal, S Dodd, M Berk

(2015), Vol. 10, pp. 98-105, Current drug safety, San Francisco, Calif., C1-1

Excessive daytime sleepiness and metabolic syndrome: a cross-sectional study

A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco

(2015), Vol. 64, pp. 244-252, Metabolism, Maryland Heights, MO, C1

STin2 VNTR polymorphism is associated with comorbid tobacco use and mood disorders.

M Pizzo de Castro, S Vargas Nunes, R Guembarovski, C Ariza, J Oda, H Vargas, L Piccoli de Melo, M Watanabe, M Berk, M Maes

(2015), Vol. 172, pp. 347-354, Journal of Affective Disorders, Amsterdam , Netherlands, C1

Mitochondrial dysfunction in schizophrenia: Pathways, mechanisms and implications.

A Rajasekaran, G Venkatasubramanian, M Berk, M Debnath

(2015), Vol. 48, pp. 10-21, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

Influence of birth cohort on age of onset cluster analysis in bipolar I disorder

M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, C Baethge, R Bauer, F Bellivier, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagiolini, M Frye, K Fountoulakis, J Garneau-Fournier, A Gonzalez-Pinto, H Harima, S Hassel, C Henry, A Iacovides, E Isometsä, F Kapczinski, S Kliwicki, B König, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, A Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Hatim Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2015), Vol. 30, pp. 99-105, European psychiatry, Amsterdam, Netherlands, C1

Evolution of adolescent mental health in a rapidly changing socioeconomic environment: a review of mental health studies in adolescents in India over last 10 years

S Aggarwal, M Berk

(2015), Vol. 13, pp. 3-12, Asian journal of psychiatry, Amsterdam, The Netherlands, C1

Fetal programming of schizophrenia: select mechanisms

M Debnath, G Venkatasubramanian, M Berk

(2015), Vol. 49, pp. 90-104, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids.

G Amminger, A Mechelli, S Rice, S Kim, C Klier, R McNamara, M Berk, P McGorry, M Schäfer

(2015), Vol. 5, pp. e495-e495, Translational Psychiatry, United States, C1

The association between use of antidepressants and bone quality using quantitative heel ultrasound

P Rauma, J Pasco, M Berk, A Stuart, H Koivumaa-Honkanen, R Honkanen, J Hodge, L Williams

(2015), Vol. 49, pp. 437-443, Australian & New Zealand journal of psychiatry, London, Eng., C1

RF rectifiers for EM power harvesting in a deep brain stimulating device

M Hosain, A Kouzani, S Tye, A Kaynak, M Berk

(2015), Vol. 38, pp. 157-172, Australasian physical and engineering sciences in medicine, Berlin, Germany, C1

Effects of asenapine in bipolar I patients meeting proxy criteria for moderate-to-severe mixed major depressive episodes: a post hoc analysis

M Berk, J Tiller, J Zhao, L Yatham, G Malhi, E Weiller

(2015), Vol. 76, pp. 728-734, Journal of clinical psychiatry, Memphis, Tenn., C1

A shared framework for the common mental disorders and Non-Communicable Disease: key considerations for disease prevention and control.

A O'Neil, F Jacka, S Quirk, F Cocker, C Taylor, B Oldenburg, M Berk

(2015), Vol. 15, pp. 15-15, BMC Psychiatry, England, C1

The impact of maternal smoking during pregnancy on depressive and anxiety behaviors in children: the Norwegian Mother and Child Cohort Study.

S Moylan, K Gustavson, S Øverland, E Karevold, F Jacka, J Pasco, M Berk

(2015), Vol. 13, pp. 24-24, BMC Medicine, England, C1

Associations of obsessive-compulsive symptoms with clinical and neurocognitive features in schizophrenia according to stage of illness

S Kim, B Jeong, J Kim, I Shin, M Hwang, G Paul Amminger, B Nelson, M Berk, P McGorry, J Yoon

(2015), Vol. 226, pp. 368-375, Psychiatry research, Shannon, Ireland, C1

N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study

E Prado, M Maes, L Piccoli, M Baracat, D Barbosa, O Franco, S Dodd, M Berk, S Vargas Nunes

(2015), Redox report, Edinburgh, Scotland, C1

Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses

G Morris, M Berk, K Walder, M Maes

(2015), Vol. 13, pp. 1-23, BMC Medicine, London, Eng., C1

Online mindfulness-based intervention for late-stage bipolar disorder: pilot evidence for feasibility and effectiveness

G Murray, N Leitan, M Berk, N Thomas, E Michalak, L Berk, S Johnson, S Jones, T Perich, N Allen, M Kyrios

(2015), Vol. 178, pp. 46-51, Journal of affective disorders, Amsterdam, The Netherlands, C1

An adjunctive antidepressant nutraceutical combination in treating major depression: study protocol and clinical considerations

J Sarris, C Stough, C Bousman, J Murphy, K Savage, D Smith, R Menon, S Chamoli, G Oliver, M Berk, G Byrne, C Ng, D Mischoulon

(2015), Vol. 2, pp. 49-56, Advances in integrative medicine, Amsterdam, The Netherlands, C1-1

A brief review of exercise, bipolar disorder, and mechanistic pathways.

D Thomson, A Turner, S Lauder, M Gigler, L Berk, A Singh, J Pasco, M Berk, L Sylvia

(2015), Vol. 6, pp. 147-147, Frontiers in Psychology, Switzerland, C1

Mitochondrial dysfunction in the pathophysiology of bipolar disorder: effects of pharmacotherapy

E Callaly, K Walder, G Morris, M Maes, M Debnath, M Berk

(2015), Vol. 15, pp. 355-365, Mini-reviews in medicinal chemistry, Amsterdam, The Netherlands, C1

The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

G Morris, M Berk

(2015), Vol. 13, pp. 1-25, BMC medicine, London, Eng., C1

Factors influencing insulin resistance in relation to atherogenicity in mood disorders, the metabolic syndrome and tobacco use disorder

C Bortolasci, H Vargas, S Vargas Nunes, L de Melo, M de Castro, E Moreira, S Dodd, D Barbosa, M Berk, M Maes

(2015), Vol. 179, pp. 148-155, Journal of affective disorders, Amsterdam, The Netherlands, C1

Influence of light exposure during early life on the age of onset of bipolar disorder

M Bauer, T Glenn, M Alda, O Andreassen, E Angelopoulos, R Ardau, C Baethge, R Bauer, B Baune, F Bellivier, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Wo Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagiolini, M Frye, K Fountoulakis, J Garneau-Fournier, A Gonzalez-Pinto, J Gottlieb, H Harima, S Hassel, C Henry, A Iacovides, E Isometsä, F Kapczinski, S Kliwicki, B König, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, Â Miranda-Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2015), Vol. 64, pp. 1-8, Journal of psychiatric research, Amsterdam, The Netherlands, C1

Instruments that prospectively predict bipolar disorder - a systematic review.

A Ratheesh, M Berk, C Davey, P McGorry, S Cotton

(2015), Vol. 179, pp. 65-73, Journal of affective disorders, Amsterdam, The Netherlands, C1

Psychiatric disorders, psychotropic medication use and falls among women: an observational study

L Williams, J Pasco, A Stuart, F Jacka, S Brennan, A Dobbins, R Honkanen, H Koivumaa-Honkanen, P Rauma, M Berk

(2015), Vol. 15, pp. 1-7, BMC psychiatry, London, Eng., C1

Oxidant/antioxidant imbalance is an inherent feature of depression

M Talarowska, J Szemraj, M Berk, M Maes, P Gałecki

(2015), Vol. 15, pp. 1-7, BMC psychiatry, London, Eng., C1

Homocysteine as a potential biomarker in bipolar disorders: a critical review and suggestions for improved studies

A Ghanizadeh, A Singh, M Berk, M Torabi-Nami

(2015), Vol. 19, pp. 1-13, Expert opinion on therapeutic targets, Oxford, Eng., C1

Cognitive impairment in first-episode mania: a systematic review of the evidence in the acute and remission phases of the illness

R Daglas, M Yücel, S Cotton, K Allott, S Hetrick, M Berk

(2015), Vol. 3, pp. 1-18, International Journal of Bipolar Disorders, Heidelberg, Germany, C1

Tobacco use in bipolar disorder.

D Thomson, M Berk, S Dodd, M Rapado-Castro, S Quirk, P Ellegaard, L Berk, O Dean

(2015), Vol. 13, pp. 1-11, Clinical Psychopharmacology and Neuroscience, Korea (South), C1

N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review

G Oliver, O Dean, D Camfield, S Blair-West, C Ng, M Berk, J Sarris

(2015), Vol. 13, pp. 12-24, Clinical psychopharmacology and neuroscience, Korea (South), C1

Effects of persisting emotional impact from child abuse and norepinephrine transporter genetic variation on antidepressant efficacy in major depression: a pilot study

A Singh, C Bousman, C Ng, K Byron, M Berk

(2015), Vol. 13, pp. 53-61, Clinical psychopharmacology and neuroscience, Korea (South), C1

Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

Deepmala, J Slattery, N Kumar, L Delhey, M Berk, O Dean, C Spielholz, R Frye

(2015), Vol. 55, pp. 294-321, Neuroscience and Biobehavioral Reviews, Amsterdam, The Netherlands, C1

Prevalence of cardiovascular and metabolic events in patients prescribed clozapine: a retrospective observational, clinical cohort study

N Hyde, S Dodd, K Venugopal, Purdie, M Berk, A O'Neil

(2015), Vol. 10, pp. 125-131, Current drug safety, San Francisco, Calif., C1

Increased serum levels of eotaxin/CCL11 in late-stage patients with bipolar disorder: An accelerated aging biomarker?

B Panizzutti, C Gubert, A Schuh, P Ferrari, G Bristot, G Fries, R Massuda, J Walz, N Rocha, M Berk, A Teixeira, C Gama

(2015), Vol. 182, pp. 64-69, Journal of affective disorders, Amsterdam, The Netherlands, C1

Prospective progression from high-prevalence disorders to bipolar disorder: Exploring characteristics of pre-illness stages

A Ratheesh, S Cotton, J Betts, A Chanen, B Nelson, C Davey, P McGorry, M Berk, A Bechdolf

(2015), Vol. 183, pp. 45-48, Journal of affective disorders, Amsterdam, The Netherlands, C1

The association between major depressive disorder, use of antidepressants and bone mineral density (BMD) in men.

P Rauma, J Pasco, M Berk, A Stuart, H Koivumaa-Honkanen, R Honkanen, J Hodge, L Williams

(2015), Vol. 15, pp. 177-185, Journal of Musculoskeletal and Neuronal Interactions, Greece, C1

Mechanisms underlying neurocognitive dysfunctions in recurrent major depression

P Gałecki, M Talarowska, G Anderson, M Berk, M Maes

(2015), Vol. 21, pp. 1535-1547, Medical Science Monitor: international medical journal for clinical and experimental research, Warsaw, Poland, C1

Excessive daytime sleepiness and falls among older men and women: cross-sectional examination of a population-based sample

A Hayley, L Williams, G Kennedy, K Holloway, M Berk, S Brennan-Olsen, J Pasco

(2015), Vol. 15, pp. 74-74, BMC geriatrics, London, Eng., C1

Nocebo effects in the treatment of major depression: results from an individual study participant-level meta-analysis of the placebo arm of duloxetine clinical trials

S Dodd, A Schacht, K Kelin, H Dueñas, V Reed, L Williams, F Quirk, G Malhi, M Berk

(2015), Vol. 76, pp. 702-711, Journal of clinical psychology, Weinheim, Germany, C1

Evolution of optogenetic microdevices

R Kale, A Kouzani, K Walder, M Berk, S Tye

(2015), Vol. 2, pp. 1-11, Neurophotonics, Bellingham, W.A., C1

Impact of cannabis use on long-term remission in bipolar I and schizoaffective disorder

S Kim, S Dodd, L Berk, J Kulkarni, A de Castella, P Fitzgerald, J Kim, J Yoon, M Berk

(2015), Vol. 12, pp. 349-355, Psychiatry Investigation, Seoul, Korea (South), C1

Peripheral vascular endothelial growth factor as a novel depression biomarker: a meta-analysis

A Carvalho, C Köhler, R McIntyre, C Knöchel, A Brunoni, M Thase, J Quevedo, B Fernandes, M Berk

(2015), Vol. 62, pp. 18-26, Psychoneuroendocrinology, Amsterdam, The Netherlands, C1

Sarcopenia and the common mental disorders: a potential regulatory role of skeletal muscle on brain function?

J Pasco, L Williams, F Jacka, N Stupka, S Brennan-Olsen, K Holloway, M Berk

(2015), Vol. 13, pp. 351-357, Current Osteoporosis Reports, New York, N.Y., C1

Effects of omega-3 PUFA on the vitamin E and glutathione antioxidant defense system in individuals at ultra-high risk of psychosis

S Smesny, B Milleit, M Schaefer, U Hipler, C Milleit, C Wiegand, J Hesse, C Klier, M Holub, I Holzer, M Berk, P McGorry, H Sauer, G Paul Amminger

(2015), Vol. 101, pp. 15-21, Prostaglandins leukot essent fatty acids, Amsterdam, The Netherlands, C1

Radio frequency energy harvesting from a feeding source in a passive deep brain stimulation device for murine preclinical research

M Hosain, A Kouzani, S Tye, M Samad, R Kale, K Bennet, F Manciu, M Berk

(2015), Vol. 37, pp. 1020-1026, Medical engineering and physics, Amsterdam, The Netherlands, C1

Antimanic-like activity of candesartan in mice: possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms

J de Souza Gomes, G de Souza, M Berk, L Cavalcante, F de Sousa, J Budni, D de Lucena, J Quevedo, A Carvalho, D Macêdo

(2015), Vol. 25, pp. 2086-2097, European neuropsychopharmacology, Amsterdam, The Netherlands, C1

N-Acetyl Cysteine (NAC) in the treatment of obsessive-compulsive disorder: a 16-week, double-blind, randomised, placebo-controlled study

J Sarris, G Oliver, D Camfield, O Dean, N Dowling, D Smith, J Murphy, R Menon, M Berk, S Blair-West, C Ng

(2015), Vol. 29, pp. 801-809, CNS Drugs, Berlin, Germany, C1

Symptoms of depression and difficulty initiating sleep from early adolescence to early adulthood: a longitudinal study

A Hayley, J Skogen, B Sivertsen, B Wold, M Berk, J Pasco, S Øverland

(2015), Vol. 38, pp. 1599-1606, Sleep, Darien, Ill., C1

Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: An 8-week randomised controlled trial

P Conus, M Berk, S Cotton, L Kader, C Macneil, M Hasty, K Hallam, M Lambert, B Murphy, P McGorry

(2015), Vol. 30, pp. 975-982, European psychiatry, Amsterdam, The Netherlands, C1-1

Evaluating discussion board engagement in the MoodSwings online self-help program for bipolar disorder: protocol for an observational prospective cohort study

E Gliddon, S Lauder, L Berk, V Cosgrove, D Grimm, S Dodd, T Suppes, M Berk

(2015), Vol. 15, pp. 1-9, BMC psychiatry, London, Eng., C1

Peripheral brain-derived neurotrophic factor (BDNF) as a biomarker in bipolar disorder: a meta-analysis of 52 studies

B Fernandes, M Molendijk, C Kohler,, J Soares, C Leite, R Machado-Vieria, T Ribeiro, J Silva, P Sales, J Quevedo, V Oertel-Knochel, E Vieta, A Gonzalez-Pinto, M Berk, A Carvalho

(2015), Vol. 13, pp. 1-22, BMC Medicine, London, Eng., C1

The use of statins for the treatment of depression in patients with acute coronary syndrome

S Kim, K Bae, J Kim, I Shin, Y Hong, Y Ahn, M Jeong, M Berk, J Yoon

(2015), Vol. 5, pp. 1-7, Translational psychiatry, London, Eng., C1-1

Wireless optogenetics: an exploration of portable microdevices for small animal photostimulation

R Kale, A Kouzani, M Berk, K Walder, J Berk, S Tye

(2015), Vol. 20, pp. 225-230, Procedia technology, Amsterdam, The Netherlands, C1

Strengthening the role of convergence science in medicine

Harris Eyre, Malcolm Forbes, Cyrus Raji, Nicholas Cork, Steven Durning, Elizabeth Armstrong, Erica Wheeler, Arlen Meyers, Bernhard Baune, Michael Berk

(2015), Vol. 1, Convergement science physical oncology, Bristol, Eng., C1

Investigating the predictive validity of an emergency department mental health triage tool

N Sands, S Elsom, M Berk, J Hosking, R Prematunga, M Gerdtz

(2014), Vol. 16, pp. 11-18, Nursing and health sciences, Milton, Qld., C1

Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome

G Anderson, M Berk, M Maes

(2014), Vol. 129, pp. 83-97, Acta Psychiatrica Scandinavica, London, UK, C1

The association between poor dental health and depression: findings from a large-scale, population-based study (the NHANES study)

A O’Neil, M Berk, K Venugopal, S Kim, L Williams, F Jacka

(2014), Vol. 36, pp. 266-270, General Hospital Psychiatry, Amsterdam, The Netherlands, C1

Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications

G Anderson, M Berk, O Dean, S Moylan, M Maes

(2014), Vol. 28, CNS Drugs, Aukland, New Zealand, C1

Stress, inflammation, and cellular vulnerability during early stages of affective disorders: biomarker strategies and opportunities for prevention and intervention

A Walker, Y Kim, J Price, R Kale, J McGillivray, M Berk, S Tye

(2014), Vol. 5, Frontiers in psychiatry, Lausanne, Switzerland, C1-1

Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders

H Vargas, S Vargas Nunes, D Barbosa, M Vargas, A Cestari, S Dodd, K Venugopal, M Maes, M Berk

(2014), Vol. 102, pp. 65-71, Life sciences, Amsterdam, The Netherlands, C1

Prevalence of excessive daytime sleepiness in a sample of the Australian adult population

A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco

(2014), Vol. 15, pp. 348-354, Sleep medicine, Amsterdam, The Netherlands, C1

Risk stratification using data from electronic medical records better predicts suicide risks than clinician assessments

T Tran, W Luo, D Phung, R Harvey, M Berk, R Kennedy, S Venkatesh

(2014), Vol. 14, pp. 1-9, BMC psychiatry, London, Eng., C1

Systematic review of N-acetylcysteine in the treatment of addictions

E Asevedo, A Mendes, M Berk, E Brietzke

(2014), Vol. 36, pp. 168-175, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1

Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?

M Maes, G Anderson, M Kubera, M Berk

(2014), Vol. 18, pp. 495-512, Expert opinion on therapeutic targets, London, England, C1

The efficacy of adjunctive N-Acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial

M Berk, O Dean, S Cotton, S Jeavons, M Tanious, K Kohlmann, K Hewitt, K Moss, C Allwang, I Schapkaitz, J Robbins, H Cobb, F Ng, S Dodd, A Bush, G Malhi

(2014), Vol. 75, pp. 628-636, Journal of clinical psychiatry, Memphis, Tenn., C1

Lowered plasma paraoxonase (PON) 1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder

C Bortolasci, H Odebrecht Vargas, A Souza-Nogueira, D Barbosa, E Moreira, S Obedrecht Vargas Nunes, M Berk, S Dodd, M Maes

(2014), Vol. 159, pp. 23-30, Journal of affective disorders, Amsterdam, The Netherlands, C1

A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania

J Kulkarni, M Berk, W Wang, L Mu, E Scarr, T Van Rheenen, R Worsely, C Gurvich, E Gavrilidis, A de Castella, P Fitzgerald, S David

(2014), Vol. 43, pp. 52-61, Psychoneuroendocrinology, Oxford, England, C1

Neuroprogression in schizophrenia : pathways underpinning clinical staging and therapeutic corollaries

J Davis, S Moylan, B Harvey, M Maes, M Berk

(2014), Vol. 48, pp. 512-529, Australian and New Zealand journal of psychiatry, London, England, C1

Oxidative & nitrosative stress in depression: why so much stress?

S Moylan, M Berk, O Dean, Y Samuni, L Williams, A O'Neil, A Hayley, J Pasco, G Anderson, F Jacka, M Maes

(2014), Vol. 45, pp. 46-62, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

Predominant polarity as a course specifier for bipolar disorder: a systematic review

A Carvalho, R McIntyre, D Dimelis, X Gonda, M Berk, P Nunes-Neto, D Cha, T Hyphantis, J Angst, K Fountoulakis

(2014), Vol. 163, pp. 56-64, Journal of affective disorders, Amsterdam, The Netherlands, C1

Relationship between sunlight and the age of onset of bipolar disorder: An international multisite study

M Bauer, T Glenn, M Alda, O Andreasssen, E Angelopoulos, R Ardua, C Baethge, R Bauer, F Belliver, R Belmaker, M Berk, T Bjella, L Bossini, Y Bersudsky, E Cheung, J Conell, M Del Zompo, S Dodd, B Etain, A Fagionlini, M Frye, K Fountoulaski, J Garneau-Fournier, A Gonzalez-Pinto, H Harima, S Hassel, C Henry, A Iacovides, E Isometsa, F Kapczinski, S Kliwicki, B Konig, R Krogh, M Kunz, B Lafer, E Larsen, U Lewitzka, C Lopez-Jaramillo, G MacQueen, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, S Monteith, G Morken, R Munoz, F Nery, C O'Donovan, Y Osher, A Pfennig, D Quiroz, R Ramesar, N Rasgon, A Reif, P Ritter, J Rybakowski, K Sagduyu, A Scippa, E Severus, C Simhandl, D Stein, S Strejilevich, A Sulaiman, K Suominen, H Tagata, Y Tatebayashi, C Torrent, E Vieta, B Viswanath, M Wanchoo, M Zetin, P Whybrow

(2014), Vol. 167, pp. 104-111, Journal of affective disorders, Amsterdam, The Netherlands, C1

Do comorbid anxiety disorders moderate the effects of psychotherapy for bipolar disorder? Results from STEP-BD

T Deckersbach, A Peters, L Sylvia, A Urdahl, P Magalhaes, M Otto, E Frank, D Miklowitz, M Berk, G Kinryn, A Nierenberg

(2014), Vol. 171, pp. 178-186, American journal of psychiatry, Arlington, VA, C1

Suicidal ideation and physical illness: Does the link lie with depression?

L Sanna, A Stuart, J Pasco, M Kotowicz, M Berk, P Girardi, L Williams

(2014), Vol. 152-154, pp. 422-426, Journal of affective disorders, Amsterdam, The Netherlands, C1

The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs)

G Morris, M Berk, P Galacki, M Maes

(2014), Vol. 49, pp. 741-756, Molecular neurobiology, New York, N. Y., C1

Impact of comorbid anxiety disorders and obsessive-compulsive disorder on 24-month clinical outcomes of bipolar I disorder

S Kim, L Berk, J Kulkarni, S Dodd, A de Castella, P Fitzgerald, G Amminger, M Berk

(2014), Vol. 166, pp. 243-248, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Lifestyle medicine for depression

J Sarris, A O'Neil, C Coulson, I Schwitzer, M Berk

(2014), Vol. 14, pp. 1-13, BMC Psychiatry, London, England, C1

Comparison of self-report and structured clinical interview in the identification of depression

A Stuart, J Pasco, F Jacka, S Brennan, M Berk, L Williams

(2014), Vol. 55, pp. 866-869, Comphrensive psychiatry, Amsterdam, The Netherlands, C1

Attributions of responsibility and recovery within a no-fault insurance compensation system

J Thompson, M Berk, M O'Donnell, L Stafford, T Nordfjaern

(2014), Vol. 59, pp. 247-255, Rehabilitation psychology, Washington DC, C1

Predicting bipolar disorder on the basis of phenomenology : implications for prevention and early intervention

G Malhi, D Bargh, C Coulston, P Das, M Berk

(2014), Vol. 16, pp. 455-470, Bipolar disorders, Copenhagen, Denmark, C1

Design and rationale of a 16-week adjunctive randomized placebo-controlled trial of mitochondrial agents for the treatment of bipolar depression

O Dean, A Turner, G Malhi, C Ng, S Cotton, S Dodd, J Sarris, Y Samuni, M Tanious, N Dowling, A Waterdrinker, D Smith, M Berk

(2014), Vol. 0, pp. 1-10, Revista Brasileira de psiquiatria, Sao Paulo, Brazil, C1

Assessing regional cerebral blood flow in depression using 320-slice computed tomography

Y Wang, H Zhang, S Tang, X Liu, A O'Neil, A Turner, F Chai, F Chen, M Berk

(2014), Vol. 9, pp. 1-10, PLoS One, San Francisco, Cal., C1

Adipokines as emerging depression biomarkers: a systematic review and meta-analysis

A Carvalho, D Rocha, R McIntyre, L Mesquita, C Köhler, T Hyphantis, P Sales, R Machado-Vieira, M Berk

(2014), Vol. 59, pp. 28-37, Journal of psychiatric research, Oxford, England, C1

Relationship between diet and mental health in children and adolescents: a systematic review

A O'Neil, S Quirk, S Housden, S Brennan, L Williams, J Pasco, M Berk, F Jacka

(2014), Vol. 104, pp. e31-e42, American journal of public health, Washington, DC, C1

Paraoxonase 1 status and interactions between Q192R functional genotypes by smoking contribute significantly to total plasma radical trapping antioxidant potential.

C Bortolasci, M Maes, H Vargas, A Souza-Nogueira, E Moreira, S Nunes, M Berk, S Dodd, D Barbosa

(2014), Vol. 581, pp. 46-51, Neuroscience letters, Shannon, Ireland, C1

The impact of insight in a first-episode mania with psychosis population on outcome at 18 months

L Smith, C Shelton, M Berk, M Hasty, S Cotton, L Henry, R Daglas, E Gentle, P McGorry, C Macneil, P Conus

(2014), Vol. 167, pp. 74-79, Journal of affective disorders, Amsterdam, The Netherlands, C1

Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis

S Kim, M Schäfer, C Klier, M Berk, S Rice, K Allott, C Bartholomeusz, S Whittle, E Pilioussis, C Pantelis, P McGorry, G Amminger

(2014), Vol. 158, pp. 39-44, Schizophrenia Research, Amsterdam, The Netherlands, C1

Application of the gradient boosted method in randomised clinical trials: participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placebo

S Dodd, M Berk, K Kelin, Q Zhang, E Eriksson, W Deberdt, J Craig Nelson

(2014), Vol. 168, pp. 284-293, Journal of affective disorders, Amsterdam, The Netherlands, C1

Pop, heavy metal and the blues: secondary analysis of persistent organic pollutants (POP), heavy metals and depressive symptoms in the NHANES National Epidemiological Survey

M Berk, L Williams, A Andreazza, J Pasco, S Dodd, F Jacka, S Moylan, E Reiner, P Magalhaes

(2014), Vol. 4, pp. 1-9, BMJ Open, London, England, C1

Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial.

A Ghanizadeh, Z Rezaee, S Dehbozorgi, M Berk, S Akhondzadeh

(2014), Vol. 219, pp. 431-435, Psychiatry Research, Ireland, C1

Data Integration Protocol In Ten-steps (DIPIT) : a new standard for medical researchers

J Dipnall, M Berk, F Jacka, L Williams, S Dodd, J Pasco

(2014), Vol. 69, pp. 237-246, Methods, Amsterdam, The Netherlands, C1

SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study

M Pizzo de Castro, M Maes, R Guembarovski, C Ariza, E Reiche, H Vargas, M Vargas, L de Melo, S Dodd, M Berk, M Watanabe, S Nunes

(2014), Vol. 15, pp. 1-9, BMC Genetics, London, England, C1

Quality of life in bipolar and schizoaffective disorder - a naturalistic approach.

M Martin-Subero, L Berk, S Dodd, V Kamalesh, M Maes, J Kulkarni, A De Castella, P Fitzgerald, M Berk

(2014), Vol. 55, pp. 1540-1545, Comprehensive Psychiatry, Malden, Mass., C1

Th17 pathway-mediated immunopathogenesis of schizophrenia: mechanisms and implications.

M Debnath, M Berk

(2014), Vol. 40, pp. 1412-1421, Schizophrenia Bulletin, Oxford , England, C1

Genetic polymorphisms in glutathione-S-transferases are associated with anxiety and mood disorders in nicotine dependence

S Odebrecht Vargas Nunes, M Pizzo de Castro, M Ehara Watanabe, R Losi Guembarovski, H Odebrecht Vargas, E Reiche, H Kaminami Morimoto, S Dodd, M Berk

(2014), Vol. 24, pp. 87-93, Psychiatric genetics, Philadelphia, PA, C1

Stage managing bipolar disorder.

M Berk, L Berk, S Dodd, S Cotton, C Macneil, R Daglas, P Conus, A Bechdolf, S Moylan, G Malhi

(2014), Vol. 16, pp. 471-477, Bipolar Disorders, Malden, Mass., C1

The integrative management of treatment-resistant depression: a comprehensive review and perspectives.

A Carvalho, M Berk, T Hyphantis, R McIntyre

(2014), Vol. 83, pp. 70-88, Psychotherapy and psychosomatics, Basel, Switzerland, C1

A head-to-head comparison of aripiprazole and risperidone for safety and treating autistic disorders, a randomized double blind clinical trial

A Ghanizadeh, A Sahraeizadeh, M Berk

(2014), Vol. 45, pp. 185-192, Child Psychiatry & Human Development, New York, NY, C1

The predictive validity of bipolar at-risk (prodromal) criteria in help-seeking adolescents and young adults: a prospective study

A Bechdolf, A Rateesh, S Cotton, B Nelson, A Chanen, J Betts, T Bingmann, A Yung, M Berk, P McGorry

(2014), Vol. 16, pp. 493-504, Bipolar Disorders: an international journal of psychiatry and neurosciences, London, Eng., C1

Atypical antipsychotic agents; peas in a pod or chalk and cheese?

A Singh, A Nierenberg, L Yatham, M Berk

(2014), Vol. 12, pp. 1-4, BMC Medicine, London, England, C1

Staging systems in bipolar disorder: An International Society for Bipolar Disorders Task Force Report

F Kapczinski, P Magalhães, V Balanzá-Martinez, V Dias, S Frangou, C Gama, A Gonzalez-Pinto, I Grande, K Ha, M Kauer-Sant'Anna, M Kunz, R Kupka, M Leboyer, C Lopez-Jaramillo, R Post, J Rybakowski, J Scott, S Strejilevitch, M Tohen, G Vazquez, L Yatham, E Vieta, M Berk

(2014), Vol. 130, pp. 354-363, Acta Psychiatrica Scandinavica, Malden, United States, C1

The Glutathione System: a new drug target in neuroimmune disorders

G Morris, G Anderson, O Dean, M Berk, P Galecki, M Martin-Subero, M Maes

(2014), Vol. 50, pp. 1059-1084, Molecular neurobiology, New York, N. Y., C1

Excessive daytime sleepiness and body composition: a population-based study of adults

A Hayley, L Williams, G Kennedy, M Berk, S Brennan, J Pasco

(2014), Vol. 9, pp. 1-8, PLoS One, San Francisco, CA, C1

Association between attributions of responsibility for motor vehicle crashes, depressive symptoms, and return to work

J Thompson, M O'Donnell, L Stafford, T Nordfjaern, M Berk

(2014), Vol. 59, pp. 376-385, Rehabilitation Psychology, Washington, D.C., United States, C1

Transcultural adaption and validation of the Spanish version of the Bipolar Depression Rating Scale (BDRS-S)

S Sarró, M Madre, P Fernández-Corcuera, M Valentí, J Goikolea, E Pomarol-Clotet, M Berk, B Amann

(2014), Vol. 172, pp. 110-115, Journal of Affective Disorders, Amsterdam , Netherlands, C1

Age at onset, course of illness and response to psychotherapy in bipolar disorder: Results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

A Peters, L Sylvia, P Da Silva Magalhães, D Miklowitz, E Frank, M Otto, N Hansen, D Dougherty, M Berk, A Nierenberg, T Deckersbach

(2014), Vol. 44, pp. 3455-3467, Psychological medicine, Cambridge, Eng., C1

Affective and content analysis of online depression communities

T Nguyen, D Phung, B Dao, S Venkatesh, M Berk

(2014), Vol. 5, pp. 217-226, IEEE Transactions on Affective Computing, Piscataway, N.J, C1

Association between alcohol consumption and self-reported depression among elderly Australian men

C Coulson, L Williams, M Berk, D Lubman, S Quirk, J Pasco

(2014), Vol. 2, pp. 3-8, Geriatric Mental Health Care, Amsterdam, The Netherlands, C1

Biomarkers and clinical staging in psychiatry

P McGorry, M Keshavan, S Goldstone, P Amminger, K Allott, M Berk, S Lavoie, C Pantelis, A Yung, S Wood, I Hickie

(2014), Vol. 13, pp. 211-223, World psychiatry, Oxford, England, C1

Paraoxonase (PON)1 Q192R functional genotypes and PON1 Q192R genotype by smoking interactions are risk factors for the metabolic syndrome, but not overweight or obesity

C Bortolasci, H Vargas, A Souza-Nogueira, E Gastaldello Moreira, S Vargas Nunes, M Berk, S Dodd, D Barbosa, M Maes

(2014), Vol. 19, pp. 232-241, Redox report, Leeds, England, C1

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): study protocol for a randomised control trial.

C Davey, A Chanen, S Cotton, S Hetrick, M Kerr, M Berk, O Dean, K Yuen, M Phelan, A Ratheesh, M Schäfer, G Amminger, A Parker, D Piskulic, S Harrigan, A Mackinnon, B Harrison, P McGorry

(2014), Vol. 15, pp. 1-9, Trials, London, Eng., C1

The impact of past direct-personal traumatic events on 12-month outcome in first episode psychotic mania: trauma and early psychotic mania

R Daglas, P Conus, S Cotton, C Macneil, M Hasty, L Kader, M Berk, K Hallam

(2014), Vol. 48, pp. 1017-1024, Australian and New Zealand journal of psychiatry, London, Eng., C1-1

Optimizing delivery of recovery-oriented online self-management strategies for bipolar disorder : a review

N Leitan, E Michalak, L Berk, M Berk, G Murray

(2014), pp. 1-13, Bipolar Disorders, Malden, United States, C1

Oxidative stress markers, cognitive functions, and psychosocial functioning in bipolar disorder : an empirical cross-sectional study

Ö Aydemir, Z Çubukçuoğlu, S Erdin, C Taş, E Onur, M Berk

(2014), Vol. 36, pp. 293-297, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1-1

Statin use and risk of depression: a Swedish national cohort study

C Redlich, M Berk, L Williams, J Sundquist, K Sundquist, X Li

(2014), Vol. 14, pp. 1-9, BMC Psychiatry, London, Eng., C1

The effects of escitalopram on myocardial apoptosis and the expression of Bax and Bcl-2 during myocardial ischemia/reperfusion in a model of rats with depression.

Y Wang, H Zhang, F Chai, X Liu, M Berk

(2014), Vol. 14, pp. 1-7, BMC Psychiatry, London, England, C1

Cognitive dysfunction in depression - pathophysiology and novel targets

A Carvalho, K Miskowiak, T Hyphantis, C Kohler, G Alves, B Bortolato, P Sales, R Machado-Vieira, M Berk, R McIntyre

(2014), Vol. 13, pp. 1-17, CNS & Neurological Disorders - Drug Targets, Bussum, Netherlands, C1

Association of paraoxonase (PON)1 activity, glutathione S-transferase GST T1/M1 and STin.2 polymorphisms with comorbidity of tobacco use disorder and mood disorders.

S Vargas Nunes, M Pizzo de Castro, E Moreira, R Guembarovski, D Barbosa, H Vargas, L Piccoli de Melo, C Bortolasci, M Watanabe, S Dodd, M Berk, M Maes

(2014), Vol. 585C, pp. 132-137, Neuroscience letters, Shannon, Ireland, C1

Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome

M Maes, J Leunis, M Geffard, M Berk

(2014), Vol. 35, pp. 445-453, Neuroendocrinology Letters, Sweden, C1

The association between dietary patterns, diabetes and depression.

J Dipnall, J Pasco, D Meyer, M Berk, L Williams, S Dodd, F Jacka

(2014), Vol. 174, pp. 215-224, Journal of Affective Disorders, Amsterdam, The Netherlands, C1

Treatment implications of predominant polarity and the polarity index: a comprehensive review.

A Carvalho, J Quevedo, R McIntyre, M Soeiro-de-Souza, K Fountoulakis, M Berk, T Hyphantis, E Vieta

(2014), Vol. 18, International Journal of Neuropsychopharmacology, England, C1

e-Mental health for mood and anxiety disorders in general practice

J Orman, B O'Dea, F Shand, M Berk, J Proudfoot, H Christensen

(2014), Vol. 43, pp. 832-837, Australian family physician, Melbourne, Vic., C1

Construct validity of the Experiences of Therapy Questionnaire (ETQ)

G Parker, A Paterson, K Fletcher, G McClure, M Berk

(2014), Vol. 14, pp. 1-6, BMC psychiatry, London, England, C1-1

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial.

O Dean, M Maes, M Ashton, L Berk, B Kanchanatawan, A Sughondhabirom, S Tangwongchai, C Ng, N Dowling, G Malhi, M Berk

(2014), Vol. 12, pp. 180-188, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1

Development of a compact rectenna for wireless powering of a head-mountable deep brain stimulation device

M Hosain, A Kouzani, S Tye, O Abulseoud, A Amiet, A Galehdar, A Kaynak, M Berk

(2014), Vol. 2, pp. 1-13, IEEE journal of translational engineering in health and medicine, Piscataway, N.J., C1

The Association Between Use of Antidepressants and Bone Quality Using Quantitative Ultrasound.

Paivi Rauma, Julie Pasco, Michael Berk, Amanda Stuart, Risto Honkanen, Heli Koivumaa-Honkanen, Jason Hodge, Lana Williams

(2014), Vol. 29, pp. S462-S462, JOURNAL OF BONE AND MINERAL RESEARCH, Houston, TX, C1-1

The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications

S Moylan, M Maes, N Wray, M Berk

(2013), Vol. 18, pp. 595-606, Molecular psychiatry, London, England, C1

Development of an online intervention for bipolar disorder. www.moodswings.net.au

S Lauder, A Chester, D Castle, S Dodd, L Berk, B Klein, D Austin, M Gilbert, J Chamberlain, G Murray, C White, L Piterman, M Berk

(2013), Vol. 18, pp. 155-165, Psychology, health and medicine, Oxon, England, C1

The sick role, illness cognitions and outcomes in bipolar disorder

M Berk, L Berk, S Dodd, P Fitzgerald, A de Castella, S Filia, K Filia, A Brnabic, K Kelin, W Montgomery, J Kulkarni, L Stafford

(2013), Vol. 146, pp. 146-149, Journal of affective disorders, Amsterdam, Netherlands, C1

Clinical characteristics and smoking cessation : an analysis of sex and depressive disorders differences

S Nunes, M de Castro, H Vargasa, M Vargas, I de Batista Fonseca, S Dodd, M Berk

(2013), Vol. 12, pp. 158-165, Addictive disorders & their treatment, Philadelphia, PA, C1

Dietary intake of fish and PUFA, and clinical depressive and anxiety disorders in women

F Jacka, J Pasco, L Williams, B Meyer, R Digger, M Berk

(2013), Vol. 109, pp. 2059-2066, British journal of nutrition, Cambridge, England, C1

Targeting the mitochondrial electron transport chain in autism, a systematic review and synthesis of a novel therapeutic approach

A Ghanizadeh, M Berk, H Farrashbandi, A Alavi shoushtari, K Villagonzalo

(2013), Vol. 13, pp. 515-519, Mitochondrion, Amsterdam, The Netherlands, C1

Diet quality and mental health problems in adolescents from East London : a prospective study

F Jacka, C Rothon, S Taylor, M Berk, S Stansfeld

(2013), Vol. 48, pp. 1297-1306, Social psychiatry and psychiatric epidemiology, Heidelberg, Germany, C1

The nocebo effect : a clinicians guide

J Data-Franco, M Berk

(2013), Vol. 47, pp. 617-623, Australian and New Zealand journal of psychiatry, London, England, C1

Quantitative Heel Ultrasound (QUS) measures of bone quality in association with mood and anxiety disorders

L Williams, J Pasco, F Jacka, J Hodge, M Kotowicz, M Berk

(2013), Vol. 146, pp. 395-400, Journal of affective disorders, Amsterdam, The Netherlands, C1

Putative neuroprotective agents in neuropsychiatric disorders

S Dodd, M Maes, G Anderson, O Dean, S Moylan, M Berk

(2013), Vol. 42, pp. 135-145, Progress in neuro-psychopharmacology and biological psychiatry, United States, C1

Neurocognitive functioning in the prodrome of mania - an exploratory study

A Ratheesh, A Lin, B Nelson, S Wood, W Brewer, J Betts, M Berk, P McGorry, A Yung, A Bechdolf

(2013), Vol. 147, pp. 441-445, Journal of affective disorders, Amsterdam, The Netherlands, C1

Selective serotonin reuptake inhibitors inhibit human osteoclast and osteoblast formation and function

J Hodge, Y Wang, M Berk, F Collier, T Fernandes, M Constable, J Pasco, S Dodd, G Nicholson, R Kennedy, L Williams

(2013), Vol. 74, pp. 32-39, Biological psychiatry, Amsterdam, The Netherlands, C1

Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways

G Anderson, M Maes, M Berk

(2013), Vol. 42, pp. 101-114, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1

Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine

M Moller, J Du Preez, F Viljoen, M Berk, R Emsley, B Harvey

(2013), Vol. 30, pp. 156-167, Brain, behavior, and immunity, Marylands Heights, Mo., C1

Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: Implications for the pathways to chronic depression and neuroprogression

M Maes, M Kubera, I Mihaylova, M Geffard, P Galecki, J Leunis, M Berk

(2013), Vol. 149, pp. 23-29, Journal of affective disorders, Amsterdam, Netherlands, C1

Development of a measure quantifying adverse psychotherapeutic ingredients : The Experiences of Therapy Questionnaire (ETQ)

G Parker, K Fletcher, M Berk, A Paterson

(2013), Vol. 206, pp. 293-301, Psychiatry research, Shannon, Ireland, C1-1

Chronic adrenocorticotrophic hormone treatment alters tricyclic antidepressant efficacy and prefrontal monoamine tissue levels

A Walker, S Burnett, K Hasebe, J McGillivray, L Gray, S McGee, K Walder, M Berk, S Tye

(2013), Vol. 242, pp. 76-83, Behavioural brain research, Amsterdam, The Netherlands, C1

Efficacy and adverse effects of venlafaxine in children and adolescents with ADHD : a systematic review of non-controlled and controlled trials

A Ghanizadeh, R Freeman, M Berk

(2013), Vol. 8, pp. 2-8, Reviews on recent clinical trials, Bussum, The Netherlands, C1

The promise of N-acetylcysteine in neuropsychiatry

M Berk, G Malhi, L Gray, O Dean

(2013), Vol. 34, pp. 167-177, Trends in pharmacological sciences, Oxford, England, C1

Metabolite profiles in the anterior cingulate cortex of depressed patients differentiate those taking N-acetyl-cysteine versus placebo

P Das, M Tanious, K Fritz, S Dodd, O Dean, M Berk, G Malhi

(2013), Vol. 47, pp. 347-354, Australian and New Zealand journal of psychiatry, London, England, C1

Biomarkers in bipolar disorder : a positional paper from the International Society for Bipolar Disorders Biomarkers Task Force

B Frey, A Andreazza, J Houenou, S Jamain, B Goldstein, M Frye, M Leboyer, M Berk, G Malhi, C Lopez-Jaramillo, V Taylor, S Dodd, S Frangou, G Hall, B Fernandes, M Kauer-Sant'Anna, L Yatham, F Kapczinski, L Young

(2013), Vol. 47, pp. 321-332, Australian and New Zealand journal of psychiatry, London, England, C1-1

Lifestyle management of unipolar depression

M Berk, J Sarris, C Coulson, F Jacka

(2013), Vol. 127, pp. 38-54, Acta psychiatrica scandinavica, Malden, Mass., C1-1

A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania

P Vieira da Silva Magalhaes, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2013), Vol. 47, pp. 564-568, Australian and New Zealand journal of psychiatry, London, England, C1

Differences between first episode schizophrenia and schizoaffective disorder

S Cotton, M Lambert, B Schimmelmann, A MacKinnon, J Gleeson, M Berk, L Hides, A Chanen, J Scott, D Schottle, P McGorry, P Conus

(2013), Vol. 147, pp. 169-174, Schizophrenia research, Amsterdam, The Netherlands, C1

Pharmacological management of unipolar depression

G Malhi, R Hitching, M Berk, P Boyce, R Porter, K Fritz

(2013), Vol. 127, pp. 6-23, Acta psychiatrica scandinavica, Malden, Mass., C1

The relationship between excessive daytime sleepiness and depressive and anxiety disorders in women

A Hayley, L Williams, M Berk, G Kennedy, F Jacka, J Pasco

(2013), Vol. 47, pp. 772-778, Australian and New Zealand journal of psychiatry, London, England, C1

Physical comorbidities in men with mood and anxiety disorders: a population-based study

L Sanna, A Stuart, J Pasco, M Kotowicz, M Berk, P Girardi, S Brennan, L Williams

(2013), Vol. 11, pp. 1-9, BMC medicine, London, England, C1

Extreme attributions predict the course of bipolar depression : results from the STEP-BD randomized controlled trial of psychosocial treatment

J Strange, L Sylvia, P Vieira da Silva Magalhaes, D Miklowitz, M Otto, E Frank, M Berk, A Nierenberg, T Deckersbach

(2013), Vol. 74, pp. 249-255, Journal of clinical psychiatry, Memphis, Tenn., C1

Gender differences in first episode psychotic mania

S Cotton, M Lambert, M Berk, B Schimmelmann, F Butselaar, P McGorry, P Conus

(2013), Vol. 13, pp. 1-8, BMC psychiatry, London, England, C1

Aspirin : a review of its neurobiological properties and therapeutic potential for mental illness

M Berk, O Dean, H Drexhage, J McNeil, S Moylan, A O'Neil, C Davey, L Sanna, M Maes

(2013), Vol. 11, pp. 1-17, BMC medicine, London, England, C1

How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders : a critical review of biological pathways

S Moylan, F Jacka, J Pasco, M Berk

(2013), Vol. 3, pp. 302-326, Brain and behavior, London, England, C1

The effects of apoptosis vulnerability markers on the myocardium in depression after myocardial infarction

Y Wang, X Liu, D Zhang, J Chen, S Liu, M Berk

(2013), Vol. 11, pp. 1-9, BMC medicine, London, England, C1

Socio-demographic lifestyle and psychological predictors of benzodiazepine and z-hypnotic use patterns

T Nordfjaern, O Bjerkeset, G Bratberg, S Moylan, M Berk, R Grawe

(2013), Vol. 68, pp. 107-116, Nordic journal of psychiatry, Oslo, Norway, C1

The impact of smoking in adolescence on early adult anxiety symptoms and the relationship between infant vulnerability factors for anxiety and early adult anxiety symptoms : The TOPP Study

S Moylan, K Gustavson, E Karevold, S Overland, F Jacka, J Pasco, M Berk

(2013), Vol. 8, PLoS one, San Francisco, Calif., C1

Psychomotor depressive symptoms may differentially respond to venlafaxine

A Singh, C Bousman, C Ng, K Byron, M Berk

(2013), Vol. 28, pp. 121-126, International clinical psychopharmacology, Philadelphia, Pa., C1

Exercising the worry away: How inflammation, oxidative and nitrogen stress mediates the beneficial effect of physical activity on anxiety disorder symptoms and behaviours

S Moylan, H Eyre, M Maes, B Baune, F Jacka, M Berk

(2013), Vol. 37, pp. 573-584, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

Oxidative stress and inflammatory markers are associated with depression and nicotine dependence

H Vargas, S Nunes, M de Castro, M Vargas, D Barbosa, C Bortolasci, K Venugopal, S Dodd, M Berk

(2013), Vol. 544, pp. 136-140, Neuroscience letters, Amsterdam, The Netherlands, C1

A randomised, controlled trial of a dietary intervention for adults with major depression (the 'SMILES' trial): study protocol

A O'Neil, M Berk, C Itsiopoulos, D Castle, R Opie, J Pizzinga, L Brazionis, A Hodge, C Mihalopoulos, M Chatterton, O Dean, F Jacka

(2013), Vol. 13, pp. 1-7, BMC psychiatry, London, England, C1

Obesity and the relationship with positive and negative affect

J Pasco, L Williams, F Jacka, S Brennan, M Berk

(2013), Vol. 47, pp. 477-482, Australian & New Zealand journal of psychiatry, London, England, C1

Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis

S Smesny, B Milleit, U Hipler, C Milleit, M Schafer, C Klier, C Holub, I Holzer, G Berger, M Otto, I Nenadic, M Berk, P McGorry, H Sauer, G Amminger

(2013), Vol. 19, pp. 317-324, Molecular psychiatry, London, England, C1

Prevention of common mental disorders: what can we learn from those who have gone before and where do we go next?

F Jacka, N Reavley, A Jorm, J Toumbourou, A Lewis, M Berk

(2013), Vol. 47, pp. 920-929, Australian & New Zealand journal of psychiatry, London, England, C1

The association between diet quality, dietary patterns and depression in adults: a systematic review

S Quirk, L Williams, A O'Neil, J Pasco, F Jacka, S Housden, M Berk, S Brennan

(2013), Vol. 13, pp. 1-22, BMC psychiatry, London, England, C1

The chemistry and biological activities of N-acetylcysteine

Y Samuni, S Goldstein, O Dean, M Berk

(2013), Vol. 1830, pp. 4117-4129, Biochim biophys acta, Amsterdam, Netherlands, C1

Socioeconomic status and quality of life in population-based Australian men: data from the Geelong Osteoporosis Study

S Brennan, L Williams, M Berk, J Pasco

(2013), Vol. 37, pp. 226-232, Australian and New Zealand journal of public health, Chichester, England, C1-1

Alcohol consumption and body composition in a population-based sample of elderly Australian men

C Coulson, L Williams, S Brennan, M Berk, M Kotowicz, D Lubman, J Pasco

(2013), Vol. 25, pp. 183-192, Aging clinical and experimental research, Cham, Switzerland, C1

Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts

H Vargas, S Vargas Nunes, M de Castro, C Bortolasci, D Barbosa, H Morimoto, K Venugopal, S Dodd, M Maes, M Berk

(2013), Vol. 150, pp. 923-930, Journal of affective disorders, Amsterdam, The Netherlands, C1

Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder

S Dodd, M Berk, K Kelin, M Mancini, A Schacht

(2013), Vol. 150, pp. 344-349, Journal of affective disorders, Amsterdam, The Netherlands, C1

Gastro oesophageal reflux disease (GORD)-related symptoms and its association with mood and anxiety disorders and psychological symptomology: a population-based study in women

L Sanna, A Stuart, M Berk, J Pasco, P Girardi, L Williams

(2013), Vol. 13, pp. 1-6, BMC psychiatry, London, England, C1

A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome (me/cfs) and sickness behavior

G Morris, G Anderson, P Galecki, M Berk, M Maes

(2013), Vol. 11, pp. 1-19, BMC medicine, London, England, C1-1

DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions

C Nemeroff, D Weinberger, M Rutter, H MacMillan, R Bryant, S Wessely, D Stein, C Pariante, F Seemuller, M Berk, G Malhi, M Preisig, M Brune, P Lysaker

(2013), Vol. 11, pp. 202-220, BMC medicine, London, England, C1

N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats

M Moller, J Du Preez, F Viljoen, M Berk, B Harvey

(2013), Vol. 28, pp. 687-696, Metabolic brain disease, New York, N. Y., C1

Molecular hydrogen: an overview of its neurobiological effects and therapeutic potential for bipolar disorder and schizophrenia

A Ghanizadeh, M Berk

(2013), Vol. 3, pp. 1-6, Medical gas research, London, England, C1

Clock face drawing test performance in children with ADHD

A Ghanizadeh, S Safavi, M Berk

(2013), Vol. 4, pp. 50-56, Basic and clinical neuroscience, Tehran, Iran, C1

Clusters of personality traits and psychological symptoms associated with later benzodiazepine prescriptions in the general population: the HUNT cohort study

T Nordfjaern, O Bjerkeset, S Moylan, M Berk, R Grawe

(2013), Vol. 38, pp. 2575-2580, Addictive behaviors, Amsterdam, The Netherlands, C1

Altered cardiac autonomic nervous function in depression

Y Wang, X Zhao, A O'Neil, A Turner, X Liu, M Berk

(2013), Vol. 13, pp. 1-7, BMC psychiatry, London, England, C1

Cardiac-self efficacy predicts adverse outcomes in coronary artery disease (CAD) patients

A O'Neil, M Berk, J Davis, L Stafford

(2013), Vol. 5, pp. 6-14, Health, London, England, C1

DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data

R McIntyre, M Tohen, M Berk, J Zhao, E Weiller

(2013), Vol. 150, pp. 378-383, Journal of affective disorders, Amsterdam, The Netherlands, C1

The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence

S Nunes, H Vargas, E Prado, D Barbosa, L Picoli de Melo, S Moylan, S Dodd, M Berk

(2013), Vol. 37, pp. 1336-1345, Neuroscience and biobehavioral reviews, Amsterdam, The Netherlands, C1

A low power micro deep brain stimulation device for murine preclinical research

A Kouzani, O Abulseoud, S Tye, M Hosain, M Berk

(2013), Vol. 1, pp. 1-9, IEEE journal of translational engineering in health and medicine, Piscataway, N.J., C1

The international society for bipolar disorders (ISBD) task force report on antidepressant use in bipolar diosrders

I Pacchiarotti, D Bond, R Baldessarini, W Nolen, H Grunze, R Licht, R Post, M Berk, G Goodwin, G Sachs, L Tondo, R Findling, E Youngstrom, M Tohen, J Undurraga, A Gonzalez-Pinto, J Goldberg, A Yildiz, L Altshuler, J Calabrese, P Mitchell, M Thase, A Koukopoulos, F Colom, M Frye, G Malhi, K Fountoulaskis, G Vazquez, R Perlis, T Ketter, F Cassidy, H Akiskal, J Azorin, M Valenti, D Mazzei, B Lafer, T Kato, L Mazzarini, A Martinez-Aran, G Parker, D Souery, A Ozerdem, S McElroy, P Girardi, M Bauer, L Yatham, C Zarate, A Nierenberg, B Birmaher, S Kanba, R El-Mallakh, A Serretti, Z Rihmer, A Young, G Kotzalidis, G MacQueen, C Bowden, S Ghaemi, C Lopez-Jaramillo, J Rybakowski, H Kyooseob, G Perugi, S Kasper, J Amsterdam, R Hirschfeld, F Kapczinski, E Vieta

(2013), Vol. 170, pp. 1-14, American journal of psychiatry, Arlington, Virginia, C1

Maternal and early postnatal nutrition and mental health of offspring by age 5 years: a prospective cohort study clinical guidance

F Jacka, E Ystrom, A Brantsaeter, E Karevold, C Roth, M Haugen, H Meltzer, S Schjolberg, M Berk

(2013), Vol. 52, pp. 1038-1047, Journal of the American academy of child & pdolescent psychiatry, Amsterdam, The Netherlands, C1

Hyponatraemia: an audit of aged psychiatry patients taking SSRIs and SNRIs

F Giorlando, J Teister, S Dodd, M Udina, M Berk

(2013), Vol. 8, pp. 175-180, Current drug safety, Bussum, The Netherlands, C1

Emerging pharmacotherapy for cancer patients with cognitive dysfunction

J Davis, F Ahlberg, M Berk, D Ashley, M Khasraw

(2013), Vol. 13, BMC neurology, London, England, C1

N-acetylcysteine versus placebo for treating nail biting, a double blind randomized placebo controlled clinical trial

A Ghanizadeh, N Derakhshan, M Berk

(2013), Vol. 12, pp. 1-6, Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry, Bussum, Netherlands, C1

Antidepressant pharmacogenetics

A Singh, C Bousman, C Ng, M Berk

(2013), Vol. 27, pp. 43-51, Current Opinion in Psychiatry, Philadelphia, PA, C1

So depression is an inflammatory disease, but where does the inflammation come from?

M Berk, L Williams, F Jacka, A O'Neil, J Pasco, S Moylan, N Allen, A Stuart, A Hayley, M Byne, M Maes

(2013), Vol. 11, pp. 1-16, BMC medicine, London, UK, C1-1

Atopic disorders and depression: Findings from a large, population-based study

L Sanna, A Stuart, J Pasco, F Jacka, M Berk, M Maes, A O'Neil, P Girardi, L Williams

(2013), Vol. 155, pp. 261-265, Journal of Affective Disorders, Amsterdam, Netherlands, C1

Depression following fracture in women: a study of age-matched cohorts

L Williams, M Berk, M Henry, A Stuart, S Brennan, F Jacka, J Pasco

(2013), Vol. 4, BMJ open, London, England, C1

World federation of societies of biological psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

M Bauer, A Pfennig, E Severus, P Whybrow, J Angst, H Moller, M Berk

(2013), Vol. 14, pp. 334-385, World journal of biological psychiatry, London, England, C1-1

Potential mechanisms of action of lithium in bipolar disorder : current understanding

G Malhi, M Tanious, P Das, C Coulston, M Berk

(2013), Vol. 27, pp. 135-153, CNS drugs, Auckland, New Zealand, C1-1

Evaluation of the acceptability and usefulness of an information website for caregivers of people with bipolar disorder

L Berk, M Berk, S Dodd, C Kelly, S Cvetkovski, A Jorm

(2013), Vol. 11, pp. 1-13, BMC medicine, London, Eng., C1-1

To a broader concept of remission: rating the health-related quality of life in bipolar disorder

M Subero, L Berk, S Dodd, J Kulkarni, A De Castella, P Fitzgerald, M Berk

(2013), Vol. 150, pp. 673-676, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

High impact child abuse may predict risk of elevated suicidality during antidepressant initiation

A Singh, C Bousman, C Ng, M Berk

(2013), Vol. 47, pp. 1191-1195, Australian & New Zealand journal of psychiatry, London, Eng., C1-1

Baseline patient characteristics associated with placebo remission and their impact on remission with duloxetine and selected SSRI antidepressants

J Nelson, Q Zhang, K Kelin, E Eriksson, W Deberdt, M Berk

(2013), Vol. 29, pp. 827-833, Current medical research and opinion, London, Eng., C1-1

Increased IL-6 trans-signaling in depression: Focus on the tryptophan catabolite pathway, melatonin and neuroprogression

G Anderson, M Kubera, W Duda, W Lasoñz, M Berk, M Maes

(2013), Vol. 65, pp. 1647-1654, Pharmacological Reports, Switzerland, C1-1

Difficult-to-treat depression

D Castle, L Piterman, M Berk

(2013), Vol. 199, pp. S4-S5, The medical journal of australia, Australia, C1-1

Tobacco smoking predicts depression and poorer quality of life in heart disease

L Stafford, M Berk, H Jackson

(2013), Vol. 13, pp. 1-10, BMC cardiovascular disorders, London, Eng., C1-1

Extreme attributions predict transition from depression to mania or hypomania in bipolar disorder

J Stange, L Sylvia, P Magalhães, E Frank, M Otto, D Miklowitz, M Berk, A Nierenberg, T Deckersbach

(2013), Vol. 47, pp. 1329-1336, Journal of psychiatric research, Amsterdam, The Netherlands, C1-1

Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications

G Morris, G Anderson, M Berk, M Maes

(2013), Vol. 48, pp. 883-903, Molecular neurobiology, New York, N.Y., C1-1

Safe and effective use of lithium

G Malhi, M Tanious, D Bargh, P Das, M Berk

(2013), Vol. 36, pp. 18-21, Australian prescriber, Surry Hills, N.S.W., C1-1

Pharmacological management of unipolar depression

G Malhi, R Hitching, M Berk, P Boyce, R Porter, K Fritz

(2013), Vol. 127, pp. 6-23, Acta psychiatrica Scandinavica, London, Eng., C1-1

Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies

A Young, J Calabrese, U Gustafsson, M Berk, S McElroy, M Thase, T Suppes, W Earley

(2013), Vol. 1, pp. 1-12, International journal of bipolar disorders, London, Eng., C1-1

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder

H Grunze, E Vieta, G Goodwin, C Bowden, R Licht, H-J Möller, S Kasper, M Berk

(2013), Vol. 14, pp. 154-219, World journal of biological psychiatry, Abingdon, Eng., C1-1

Edoxaban versus warfarin in patients with atrial fibrillation

R Giugliano, C Ruff, E Braunwald, S Murphy, S Wiviott, J Halperin, A Waldo, M Ezekowitz, J Weitz, J Špinar, W Ruzyllo, M Ruda, Y Koretsune, J Betcher, M Shi, L Grip, S Patel, I Patel, J Hanyok, M Mercuri, E Antman, L Peruzzotti-Jametti, Y Malynovsky, S Morin, E Hoffman, N Deenadayalu, H Lanz, V Curt, A Duggal, J Davé, D Morgan, Y Choi, J Jin, J Xie, W Crerand, J Kappelhof, W Maxwell, M Skinner, G Selicato, C Otto, C Reissner, K Smith, J Ostroske, A Ron, S Connolly, J Camm, E Paolasso, P Aylward, H Heidbuchel, J Nicolau, A Goudev, D Roy, R Corbalán, Y Yang, R Botero, M Bergovec, P Grande, C Hassager, J Voitk, H Huikuri, M Nieminen, J Blanc, J LeHeuzey, V Mitrovic, D Alexopoulos, G Sotomora, R Kiss, B SomaRaju, B Lewis, P Merlini, M Metra, T Yamashita, A García-Castillo, T Ophuis, H White, D Atar, M Horna, N Babilonia, J Morais, M Dorobantu, M Ostojic, T Duris, A Dalby, N Chung, J Zamorano, S Juul-Möller, T Moccetti, S Chen, P Sritara, A Oto, A Parkhomenko, R Senior, F Verheugt, A Skene, J Anderson, K Bauer, J Easton, S Goto, C Lowe

(2013), Vol. 369, pp. 2093-2104, New England Journal of Medicine, United States, C1-1

Psychometric properties of a scale to measure investment in the sick role : the Illness Cognitions Scale

M Berk, L Berk, S Dodd, F Jacka, P Fitzgerald, A de Castella, S Filia, K Filia, J Kulkarni, H Jackson, L Stafford

(2012), Vol. 18, pp. 360-364, Journal of evaluation of clinical practice, Oxford, England, C1-1

Dietary selenium intake and major depressive disorder: a nested case-control study

J Pasco, F Jacka, L Williams, M Evans-Cleverdon, S Brennan, M Kotowicz, G Nicholson, M Ball, M Berk

(2012), Vol. 20, pp. 119-123, Complementary therapies in medicine, Kidlington, England, C1

Pure and comorbid depression : a comparison of symptom profile and impairment in 64.000 adults. The HUNT Study.

O Bjerkeset, L Williams, U Romild, M Berk

(2012), British journal of psychiatry, London, England, C1

Nutrient intakes and the common mental disorders in women

F Jacka, M Maes, J Pasco, L Williams, M Berk

(2012), Vol. 141, pp. 79-85, Journal of affective disorders, Amsterdam, The Netherlands, C1

A comparison of inflammatory markers in depressed and nondepressed smokers.

S Nunes, H Vargas, J Brum, E Prado, M Vargas, M de Castro, S Dodd, M Berk

(2012), Vol. 14, pp. 540-546, Nicotine and tobacco research, Oxford , England, C1-1

Co-morbid cardiovascular disease and depression : sequence of disease onset is linked to mental but not physical self-rated health. Results from a cross-sectional, population-based study

A O'Neil, E Williams, C Stevenson, B Oldenburg, M Berk, K Sanderson

(2012), Vol. 47, pp. 1145-1151, Social psychiatry and psychiatric epidemiology, Heidelberg , Germany, C1

The role of alprazolam for the treatment of panic disorder in Australia

S Moylan, F Giorlando, T Nordfjaern, M Berk

(2012), Vol. 46, pp. 212-224, Australian and New Zealand Journal of Psychiatry, Melbourne, Vic., C1

Increased IgA and IgM responses against gut commensals in chronic depression : further evidence for increased bacterial translocation or leaky gut

M Maes, M Kubera, J Leunis, M Berk

(2012), Vol. 141, pp. 55-62, Journal of affective disorders, Amsterdam, Netherlands, C1

Complementary medicine, self-help and lifestyle interventions for Obessive Compulsive Disorder (OCD) and the OCD spectrum : a systematic review

J Sarris, D Camfield, M Berk

(2012), Vol. 138, pp. 213-221, Journal of affective disorders, Amsterdam, Netherlands, C1

Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder

A Bechdolf, A Ratheesh, S Wood, T Tecic, P Conus, B Nelson, S Cotton, A Chanen, G Amminger, S Ruhrmann, F Schultze-Lutter, J Kosterkotter, P Fusar Poli, A Yung, M Berk, P McGorry

(2012), Vol. 18, pp. 358-375, Current pharmaceutical design, Bussum, The Netherlands, C1-1

Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder

G Malhi, D Bargh, R McIntyre, M Gitlin, M Frye, M Bauer, M Berk

(2012), Vol. 14, pp. 1-21, Bipolar disorders supplement, Malden, Mass., C1

Impact of sunlight on the age of onset of bipolar disorder

M Bauer, T Glenn, M Alda, O Andreassen, R Ardau, F Bellivier, M Berk, T Bjella, L Bossini, M Del Zompo, S Dodd, A Fagiolini, M Frye, A Gonzalex-Pinto, C Henry, F Kapczinski, S Kliwicki, B Konig, M Kunz, B Lafer, C Lopez-Jaramillo, M Manchia, W Marsh, M Martinez-Cengotitabengoa, I Melle, R Morken, R Munoz, C O'Donovan, F Nery, A Pfennig, D Quiroz, N Rasgon, A Reif, J Rybakowski, K Sagduyu, C Simhandi, C Torrent, E Vieta, M Zetin, P Whybrow

(2012), Vol. [early view], pp. 1-10, Bipolar disorders, Malden, Mass., C1

Deep brain stimulation for treatment-resistant depression : efficacy, safety and mechanisms of action

R Anderson, M Frye, O Abulseound, K Lee, J McGillivray, M Berk, S Tye

(2012), Vol. 36, pp. 1920-1933, Neuroscience and biobehavioral reviews, Oxford, England, C1

Pain and the relationship with mood and anxiety disorders and psychological symptoms

L Williams, J Pasco, F Jacka, S Dodd, M Berk

(2012), Vol. 72, pp. 452-456, Journal of psychosomatic research, Philadelphia, Pa., C1

Biological underpinnings of the commonalities in depression, somatization and chronic fatigue syndrome

G Anderson, M Maes, M Berk

(2012), Vol. 78, pp. 752-756, Medical hypotheses, Kidlington, England, C1

The use of hormonal contraceptive agents and mood disorders in women

G Svendal, M Berk, J Pasco, F Jacka, A Lund, L Williams

(2012), Vol. 140, pp. 92-96, Journal of affective disorders, Amsterdam, Netherlands, C1

Inflammation-related disorders in the tryptophan catabolite pathway in depression and somatization

G Anderson, M Maes, M Berk

(2012), Vol. 88, pp. 27-48, Advances in protein chemistry and structural biology, Maryland Heights, Miss., C1

Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope and building morale

M Berk, L Berk, M Udina, S Moylan, L Stafford, K Hallam, S Goldstone, P McGorry

(2012), Vol. 46, pp. 92-99, Australian and New Zealand journal of psychiatry, London, England, C1

Can a targeted psychological intervention be effective for young people following a first manic episode? Results from an 18-month pilot study

C Macneil, M Hasty, S Cotton, M Berk, K Hallam, L Kader, P McGorry, P Conus

(2012), Vol. 6, pp. 380-388, Early intervention in psychiatry, Richmond, Vic., C1-1

Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder

P Magalhaes, O Dean, A Bush, D Copolov, D Weisinger, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2012), Vol. 37, pp. 132-135, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1

Illness burden and medical comorbidity in the systematic treatment enhancement program for bipolar disorder

P Magalhaes, F Kapczinski, A Nierenberg, T Deckersbach, D Weisinger, S Dodd, M Berk

(2012), Vol. 125, pp. 303-308, Acta psychiatrica scandinavica, Malden, Mass., C1

Minocycline : therapeutic potential in psychiatry

O Dean, J Data-Franco, F Giorlando, M Berk

(2012), Vol. 26, pp. 391-401, CNS Drugs, Auckland, New Zealand, C1

Amygdala and insula volumes prior to illness onset in bipolar disorder : a magnetic resonance imaging study

A Bechdolf, S Wood, B Nelson, D Velakoulis, M Yucel, T Takahashi, A Yung, M Berk, M Wong, C Pantelis, P McGorry

(2012), Vol. 201, pp. 34-39, Psychiatry research : neuroimaging, County Clare, Ireland, C1-1

Depressive symptoms in first episode schizophrenia spectrum disorder

S Cotton, M Lambert, B Schimmelmann, A Mackinnon, J Gleeson, M Berk, L Hides, A Chanen, P McGorry, P Conus

(2012), Vol. 134, pp. 20-26, Schizophrenia research, Amsterdam, Netherlands, C1

New drug targets in depression : inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors

M Maes, Z Fisar, M Medina, G Scapagnini, G Nowak, M Berk

(2012), Vol. 20, pp. 127-150, Inflammopharmacology, Basel, Switzerland, C1-1

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

M Maes, M Berk, L Goehler, C Song, G Anderson, P Galecki, B Leonard

(2012), Vol. 10, pp. 1-19, BMC medicine, London, England, C1-1

Maintenance N-acetyl cysteine treatment for bipolar disorder : a double-blind randomised placebo controlled trial

M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, K Moss, C Allwang, I Schapkaitz, H Cobb, A Bush, S Dodd, G Malhi

(2012), Vol. 10, pp. 1-11, BMC medicine, London, England, C1

Increased autoimmune activity against 5-HT : a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression

M Maes, K Ringel, M Kubera, M Berk, J Rybakowski

(2012), Vol. 136, pp. 386-392, Journal of affective disorders, Amsterdam, The Netherlands, C1

Cigarette smoking, nicotine dependence and anxiety disorders : a systematic review of population-based, epidemiological studies

S Moylan, F Jacka, J Pasco, M Berk

(2012), Vol. 10, pp. 1-14, BMC medicine, London, England, C1

Depression, diet and exercise

F Jacka, M Berk

(2012), Vol. Open 1, pp. 21-23, Medical journal of Australia, Strawberry Hills, N.S.W., C1

Complementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders : a review of current evidence

J Sarris, S Moylan, D Camfield, M Pase, D Mischoulon, M Berk, F Jacka, I Schweitzer

(2012), Vol. 2012, pp. 1-20, Evidence based complementary and alternative medicine, New York, N.Y., C1

Using lithium as a neuroprotective agent in patients with cancer

M Khasraw, D Ashley, G Wheeler, M Berk

(2012), Vol. 10, pp. 1-7, BMC Medicine, London, England, C1

Zinc for treating of children and adolescents with attention-deficit hyperactivity disorder : a systematic review of randomized controlled clinical trials

A Ghanizadeh, M Berk

(2012), Vol. 67, pp. 122-124, European journal of clinical nutrition, London, England, C1

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression

A Singh, C Bousman, C Ng, K Byron, M Berk

(2012), Vol. 2, pp. 1-6, Translational psychiatry, London, England, C1

Moving towards a population health approach to the primary prevention of common mental disorders

F Jacka, A Mykletun, M Berk

(2012), Vol. 10, pp. 1-6, BMC medicine, London, England, C1

Co-prescription of medication for bipolar disorder and diabetes mellitus : a nationwide population based study with focus on gender differences

G Svendal, O Fasmer, A Engeland, M Berk, A Lund

(2012), Vol. 10, pp. 1-6, BMC medicine, England, London, C1

Adjunctive antioxidants for bipolar disorder

P Magalhaes, O Dean, A Andreazza, M Berk, F Kapczinski

(2012), pp. 1-11, The Cochrane collaboration, Oxford, England, C1-1

Canadian network for mood and anxiety treatments (CANMAT) and international society for bipolar disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder : update 2013

L Yatham, S Kennedy, S Parikh, A Schaffer, S Beaulieu, M Alda, C O'Donovan, G MacQueen, R McIntyre, V Sharma, A Ravindran, L Young, R Milev, D Bond, B Frey, B Goldstein, B Lafer, B Birmaher, K Ha, W Nolen, M Berk

(2012), Vol. 15, pp. 1-44, Bipolar Disorders, Malden, Mass., C1

State-related alterations of gene expression in bipolar disorder : a systematic review

K Munkholm, M Vinberg, M Berk, L Kessing

(2012), Vol. 14, pp. 684-696, Bipolar disorders, Malden, Mass., C1

The science and practice of lithium therapy

G Malhi, M Tanious, P Das, M Berk

(2012), Vol. 46, pp. 192-211, Australian and New Zealand journal of psychiatry, London, England, C1

Treatment and outcomes of an Australian cohort of outpatients with bipolar 1 or schizoaffective disorder over twenty-four months : implications for clinical practice

J Kulkarni, S Filia, L Berk, K Filia, S Dodd, A de Castella, A Brnabic, A Lowry, K Kelin, W Montgomery, P Fitzgerald, M Berk

(2012), Vol. 12, pp. 1-11, BMC psychiatry, London, England, C1

Cumulative morbidity and prognostic staging of illness in the systematic treatment enhancement program for Bipolar Disorder (STEP-BD)

P Magalhaes, S Dodd, A Nierenberg, M Berk

(2012), Vol. 46, pp. 1058-1067, Australian and New Zealand journal of psychiatry, London, England, C1

Mania : diagnosis and treatment recommendations

G Malhi, M Tanious, M Berk

(2012), Vol. 14, pp. 676-686, Current psychiatry reports, Philadelphia, Pa., C1

Effects of N-acetyl cysteine on cognitive function in bipolar disorder

O Dean, A Bush, D Copolov, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2012), Vol. 66, pp. 514-517, Psychiatry and clinical neurosciences, Richmond, Vic., C1

In depression, bacterial translocation may drive inflammatory responses, oxidative and nitrosative stress (O&NS) and autoimmune responses directed against O&NS- damaged neoepitopes

M Maes, M Kubera, J Leunis, M Berk, M Geffard, E Bosmans

(2012), Vol. 127, pp. 344-354, Acta psychiatrica scandinavica, Malden, Mass., C1

The impact of statins on psychological wellbeing : a systematic review and meta-analysis

A O'Neil, L Sanna, C Redlich, K Sanderson, F Jacka, L Williams, J Pasco, M Berk

(2012), Vol. 10, pp. 1-9, BMC medicine, London, England, C1

Pathways to new drug discovery in neuropsychiatry

M Berk

(2012), Vol. 10, pp. 1-4, BMC medicine, London, England, C1

Habitual physical activity and the risk for depressive and anxiety disorders among older men and women

J Pasco, L Williams, F Jacka, M Henry, C Coulson, S Brennan, E Leslie, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 23, pp. 292-298, International psychogeriatrics, Cambridge, England, C1

Lower levels of physical activity in childhood associated with adult depression

F Jacka, J Pasco, L Williams, E Leslie, S Dodd, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 14, pp. 222-226, Journal of science and medicine in sport, Chatswood, N.S.W., C1

Diet quality in bipolar disorder in a population-based sample of women

F Jacka, J Pasco, A Mykietun, L Williams, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 129, pp. 332-337, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Annual high-dose vitamin D3 and mental well-being: randomised controlled trial

K Sanders, A Stuart, E Wiliamson, F Jacka, S Dodd, G Nicholson, M Berk

(2011), Vol. 198, pp. 357-364, British journal of psychiatry, London, England, C1-1

Qualitative methods in early-phase drug trials : data and methods from a trial of N-acetylcysteine in schizophrenia

M Berk, A Munib, O Dean, G Malhi, K Kohlmann, I Schapkaitz, S Jeavons, F Katz, M Anderson-Hunt, P Conus, B Hanna, R Otmar, F Ng, D Copolov, A Bush

(2011), Vol. 72, pp. 909-913, Journal of clinical psychiatry, [Memphis, Tenn.], C1-1

N-acetylcysteine in psychiatry - current therapeutic evidence and potential mechanisms of action

O Dean, F Giorlando, M Berk

(2011), Vol. 36, pp. 78-86, Journal of psychiatry and neuroscience, Ottowa, Canada, C1-1

N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats : relevance to schizophrenia and bipolar disorder

O Dean, M van den Buuse, M Berk, D Copolov, C Mavros, A Bush

(2011), Vol. 499, pp. 149-153, Neuroscience letters, Clare, Ireland, C1-1

Antioxidant treatments for schizophrenia

P Magalhaes, A Andreazza, M Berk, F Kapczinski, O Dean

(2011), pp. 1-13, Cochrane database of systematic reviews, Oxford, U. K., C1-1

N-acetyl cysteine add-on treatment for bipolar II disorder : a subgroup analysis of a randomised placebo-controlled trial

P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2011), Vol. 129, pp. 317-320, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Dimensions of improvement in a clinical trial of N-acetyl cysteine for bipolar disorder.

P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2011), Vol. 23, pp. 87-88, Acta neuropsychiatrica, Oxford, England, C1-1

Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention

M Berk, A Brnabic, S Dodd, K Kelin, M Tohen, G Malhi, L Berk, P Conus, P McGorry

(2011), Vol. 13, pp. 87-98, Bipolar disorders, Malden, Mass, C1

Pathways underlying neuroprogression in bipolar disorder : focus on inflammation, oxidative stress and neurotrophic factors

M Berk, F Kapczinski, A Andreazza, O Dean, F Giorlando, M Maes, M Yücel, C Gama, S Dodd, B Dean, P Magalhães, P Amminger, P McGorry, G Malhi

(2011), Vol. 35, pp. 804-817, Neuroscience & biobehavioral reviews, Oxford, England, C1-1

The relationship between substance use and post-traumatic stress disorder in a methadone maintenance treatment program

K Villagonzalo, S Dodd, F Ng, S Mihaly, A Langbein, M Berk

(2011), Vol. 52, pp. 562-566, Comprehensive psychiatry, Maryland Heights, MO, C1-1

Bipolar disorder and adiposity : a study using whole body dual energy X-ray absorptiometry scans

L Williams, J Pasco, F Jacka, M Henry, S Dodd, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 23, pp. 219-223, Acta neuropsychiatrica, Malden, Mass, C1

Paracetamol (acetaminophen) use, fracture and bone mineral density

L Williams, J Pasco, M Henry, K Sanders, G Nicholson, M Kotowicz, M Berk

(2011), Vol. 48, pp. 1277-1281, Bone, New York, N. Y., C1

The association between depressive and anxiety symptoms and bone mineral density in the general population : the HUNT study

L Williams, O Bjerkeset, A Langhammer, M Berk, J Pasco, M Henry, B Schei, S Forsmo

(2011), Vol. 131, pp. 164-171, Journal of affective disorders, Amsterdam , The Netherlands, C1

Area-based socioeconomic status and mood disorders : cross-sectional evidence from a cohort of randomly selected adult women

L Williams, S Brennan, M Henry, M Berk, F Jacka, G Nicholson, M Kotowicz, J Pasco

(2011), Vol. 69, pp. 173-178, Maturitas, Shannon, Ireland, C1

Glutamate cysteine ligase (GCL) and self reported depression : an association study from the HUNT

M Berk, S Johansson, N Wray, L Williams, C Olsson, J Haavik, O Bjerkeset

(2011), Vol. 131, pp. 207-213, Journal of affective disorders, Amsterdam, The Netherlands, C1

Modeling gene-environment interaction in longitudinal data : risk for neuroticism due to interaction between maternal care and the Dopamine 4 Receptor gene (DRD4)

P Badcock, E Moore, E Williamson, M Berk, L Williams, O Bjerkeset, H Nordahl, G Patton, C Olsson

(2011), Vol. 63, pp. 18-25, Australian journal of psychology, Oxford, England, C1-1

A prospective study of diet quality and mental health in adolescents

F Jacka, P Kremer, M Berk, A de Silva-Sanigorski, M Moodie, E Leslie, J Pasco, B Swinburn

(2011), Vol. 6, pp. 1-7, PLos one, San Francisco, Calif., C1

Don't worry, be active : positive affect and habitual physical activity

J Pasco, F Jacka, L Williams, S Brennan, E Leslie, M Berk

(2011), Vol. 45, pp. 1047-1052, Australian & New Zealand journal of psychiatry, London, England, C1

The association between habitual diet quality and the common mental disorders in community-dwelling adults : The Hordaland health study

F Jacka, A Mykletun, M Berk, I Bjelland, G Tell

(2011), Vol. 73, pp. 483-490, Psychosomatic medicine, New York, N. Y., C1-1

Nutraceuticals in the treatment of obsessive compulsive disorder (OCD) : a review of mechanistic and clinical evidence

D Camfield, J Sarris, M Berk

(2011), Vol. 35, pp. 887-895, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression : an open label trial

M Berk, O Dean, S Cotton, C Gama, F Kapczinski, B Fernandes, K Kohlmann, S Jeavons, K Hewitt, C Allwang, H Cobb, A Bush, I Schapkaitz, S Dodd, G Malhi

(2011), Vol. 135, pp. 389-394, Journal of affective disorders, Amsterdam, Netherlands, C1

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder

S Dodd, G Malhi, J Tiller, I Schweitzer, I Hickie, J Khoo, D Bassett, B Lyndon, P Mitchell, G Parker, P Fitzgerald, M Udina, A Singh, S Moylan, F Giorlando, C Doughty, C Davey, M Theodoros, M Berk

(2011), Vol. 45, pp. 712-725, Australian and New Zealand journal of psychiatry, London, England, C1

Venlafaxine modulates depression-induced behaviour and the expression of Bax mRNA and Bcl-xl mRNA in both hippocampus and myocardium

Y Wang, Z Xiao, X Liu, M Berk

(2011), Vol. 26, pp. 95-101, Human psychopharmacology : clinial and experimental, West Sussex, England, C1

Development of guidelines for caregivers of people with bipolar disorder : a Delphi expert consensus study

L Berk, A Jorm, C Kelly, S Dodd, M Berk

(2011), Vol. 13, pp. 556-570, Bipolar disorders, Malden Mass., C1

Meta-analytic review of neurocognition in bipolar II disorder

E Bora, M Yucel, C Pantelis, M Berk

(2011), Vol. 123, pp. 165-174, Acta psychiatrica scandinavica, Malden Mass., C1

Who's left? Symptoms of schizophrenia that predict clinical trial dropout

J Thompson, M Berk, O Dean, K Kohlmann, S Jeavons, A Bush, D Copolov

(2011), Vol. 26, pp. 609-613, Human psychopharmacology, West Sussex, England, C1-1

N-acetylcysteine for major depressive episodes in bipolar disorder

P Magalhães, O Dean, A Bush, D Copolov, G Malhi, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, M Berk

(2011), Vol. 33, pp. 374-378, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1

The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.

S Moylan, J Staples, S Ward, J Rogerson, D Stein, M Berk

(2011), Vol. 31, pp. 647-652, Journal of clinical psychopharmacology, Philadelphia, Pa., C1

The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression : proof of concept for the inflammatory and oxidative hypotheses of depression?

L Stafford, M Berk

(2011), Vol. 72, pp. 1229-1235, Journal of clinical psychiatry, Memphis, Tenn., C1-1

Psychological needs of adolescents in the early phase of bipolar disorder : implications for early intervention

C Macneil, M Hasty, M Berk, L Henry, M Evans, C Redlich, R Daglas, P McGorry, P Conus

(2011), Vol. 5, pp. 100-107, Early intervention in psychiatry, Richmond, Vic., C1-1

Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients

M Maes, P Ruckoanich, Y Chang, N Mahanonda, M Berk

(2011), Vol. 35, pp. 769-783, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1-1

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

M Maes, P Galecki, Y Chang, M Berk

(2011), Vol. 35, pp. 676-692, Progress in neuro-psychopharmacology and biological psychiatry, Philadelphia, Pa., C1-1

An examination of risk factors for readmission to acute adult mental health services within 28 days of discharge in the Australian setting

T Callaly, T Trauer, M Hyland, T Coombs, M Berk

(2011), Vol. 19, pp. 221-225, Australasian Psychiatry, England, C1-1

Association of western and traditional diets with depression and anxiety in women

F Jacka, J Pasco, A Mykletun, L Williams, A Hodge, S O'Reilly, G Nicholson, M Katowice, M Berk

(2010), Vol. 167, pp. 305-311, American journal of psychiatry, Arlington, Va., C1-1

Associations between diet quality and depressed mood in adolescents : results from the Australian healthy neighbourhoods study

F Jacka, P Kremer, E Leslie, M Berk, G Patton, J Toumbourou, J Williams

(2010), Vol. 44, pp. 435-442, Australian & New Zealand journal of psychiatry, London, England, C1

Mental health services for young people - the challenge of integrating services

T Callaly, K Von Treuer, S Dodd, M Berk

(2010), Vol. 22, pp. 158-160, Acta neuropsychiatrica, Oxford, England, C1

Readmission to an acute psychiatric unit within 28 days of discharge : identifying those at risk

T Callaly, M Hyland, T Trauer, S Dodd, M Berk

(2010), Vol. 34, pp. 282-285, Australian health review, Melbourne, Vic., C1

A naturalistic study of treatment outcomes with aripiprazole in young people with first episode psychosis

S Dodd, T Callaly, A Thampi, S McConnell, P Hantz, D Goodman, K Kohlmann, P Vieira da Silva Magalhaes, M Berk

(2010), Vol. 8, pp. 105-110, Clinical psychopharmacology and neuroscience, Seoul, Korea, C1

Obesity is associated with previous suicide attempts in bipolar disorder

F Gomes, M Kauer-Sant'Anna, P Magalhães, F Jacka, S Dodd, C Gama, Â Cunha, M Berk, F Kaczinski

(2010), Vol. 22, pp. 63-67, Acta neuropsychiatrica, Oxford, England, C1-1

Prevalence of mood and anxiety disorder in self reported irritable bowel syndrome (IBS). An epidemiological population based study of women

A Mykletun, F Jacka, L Williams, J Pasco, M Henry, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 10, pp. 1-9, BMC gastroenterology, London, England, C1-1

Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression

J Pasco, F Jacka, L Williams, M Henry, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 79, pp. 323-325, Psychotherapy and psychosomatics, New York, N. Y., C1-1

Association of high-sensitivity C-reactive protein with de novo major depression

J Pasco, G Nicholson, L Williams, F Jacka, M Henry, M Kotowicz, H Schneider, B Leonard, M Berk

(2010), Vol. 197, pp. 372-377, British journal of psychiatry, London, England, C1-1

The prevalence of mood and anxiety disorders in Australian women

L Williams, F Jacka, J Pasco, M Henry, S Dodd, G Nicholson, M Kotowicz, M Berk

(2010), Vol. 18, pp. 250-255, Australasian psychiatry, London, England, C1-1

Termination of therapy: what can clinicians do to maximise gains?

C Macneil, M Hasty, P Conus, M Berk

(2010), Vol. 22, pp. 43-45, Acta neuropsychiatrica, Malden, Mass., C1-1

Enhancing medication adherence in patients with bipolar disorder

L Berk, K Hallam, F Colom, E Vieta, M Hasty, C Macneil, M Berk

(2010), Vol. 25, pp. 1-16, Human psychopharmacology : clinical and experimental, West Sussex, England, C1-1

Effects of n-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats

K Choy, O Dean, M Berk, A Bush, M van den Buuse

(2010), Vol. 649, pp. 224-228, European journal of pharmacology, Amsterdam, The Netherlands, C1-1

Interaction of glutathione depletion and psychotropic drug treatment in prepulse inhibition in rats and mice

O Dean, A Bush, M Berk, D Copolov, M van den Buuse

(2010), Vol. 97, pp. 293-300, Pharmacology, biochemistry and behavior, Philadelphia, Pa., C1-1

Oxidative pathways as a drug target for the treatment of autism

K Villagonzalo, S Dodd, O Dean, K Gray, B Tonge, M Berk

(2010), Vol. 14, pp. 1301-1310, Expert opinion on therapeutic targets, London, England, C1-1

Restless leg syndrome caused by olanzapine: a case series

S Aggarwal, S Dodd, M Berk

(2010), Vol. 5, pp. 129-131, Current drug safety, San Francisco, Ca., C1-1

From neuroprogression to neuroprotection : implications for clinical care

M Berk, P Conus, F Kapczinski, A Andreazza, M Yücel, S Wood, C Pantelis, G Malhi, S Dodd, A Bechdolf, G Amminger, I Hickie, P McGorry

(2010), Vol. 193, pp. 36-40, Medical journal of australia, Strawberry Hills, N.S.W., C1-1

The validity and internal structure of the bipolar depression rating scale (BDRS): data from a clinical trial of N-acetylcysteine as adjunctive therapy in bipolar disorder

M Berk, S Dodd, O Dean, K Kohlmann, L Berk, G Malhi

(2010), Vol. 22, pp. 237-242, Acta neuropsychiatrica, Oxford, England, C1-1

Evidence and implications for early intervention in bipolar disorder

M Berk, K Hallam, G Mahli, L Henry, M Hasty, C Macneil, M Yucel, C Pantelis, B Murphy, E Vieta, S Dodd, P McGorry

(2010), Vol. 19, pp. 113-126, Journal of mental health, Abingdon, England, C1-1

Do we need to flick the switch? The need for a broader conceptualization of iatrogenic course aggravation in clinical trials of bipolar disorder?

M Berk, F Ng, S Dodd, J Goldberg, G Malhi

(2010), Vol. 64, pp. 367-371, Psychiatry and clinical neurosciences, Richmond, Vic., C1-1

A qualitative evaluation of a regional early psychosis service 3 years after its commencement

T Callaly, C Ackerly, M Hyland, S Dodd, M O'Shea, M Berk

(2010), Vol. 34, pp. 382-385, Australian health review, Melbourne, Vic., C1-1

A prospective study of the impact of smoking on outcomes in bipolar and schizoaffective disorder

S Dodd, A Brnabic, L Berk, P Fitzgerald, A de Castella, S Filia, K Filia, K Kelin, M Smith, W Montgomery, J Kulkarni, M Berk

(2010), Vol. 51, pp. 504-509, Comprehensive psychiatry, Maryland Heights, MO, C1-1

A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder

S Dodd, J Kulkarni, L Berk, F Ng, P Fitzgerald, A de Castella, S Filia, K Filia, W Montgomery, K Kelin, M Smith, A Brnabic, M Berk

(2010), Vol. 124, pp. 22-28, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia

J Kulkarni, C Gurvich, S Lee, H Gilbert, E Gavrilidis, A de Castella, M Berk, S Dodd, P Fitzgerald, S Davis

(2010), Vol. 35, pp. 1142-1147, Psychoneuroendocrinology, Oxford, England, C1-1

The role of psychotherapy in bipolar disorder

S Lauder, M Berk, D Castle, S Dodd, L Berk

(2010), Vol. 193, pp. 31-35, Medical journal of australia, Sydney, N.S.W., C1-1

The utility of the Mood Disorders Questionnaire as a screening tool in a methadone maintenance treatment program

K Villagonzalo, S Dodd, F Ng, S Mihaly, A Langbein, M Berk

(2010), Vol. 14, pp. 150-153, International journal of psychiatry in clinical practice, London, England, C1-1

Patterns of alcohol use and associated physical and lifestyle characteristics according to new Australian guidelines

C Coulson, L Williams, M Henry, M Berk, D Lubman, S Brennan, G Nicholson, M Kotowicz, S Korn, J Pasco

(2010), Vol. 44, pp. 946-951, Australian and New Zealand journal of psychiatry, Abingdon, England, C1-1

A preliminary evaluation of the validity of at-risk criteria for bipolar disorders in help-seeking adolescents and young adults

A Bechdolf, B Nelson, S Cotton, A Chanen, A Thompson, J Kettle, P Conus, G Amminger, A Yung, M Berk, P McGorry

(2010), Vol. 127, pp. 316-320, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Group-based psychosocial intervention for bipolar disorder : randomised controlled trial

D Castle, C White, J Chamberlain, M Berk, L Berk, S Lauder, G Murray, I Schweitzer, L Piterman, M Gilbert

(2010), Vol. 196, pp. 383-388, British journal of psychiatry, London, Eng., C1-1

Characterisation of the prodrome to a first episode of psychotic mania : results of a retrospective study

P Conus, J Ward, N Lucas, S Cotton, A Yung, M Berk, P McGorry

(2010), Vol. 124, pp. 341-345, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

The impact of smoking on clinical outcomes after first episode psychosis: longer-term outcome findings from the EPPIC 800 follow-up study

M Berk, L Henry, K Elkins, S Harrigan, M Harris, H Herrman, H Jackson, P McGorry

(2010), Vol. 6, pp. 212-234, Journal of dual diagnosis, Philadelphia, Pa., C1-1

Pretreatment and outcome correlates of past sexual and physical trauma in 118 bipolar I disorder patients with a first episode of psychotic mania

P Conus, S Cotton, B Schimmelmann, M Berk, R Daglas, P McGorry, M Lambert

(2010), Vol. 12, pp. 244-252, Bipolar disorders, Hoboken, N.J., C1-1

Pre-morbid and outcome correlates of first episode mania with psychosis: is a distinction between schizoaffective and bipolar I disorder valid in the early phase of psychotic disorders?

P Conus, A Abdel-Baki, S Harrigan, M Lambert, P McGorry, M Berk

(2010), Vol. 126, pp. 88-95, Journal of affective disorders, Amsterdam, Netherlands, C1-1

Assessing oxidative pathway genes as risk factors for bipolar disorder

J Fullerton, Y Tiwari, G Agahi, A Heath, M Berk, P Mitchell, P Schofield

(2010), Vol. 12, pp. 550-556, Bipolar disorders, Hoboken, N.J., C1-1

Duloxetine 60 mg/day for the prevention of depressive recurrences: post hoc analyses from a recurrence prevention study

K Kelin, M Berk, M Spann, D Sagman, J Raskin, D Walker, D Perahia

(2010), Vol. 64, pp. 719-726, International journal of clinical practice, Chichester, Eng., C1-1

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression

H Grunze, E Vieta, G Goodwin, C Bowden, R Licht, H-J Möller, S Kasper, M Berk, WFSBP Task Force On Treatment Guidelines For Bipol

(2010), Vol. 11, pp. 81-109, World journal of biological psychiatry, Abingdon, Eng., C1-1

Description and qualitative evaluation of Jigsaw, an integrated young persons' mental health program

T Callaly, S Dodd, C Ackerly, P Hantz, M O'Shea, M Berk

(2009), Vol. 17, pp. 480-483, Australasian Psychiatry, London, England, C1-1

Suicidality - the challenge for public mental health services

T Callaly, M Berk, S Dodd

(2009), Vol. 21, pp. 41-43, Acta neuropsychiatrica, Oxford, England, C1-1

Vitamin D: is it relevant to psychiatry?

M Berk, S Dodd, L Williams, F Jacka, J Pasco

(2009), Vol. 21, pp. 205-206, Acta neuropsychiatrica, Oxford, England, C1-1

Reliability of the mood disorder questionnaire : comparison with the structured clinical interview for the DSM-IV-TR in a population sample

S Dodd, L Williams, F Jacka, J Pasco, O Bjerkeset, M Berk

(2009), Vol. 43, pp. 526-530, Australian and New Zealand journal of psychiatry, Melbourne, Vic., C1-1

Association between magnesium intake and depression and anxiety in community-dwelling adults : The Hordaland Health Study

F Jacka, S Overland, R Stewart, G Tell, I Bjelland, A Mykletun

(2009), Vol. 43, pp. 45-52, Australian & New Zealand journal of psychiatry, Melbourne, Vic., C1-1

Depression and bone metabolism : a review

L Williams, J Pasco, F Jacka, M Henry, S Dodd, M Berk

(2009), Vol. 78, pp. 16-25, Psychotherapy and psychosomatics, New York, N. Y., C1-1

Lifetime psychiatric disorders and body composition : a population-based study

L Williams, J Pasco, M Henry, F Jacka, S Dodd, G Nicholson, M Kotowicz, M Berk

(2009), Vol. 118, pp. 173-179, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting

M Berk, S Jeavons, O Dean, S Dodd, K Moss, C Gama, G Malhi

(2009), Vol. 14, pp. 357-360, CNS spectrums, New York, N.Y., C1-1

Glutathione depletion in the brain disrupts short-term spatial memory in the Y-maze in rats and mice

O Dean, A Bush, M Berk, D Copolov, M van den Buuse

(2009), Vol. 198, pp. 258-262, Behavioural brain research, Amsterdam, The Netherlands, C1-1

A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice.

O Dean, M van den Buuse, A Bush, D Copolov, F Ng, S Dodd, M Berk

(2009), Vol. 16, pp. 2965-2976, Current medicinal chemistry, Schiphol, The Netherlands, C1-1

Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics : a double-blind, randomised, placebo-controlled clinical trial

M Berk, C Gama, S Sundram, H Hustig, L Koopowitz, R D'Souza, H Malloy, C Rowland, A Monkhouse, A Monkhouse, F Bole, S Sathiyamoorthy, D Piskulic, S Dodd

(2009), Vol. 24, pp. 233-238, Human psychopharmacology : clinical and experimental, West Sussex, England, C1-1

Early intervention in bipolar disorders : clinical, biochemical and neuroimaging imperatives

M Berk, G Malhi, K Hallam, C Gama, S Dodd, A Andreazza, B Frey, F Kapczinski

(2009), Vol. 114, pp. 1-13, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Effects of N-acetylcysteine on substance use in bipolar disorder : a randomized placebo controlled clinical trial

M Bernardo, S Dodd, C Gama, D Copolov, O Dean, K Kohlmann, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush, M Berk

(2009), Vol. 21, pp. 239-245, Acta neuropsychiatrica, Oxford, England, C1-1

The impact of age at onset of bipolar I disorder on functioning and clinical presentation

F Biffin, S Tahtalian, K Filia, P Fitzgerald, A De Castella, S Filia, M Berk, S Dodd, P Callaly, L Berk, K Kelin, M Smith, W Montgomery, J Kulkarni

(2009), Vol. 21, pp. 191-196, Acta neuropsychiatrica, Oxford, England, C1-1

Client-reported reasons for non-engagement in drug and alcohol treatment

C Coulson, F Ng, M Geertsema, S Dodd, M Berk

(2009), Vol. 28, pp. 372-378, Drug and alcohol review, Oxford, England, C1-1

'Mind and body' : a lifestyle programme for people on antipsychotic medication

A Jones, A Benson, S Griffiths, M Berk, S Dodd

(2009), Vol. 15, pp. 276-280, Journal of evaluation of clinical practice, Oxford, England, C1-1

Improvement of negative and positive symptoms in treatment-refractory schizophrenia : a double-blind, randomized, placebo-controlled trial with memantine as add-On therapy to clozapine

D De Lucena, B Fernandes, M Berk, S Dodd, D Medeiros, M Pedrini, M Kunz, F Gomes, L Giglio, M Lobato, P Belmonte-de-Abreu, C Gama

(2009), Vol. 70, pp. 1416-1423, Journal of clinical psychiatry, Memphis, Tenn., C1-1

The management of individuals with bipolar disorder : a review of the evidence and its integration into clinical practice

G Malhi, D Adams, C Cahill, S Dodd, M Berk

(2009), Vol. 69, pp. 2063-2101, Drugs, London, England, C1-1

Clinical practice recommendations for depression

G Malhi, D Adams, R Porter, A Wignall, L Lampe, N O'Connor, M Paton, L Newton, G Walter, A Taylor, M Berk, R Mulder

(2009), Vol. 119, pp. 8-26, Acta psychiatrica Scandinavica, London, Eng., C1-1

Are illness perceptions about coronary artery disease predictive of depression and quality of life outcomes?

L Stafford, M Berk, H Jackson

(2009), Vol. 66, pp. 211-220, Journal of psychosomatic research, Amsterdam, The Netherlands, C1-1

Medial temporal lobe glutathione concentration in first episode psychosis : a 1H-MRS investigation

S Wood, G Berger, R Wellard, T Proffitt, M McConchie, M Berk, P McGorry, C Pantelis

(2009), Vol. 33, pp. 354-357, Neurobiology of disease, Amsterdam, The Netherlands, C1-1

Is lithium in a class of its own? A brief profile of its clinical use

G Malhi, D Adams, M Berk

(2009), Vol. 43, pp. 1096-1104, Australian and New Zealand journal of psychiatry, London, Eng., C1-1

Medicating mood with maintenance in mind : bipolar depression pharmacotherapy

G Malhi, D Adams, M Berk

(2009), Vol. 11, pp. 55-76, Bipolar disorders, London, Eng., C1-1

The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

M Tohen, E Frank, C Bowden, F Colom, S Ghaemi, L Yatham, G Malhi, J Calabrese, W Nolen, E Vieta, F Kapczinski, G Goodwin, T Suppes, G Sachs, K Chengappa, H Grunze, P Mitchell, S Kanba, M Berk

(2009), Vol. 11, pp. 453-473, Bipolar disorders, London, Eng., C1-1

Clinical practice recommendations for bipolar disorder

G Malhi, D Adams, L Lampe, M Paton, N O'Connor, L Newton, G Walter, A Taylor, R Porter, R Mulder, M Berk

(2009), Vol. 119, pp. 27-46, Acta psychiatrica Scandinavica, London, Eng., C1-1

The potential use of biomarkers as an adjunctive tool for staging bipolar disorder

F Kapczinski, V Dias, M Kauer-Sant'Anna, E Brietzke, G Vazquez, E Vieta, M Berk

(2009), Vol. 33, pp. 1366-1371, Progress in neuro-psychopharmacology and biological psychiatry, Amsterdam, The Netherlands, C1-1

Neuroprogression: pathways to progressive brain changes in bipolar disorder

M Berk

(2009), Vol. 12, pp. 441-445, International journal of neuropsychopharmacology, Cambridge, Eng., C1-1

Clinical implications of a staging model for bipolar disorders

F Kapczinski, V Dias, M Kauer-Sant'Anna, B Frey, R Grassi-Oliveira, F Colom, M Berk

(2009), Vol. 9, pp. 957-966, Expert review of neurotherapeutics, London, Eng., C1-1

Intervention in individuals at ultra-high risk for psychosis: a review and future directions

P McGorry, B Nelson, G Amminger, A Bechdolf, S Francey, G Berger, A Riecher-Rössler, J Klosterkötter, S Ruhrmann, F Schultze-Lutter, M Nordentoft, I Hickie, P McGuire, M Berk, E Chen, M Keshavan, A Yung

(2009), Vol. 70, pp. 1206-1212, Journal of clinical psychiatry, Memphis, Tenn., C1-1

Cognitive-personality style as vulnerability to depression in patients with coronary artery disease: roles of sociotropy and autonomy

L Stafford, H Jackson, M Berk

(2009), Vol. 71, pp. 63-69, Psychosomatic medicine, Philadelphia, Pa., C1-1

Improved stress response in bipolar affective disorder with adjunctive spironolactone (mineralocorticoid receptor antagonist): case series

M Juruena, C Gama, M Berk, P Belmonte-de-Abreu

(2009), Vol. 23, pp. 985-987, Journal of psychopharmacology, Thousand Oaks, Calif., C1-1

The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments

F Ng, O Mammen, I Wilting, G Sachs, I Ferrier, F Cassidy, S Beaulieu, L Yatham, M Berk

(2009), Vol. 11, pp. 559-595, Bipolar disorders, London, Eng., C1-1

The elephant on the couch: side-effects of psychotherapy

M Berk, G Parker

(2009), Vol. 43, pp. 787-794, Australian and New Zealand journal of psychiatry, London, Eng., C1-1

Levels of neuregulin 1 and 3 proteins in Brodmann's area 46 from subjects with schizophrenia and bipolar disorder

S Boer, M Berk, B Dean

(2009), Vol. 466, pp. 27-29, Neuroscience letters, Shannon, Ireland, C1-1

Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis

F Benazzi, M Berk, M Frye, W Wang, A Barraco, M Tohen

(2009), Vol. 70, pp. 1424-1431, Journal of clinical psychiatry, Memphis, Tenn., C1-1

Differences between subjective and objective assessments of the utility of electroconvulsive therapy in patients with bipolar and unipolar depression

K Hallam, D Smith, M Berk

(2009), Vol. 112, pp. 212-218, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Predominant previous polarity as an outcome predictor in a controlled treatment trial for depression in bipolar I disorder patients

E Vieta, M Berk, W Wang, F Colom, M Tohen, R Baldessarini

(2009), Vol. 119, pp. 22-27, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

A critical update on psychological interventions for bipolar disorders

E Vieta, I Pacchiarotti, M Valentí, M Berk, J Scott, F Colom

(2009), Vol. 11, pp. 494-502, Current psychiatry reports, [Philadelphia, Pa.], C1-1

Family intervention for suicide prevention: a specialized emergency department intervention for suicidal youths

J Asarnow, M Berk, L Baraff

(2009), Vol. 40, pp. 118-125, Professional psychology: research and practice, [Washington, D.C.], C1-1

Clinical practice recommendations for depression

G Malhi, D Adams, R Porter, A Wignall, L Lampe, N O'Connor, M Paton, L Newton, G Walter, A Taylor, M Berk, R Mulder

(2009), Vol. 119, pp. 8-26, Acta psychiatrica Scandinavica, Chichester, Eng., C1-1

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania

Heinz Grunze, Eduard Vieta, Guy Goodwin, Charles Bowden, Rasmus Licht, Hans-Jurgen Moller, Siegfried Kasper, H Akiskal, J Ayuso-Gutierrez, M Bauer, P Bech, Michael Berk, I Bitter, G Burrows, J Calabrese, G Cassano, M Cetkovich-Bakmas, J Cookson, I Ferrier, W Gattaz, F Goodwin, G Heinze, T Higuchi, R Hirschfeld, C Hoeschl, E Holsboer-Trachsler, K Redfield Jamison, C Katona, M Keller, E Kostukova, H Kruger, P Kulhara, Y Lecruibier, V Larach

(2009), Vol. 10, pp. 85-116, World journal of biological psychiatry, Abingdon, Eng., C1-1

A descriptive interview with 64 patients discharged from an acute-psyciatric-inpatient service

T Callaly, S Dodd, D Goodman, Y Asgari, M Berk

(2008), Vol. 14, pp. 990-995, Journal of evaluation in clinical practice, Oxford, England, C1-1

Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample

M Berk, F Jacka, L Williams, F Ng, S Dodd, J Pasco

(2008), Vol. 42, pp. 874-878, Australian and New Zealand journal of psychiatry, Abingdon, England, C1-1

Serum levels of brain-derived neurotrophic factor in schizophrenia on a hypocaloric diet

L Guimarães, F Jacka, C Gama, M Berk, C Leitão-Azevedo, M Belmonte de Abreu, M Lobato, A Andreazza, K Ceresér, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 32, pp. 1595-1598, Progress in neuro-psychopharmacology & biological psychiatry, Amsterdam, The Netherlands, C1-1

Brain-derived neurotrophic factor: a modifiable common mediator in both the pathophysiology of psychiatric illness and in successful pharmacological treatments

F Jacka, C Gama, M Berk

(2008), Vol. 20, pp. 223-225, Acta neuropsychiatrica, Oxford, England, C1-1

Leptin in depressed women : Cross-sectional and longitudinal data from an epidemiologic study

J Pasco, F Jacka, L Williams, M Henry, G Nicholson, M Kotowicz, M Berk

(2008), Vol. 107, pp. 221-225, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Tobacco smoking as a risk factor for major depressive disorder : a population-based study

J Pasco, L Williams, F Jacka, F Ng, M Henry, G Nicholson, M Kotowicz, M Berk

(2008), Vol. 193, pp. 322-326, British journal of psychiatry, London, England, C1-1

Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression

L Williams, M Henry, M Berk, S Dodd, F Jacka, M Kotowicz, G Nicholson, J Pasco

(2008), Vol. 23, pp. 84-87, International clinical psychopharmacology, Philadelphia, Pa., C1-1

N-acetyl cysteine for depressive symptoms in bipolar disorder - a double blind, randomized, placebo-controlled trial

M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, A Bush

(2008), Vol. 64, pp. 468-475, Biological psychiatry, Philadelphia, Pa., C1-1

N-Acetyl cysteine as a glutathione precursor for schizophrenia : a double blind, randomized, placebo-controlled trial

M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush

(2008), Vol. 64, pp. 361-368, Biological psychiatry, Philadelphia, Pa., C1-1

Glutathione : a novel treatment target in psychiatry

M Berk, F Ng, O Dean, S Dodd, A Bush

(2008), Vol. 29, pp. 346-351, Trends in pharmacological sciences, London, England, C1-1

Oxidative stress in psychiatric disorders : evidence base and therapeutic implications

F Ng, M Berk, O Dean, A Bush

(2008), Vol. 11, pp. 851-876, International journal of neuropsychopharmacology, Cambridge, England, C1-1

N-acetylcysteine for antioxidant therapy : pharmacology and clinical utility

S Dodd, O Dean, D Copolov, G Malhi, M Berk

(2008), Vol. 8, pp. 1955-1962, Expert opinion on biological therapy, London, England, C1-1

Small shifts in diurnal rhythms are associated with an increase in suicide : the effect of daylight saving

M Berk, S Dodd, K Hallam, L Berk, J Gleeson, M Henry

(2008), Vol. 6, pp. 22-25, Sleep and biological rhythms, Wiley-Blackwell Publishing Asia, C1-1

The validity of the CGI severity and improvement scales as measures of clinical effectiveness suitable for routine clinical use

M Berk, F Ng, S Dodd, T Callaly, S Campbell, M Bernardo, T Trauer

(2008), Vol. 14, pp. 979-983, Journal of evaluation of clinical practice, Oxford, England, C1-1

Going up in smoke : tobacco smoking is associated with worse treatment outcomes in mania

M Berk, F Ng, W Wang, M Tohen, D Lubman, E Vieta, S Dodd

(2008), Vol. 110, pp. 126-134, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Olanzapine / fluoxetine combination for treatment resistant depression : efficacy and clinical utility

S Dodd, M Berk

(2008), Vol. 8, pp. 1299-1306, Expert review of neurotherapeutics, London, England, C1-1

Duloxetine for major depression

S Dodd, M Berk

(2008), Vol. 9, pp. 65-66, Medicine today, Neutral Bay, N.S.W., C1-1

The bipolar comprehensive outcomes study (BCOS) : baseline findings of an Australian cohort study

J Kulkarni, M Berk, P Fitzgerald, A de Castella, W Montgomery, K Kelin, A Brnabic, R Granger, S Dodd

(2008), Vol. 107, pp. 135-144, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Depressive disorders and bone mineral density in a community based sample of premenopausal women

L Williams, J Pasco, F Jacka, S Dodd, G Nicholson, M Berk

(2008), Vol. 107, pp. 96-97, Journal of affective disorders, Amsterdam, The Netherlands, C1-1

Illness beliefs about heart disease and adherence to secondary prevention regimens

L Stafford, H Jackson, M Berk

(2008), Vol. 70, pp. 942-948, Psychosomatic Medicine, Philadelphia, Pa., C1-1

Major psychoses with mixed psychotic and mood symptoms: are mixed psychoses associated with different neurobiological markers?

E Bora, M Yucel, A Fornito, M Berk, C Pantelis

(2008), Vol. 118, pp. 172-187, Acta Psychiatrica Scandinavica, Hoboken, N.J., C1-1

Decreased serum neurotrophin 3 in chronically medicated schizophrenic males

H Vargas, C Gama, A Andreazza, D Medeiros, L Stertz, G Fries, J Palha, K Cereser, M Berk, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 440, pp. 197-201, Neuroscience Letters, Shannon, Clare Ireland, C1-1

N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial

M Berk, D Copolov, O Dean, K Lu, S Jeavons, I Schapkaitz, M Anderson-Hunt, F Judd, F Katz, P Katz, S Ording-Jespersen, J Little, P Conus, M Cuenod, K Do, A Bush

(2008), Vol. 64, pp. 361-368, Biological Psychiatry, Philadelphia, Pa., C1-1

The empirical redefinition of the psychometric criteria for remission in bipolar disorder

M Berk, F Ng, W Wang, J Calabrese, P Mitchell, G Malhi, M Tohen

(2008), Vol. 106, pp. 153-158, Journal of Affective Disorders, Amsterdam, The Netherlands, C1-1

Pure and mixed manic subtypes: A review of diagnostic classification and validation

F Cassidy, L Yatham, M Berk, P Grof

(2008), Vol. 10, pp. 131-143, Bipolar Disorders, Denmark, C1-1

Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression

G Malhi, F Ng, M Berk

(2008), Vol. 42, pp. 346-349, Australian & New Zealand Journal of Psychiatry, London, Eng., C1-1

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

M Kunz, C Gama, A Andreazza, M Salvador, K Ceresér, F Gomes, P Belmonte-de-Abreu, M Berk, F Kapczinski

(2008), Vol. 32, pp. 1677-1681, Progress in Neuro-Psychopharmacology & Biological Psychiatry, Philadelphia, Pa., C1-1

Serum levels of brain-derived neurotrophic factor and thiobarbituric acid reactive substances in chronically medicated schizophrenic patients: a positive correlation

C Gama, M Berk, A Andreazza, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 30, pp. 337-340, Revista Brasileira de Psiquiatria, Sao Paulo, Brazil, C1-1

Effect of chronic N-acetyl cysteine administration on oxidative status in the presence and absence of induced oxidative stress in rat striatum

B Harvey, C Joubert, J du Preez, M Berk

(2008), Vol. 33, pp. 508-517, Neurochemical Research, New York, N.Y., C1-1

Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients

S Lavoie, M Murray, P Deppen, M Knyazeva, M Berk, O Boulat, P Bovet, A Bush, P Conus, D Copolov, E Fornari, R Meuli, A Solida, P Vianin, M Cuénod, T Buclin, K Do

(2008), Vol. 33, pp. 2187-2199, Neuropsychopharmacology, London, Eng., C1-1

Tobacco smoking as a risk factor for major depressive disorder: population-based study

J Pasco, L Williams, F Jacka, F Ng, M Henry, G Nicholson, M Kotowicz, M Berk

(2008), Vol. 193, pp. 322-326, British Journal of Psychiatry, London, Eng., C1-1

Elevated serum thiobarbituric acid reactive substances in clinically symptomatic schizophrenic males

C Gama, M Salvador, A Andreazza, M Lobato, M Berk, F Kapczinski, P Belmonte-de-Abreu

(2008), Vol. 433, pp. 270-273, Neuroscience Letters, Shannon, Clare Ireland, C1-1

The proximal prodrome to first episode mania--a new target for early intervention

P Conus, J Ward, K Hallam, N Lucas, C Macneil, P McGorry, M Berk

(2008), Vol. 10, pp. 555-565, Bipolar Disorders, Hoboken, N.J., C1-1

A functional MRI study of Theory of Mind in euthymic bipolar disorder patients

G Malhi, J Lagopoulos, P Das, K Moss, M Berk, C Coulston

(2008), Vol. 10, pp. 943-956, Bipolar Disorders, Hoboken, N.J., C1-1

Effects of a walking program in the psychiatric in-patient treatment setting: a cohort study.

F Ng, S Dodd, F Jacka, E Leslie, M Berk

(2007), Vol. 18, pp. 39-42, Health promotion journal of Australia, West Perth, W.A., C1

The bipolar depression rating scale (BDRS) : its development, validation and utility

M Berk, G Malhi, C Cahill, A Carman, D Hadzi-Pavlovic, M Hawkins, M Tohen, P Mitchell

(2007), Vol. 9, pp. 571-579, Bipolar disorders, Copenhagen, Denmark, C1-1

Vitamin D deficiency may play a role in depression

M Berk, K Sanders, J Pasco, F Jacka, L Williams, A Hayles, S Dodd

(2007), Vol. 69, pp. 1316-1319, Medical hypotheses, Amsterdam, The Netherlands, C1-1

Depression and bone mineral density in a community sample of men : Geelong Osteoporosis Study

F Jacka, J Pasco, M Henry, S Korn, L Williams, M Kotowicz, G Nicholson, M Berk

(2007), Vol. 4, pp. 292-297, Journal of men's health & gender, Amsterdam, The Netherlands, C1-1

Self-reported depression and cardiovascular risk factors in a community sample of women

F Jacka, J Pasco, S McConnell, L Williams, M Kotowicz, G Nicholson, M Berk

(2007), Vol. 48, pp. 54-59, Psychosomatics, Amsterdam, The Netherlands, C1-1

Food for thought

F Jacka, M Berk

(2007), Vol. 19, pp. 321-323, Acta neuropsychiatrica, Oxford, England, C1-1

Setting the stage : from prodrome to treatment resistance in bipolar disorder

M Berk, P Conus, N Lucas, K Hallam, G Malhi, S Dodd, L Yatham, A Yung, P McGorry

(2007), Vol. 9, pp. 671-678, Bipolar disorders, Copenhagen, Denmark, C1-1

History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder